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CHAPTER 1 
INTRODUCTION 

CHAPTER l 
INTRODUCTION 
Now that so many therapeutic modalities have become available, the 
identification of 'excess risk' in established coronary artery disease is 
an important step in secondary prevention in cardiology, in particular in 
patients after a recent myocardial infarction. Risk is here defined as the 
probability of mortality in the individual patient during a given period 
of time - and depends on different prognostic factors. The probability of 
mortality has to be derived from the relative frequencies of death in 
groups of patients observed in follow up studies, where the analysis 
focusses on relating the outcome to prognostic variables by means of 
statistical models. For economical reasons this risk identification should 
be carried out in the most 'efficient' way. The most 'efficient' way is 
defined here as the greatest information at the lowest possible cost. In 
fact, cost containment has become an important issue in cardiology in the 
l past decade , a period where we have witnessed a rapid increase of the 
armamentarium available to the cardiologist for the evaluation of cardiac 
function. Non-invasive as well as invasive methods, such as echocardio-
graphy, radionuclide studies, electrophysiological studies, exercise tests 
and coronary angiography, all have proven to have some prognostic value in 
post-infarct patients. However, important questions remain: which of these 
tests are the most predictive? Do we need all of them in every patient? Do 
they provide relevant additional information for clinical management 
beyond that of usual routine clinical and laboratory findings such as 
demographic data, clinical history, physical examination, blood samples, 
12-lead electrocardiogram and chest X-ray which are routinely available 
for all patients? 
So far, few studies have addressed this problem in a sizable population of 
post-infarction patients studied at discharge with each of these test 
modalities2 . 
The need to identify individuals with increased as well as neglibible 
risk of mortality requires the following: 
1. Optimal patient evaluation with the minimal number of tests, pre-
ferably of the non-invasive and low cost type; 
2. Reassurance of those patients at low risk and "discharge" from the 
13 
system; 
3. Risk modifications in patients with high and intermediate risk indi-
cators by timely and appropriate intervention; 
While the first two points can be achieved relatively easily, the third 
point is much more difficult. Can something be done to reduce the risk in 
patients with high and intermediate risk, once they are so identified? The 
answer must be positive since in the last few years, many large trials 
with drugs or mechanical interventions, such as coronary artery bypass 
surgery, have shown improved survival. Some secondary prevention trials, 
with different drugs, have shown mixed results3 ' 4 . Trials with anti-
arrhythmics5'6 anticoagulants?-ll and, with some exceptions, aspirinlZ-lG 
. 17-19 
and sulfl.lpyrazone , have failed to reduce the mortality rate after 
myocardial infarction in a significant manner. 
In contrast it has been shown in numerous studies with beta-blockers, 
that they reduce cardiac mortality after myocardial infarction signifi-
cantly3. In particular, the Beta Blocker Heart Attack Trial (BHAT) 20 , and 
the MIAMI trial21 suggested that beta-blockers provided higher mortality 
reduction in the patients at highest risk, that is in those patients with 
most evidence of left ventricular dysfunction, while in the lowest risk 
groups, no major benefit could be demonstrated. 
These data suggest that, while many physicians in practice treat with 
beta blockers low risk patients who will be unlikely to benefit in term of 
reduced mortality, it is the high risk patient who should to be treated 
with beta blockers, unless overt clinical signs or symptoms of left 
ventricular dysfunction provide a contraindication. Again, therefore a 
need to stratify. 
Coronary revascularisation by coronary artery bypass grafting22 , 23 and, 
more recently percutaneous transluminal coronary angioplasty24 , have been 
shown to improve the prognosis of some subsets of postinfarct patients and 
this is another reason to classify patients after myocardial infarction 
appropriately. In 
coronary 
a recent article, Julian 
artery surgical trials23 , 
reviewed the three most im-
portant 
25 Study , the European Coronary Artery 
the Veteran Administration 
8 Surgery Study and the Coronary 
22 23 Artery Surgery Study • He concluded that "we can be reasonably con-
fident that surgery improves prognosis in certain groups of patients with 
ischemic heart disease. The ones most likely to benefit are those with 
disease of the left main coronary artery and those with three vessel 
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disease or two vessel disease in which the proximal left anterior des-
cending coronary artery is involved. Arteriography alone, however, pro-
vides an inadequate guide to prognosis, as it seems that surgery is most 
helpful when such anatomical features are accompanied by evidence of left 
ventricular dysfunction at rest or on exercise". He finally points out 
that, limited to patients with angina, "physicians should consider the 
possible effect of surgery on prognosis. In doing so, they should take 
into account symptoms and non-invasive indexes of left ventricular func-
tion, particular the response to exercise. If these features indicate a 
substantially worsened prognosis, coronary arteriography should be under-
taken if the surgical approach seems a reasonable option". However, the 
large coronary artery surgery trials include a different population than 
that of the present study, which only consists of post-infarction patients 
evaluated at hospital discharge. Therefore, it is uncertain if the results 
of such trials completely apply to such a group, although the problem of 
residual ischemia is identical. 
The development of coronary angioplasty in the last few years has 
provided a new and powerful tool for treatment for patients with coronary 
artery disease, which has been applied with success also in post-infarct 
patients with post-infarct angina26 . Its impact on relief of stable angina 
pectoris is already well established. The potential for improving prog-
nosis by this technique appears promising but has not yet been proven. 
All these observations underscore the importance of the non invasive, 
identification of the high-risk individuals. A clear protocol for those 
who should be referred for invasive evaluation is particularly important 
for the physician in district hospital who does not have immediate access 
to coronary arteriography. 
Patient population and methods 
In order to answer the questions posed earlier, we established a com-
puterized data base which included the data obtained during hospitali-
zation of 706 consecutive patients with a proven acute myocardial in-
farction, who had been admitted to the coronary care unit of the Thorax-
center between March 1981 and December 1983. At hospital discharge all 
patients underwent symptom limited bicycle ergometry, unless contra-
indicated. Five hundred and twenty patients also underwent resting radio-
nuclide ventriculography and 24-hour ambulatory electrocardiographic 
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monitoring was performed in 389 patients. The latter two tests were not 
completed in all patients for organizational reasons~ especially in the 
first year of the study and, in a few cases~ because of refusal of the 
patients. We chose these three tests because they provide information on 
left ventricular function~ myocardial ischemia and ventricular arrhyth-
mias~ and they allow quantification of the response to the tests. 
Radionuclide ventriculography was chosen for the assessment of left 
ventricular function since it provides quantitative information of left 
ventricular ejection fraction in virtually all patients. Echocardiography 
provides in principle similar information, however quantification is 
possible in a lower percentage patients, of about 75%. For this reason 
echocardiography was not used in this study. After discharge, patients 
were followed for one year, mostly by regular out-patient visits. Only 6 
patients were lost to follow-up. This data base therefore has been created 
prospectively and encompasses the complete spectrum of patients admitted 
to the Thoraxcenter with acute myocardial infarction over several years. 
The data base includes demographic and routine clinical variables col-
lected during the different phases of hospitalization, variables from 
bicycle ergometry, variables from radionuclide ventriculography to include 
global left ventricular function and regional wall motion, variables from 
24-hour ambulatory electrocardiographic monitoring and variables regarding 
follow-up (appendix A). Ten variables regarding left ventriculography and 
coronary angiography were also collected in those patient.s who underwent 
cardiac catheterizat.ion, even t.hough cardiac catheterization was not the 
main part of this study. 
Even if the primary aim of this study was that of finding the most 
'efficient' procedure based on clinical and non-invasive tests for risk 
assessment, such a large and rather complete data base, allowed ancillary 
questions to be answered which arose while the study was underway. In fact 
we realized that one advantage of such a data base is that, if it is 
properly designed and maintained, one is not confronted with the need for 
creating a separate data collection and analysis system whenever a new 
problem or question is encountered. 
An analysis of these results has been performed for the complete group 
of 706 patients in 2 of the reported studies (chapter 3 and 4), while the 
other chapters refer to the patient data collected during the first two 
years of the study, to include subsets of patients, as summarized in table 
l. Actually, other reports have been published with even smaller numbers 
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Table 1: PATlf.NT POPULATION INCLUDED IN THE DIFFERENT STUDIES. 
CIIAPTER ENTRY PERIOD 
2 March '81 -Dec, '82 
3 March '81 - Dec, 1 83 
4 March '81 -Dec, 1 83 
5 Narch '81 -Dec, '82 
6 March '81 -Dec, '82 
7 March '81 -Dec, '82 
CCU ADMISSIONS 
with AMI 
529 
706 
706 
529 
529 
529 
NUMBER OF 
PATIENTS 
405 
449 
474 
266 
119 
68 
PREDICTORS STUDIED 
- clinical variables 
- bicycle ergometry 
- clinical variables 
- bicycle ergometry 
- radionuclide ventriculography 
- 24-h EGG monitoring 
- clinical variables 
- 12-lead ECG 
- peak serum CPK (in first 
infarction) 
- clinical variables 
- bl~ycle ergometry after a 
first uncomplicated infarction. 
- early post infarct angina: 
coronary artery bypass surgery 
v~rsus medical therapy. 
Abbreviatl.ons: AMI: acute myocardial infarction; EGG: electrocardiography; 
CCU: coronary care unit; CPK: creatine phosphokinase; 
~ 24-h ECG: 24 hour ambulatory electrocardiographic monitoring. 
~ 
of patients. They are not part of this thesis, but for completeness sake 
we report the abstracts of four of these in the appendix B. The role of 
table 1 is to demonstrate that the subsets of patients in the different 
studies are part of the total data base and can be considered to be 
representative. 
Specific aim of the study 
This study is a description of the follow up during the first year of 
706 consecutive patients admitted at from the coronary care unit of the 
Thoraxcenter with a proven diagnosis of acute myocardial infarction 
between March 1981 and December 1983. 
The main aim, outlined in this chapter, was to assess the relative 
value of the usual clinical variables compared to that of multiple non-
invasive tests at discharge to predict survival after hospital discharge • 
In chapter 2 we addressed the problem of comparing clinical variables 
and predischarge bicycle ergometry results to predict mortality and other 
non-fatal events during follow up. Patients judged non eligible for stress 
test were separately analyzed. 
In chapter 3 we assessed the relative merits of clinical data, bicycle 
ergomet.ry, radionuclide ventriculography and 24-hour ambulatory electro-
cardiographic monitoring to predict one year survival. 
Since the 12-lead electrocardiogram is always performed at discharge 
and since there has recently been renewed interest in the prognostic value 
of the electrocardiogram in post-infarction patients, we studied in 
chapter 4 the prognostic value of different variables derived from the 
electrocardiogram. In particular the risk estimation compared to that 
obtained from other clinical variables was analyzed. 
In chapter 5 the follow up is described during the first year of 
patients with a first myocardial infarction, in terms of their peak serum 
creatine phosphokinase. The rationale for that analysis was to test 
whether patients with a small initial infarct were subject to more or 
fewer ischemic events during follow-up, compared to those with interme-
diate or large size infarctions. 
The prognosis of patients below 60 years who survived the hospital 
phase of a first myocardial infarction with an uncomplicated clinical 
course, was investigated in Chapter 6. Here the role of exercise testing 
in guiding the decision to proceed with coronary angiography formed the 
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main study object. 
In chapter 7 a description is given of the clinical course of 34 
patients who underwent coronary artery bypass surgery before hospital 
discharge, mostly because of "early" post-infarction angina. Their 
sequential events were compared to those of all other post-infarction 
patients and also with a subset retrospectively matched on the basis of 
demographic, clinical, ventriculographic and coronary angiographic data. 
The study was undertaken to assess the risk of coronary artery bypass 
surgery in the 'early' post-infarction patients with that of a similar 
group of patients treated medically. 
In chapter 8 the recommendations are summarized for the assessment of 
post-infarct patients at hospital discharge, based on the results of these 
data and in the current experience in our hospital. 
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PREDICTION OF MORTALITY DURING THE FIRST YEAR AFTER 
ACUTE MYOCARDIAL INFARCTION FROM CLINICAL VARIABLES 
AND STRESS TEST AT HOSPITAL DISCHARGE. 
By 
Paolo Fioretti, MD, R.W. Brower*, Maarten L. Simoons, MD, Robert J. Bos, 
MD, Taco Baardman BSc, Anita Beelen BSc, and Paul G. Hugenholtz. 
From the Thoraxcenter, Erasmus University, Rotterdam, and *the Interuniversity 
Cardiology Institute, Rotterdam, theN etherlands. 
Am J Cardio!l985, 55: 1313-!318. 

Prediction of Mortality During the First Year After Acute 
Myocardial infarction from Clinical Variables 
and Stress Test at Hospital Discharge 
PAOLO FIORETTI, MD, R. W. BROWER, PhD, MAARTEN l. SIMOONS, MD. 
ROBERT J. BOS, MD, TACO BAARDMAN, SSe, ANITA BEELEN, SSe, 
and PAUL G. HUGENHOLTZ, MD 
The predictive value of a predischarge symptom-
limited stress test was studied in 405 consecutive 
survivors of acute myocardial infarction (AMI). 
Three hundred patients performed bicycle er-
gometry; 105 could not perform it. Among these 
latter 1 OS patients, the stress test was contraindi-
cated in 43 because of angina or heart failure and 
in 62 because of noncardiac limitations. One-year 
survival was 44% in the "cardiac-limited" group (19 
of 43) and 92% in the "non-cardiac-limited" group 
(57 of 62). One-year survival among the patients 
who performed an exercise test at discharge was 
93% (280 out of 300). The best stress test predictor 
of mortality by univariate analysis was the extent of 
blood pressure (BP) increase: 42 ± 24 mm Hg in 
Predischarge stress testing of hospital survivors of acute 
myocardial infarction (AMI) has become a routine 
procedure.1-3 The stress test is considered a useful ex-
amination to individualize medication, specify subse-
quent activity programs4 and to establish the progno-
sis. &.6 However. only few studies have been designed to 
assess whether the stress test provides additional in-
formation independent of clinical data alone.W. Fur-
thermore, little attention has been given to the defini-
tion of the baseline characteristics and the follow-up of 
patients who cannot perform the bicycle ergometry test. 
This prospective study assesses whether the test pro-
vides additional information beyond clinical data alone 
From the Thoraxcenter. Erasmus University and University Hospital 
Dljkzlgt. Rotterdam. and the Interuniversity Cardiology Institute. Rot-
terdam. The Netherlands. Manuscript received September 25, 1984; 
revised matluscrlpt received January 30. 1985. accepted February 1. 
t985. 
Address for reprints: Paolo Fioretti. MD. Thoraxcenter. Erasmus 
University. Dr. Molewatorpleln 40. 3015 GO Rotterdam. The Nether-
lands. 
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280 survivors vs 21 ± 14 mm Hg in 20 nonsurvivors 
(p <0.001). Among the 212 patients in whom BP 
increased 30 mm Hg or more, mortality was3% (n 
= 6), while it was 16% (n = 14) among the 88 pa-
tients in whom BP increased less than 30 mm Hg. 
Angina, ST changes and arrhythmias were not as 
predictive. Stepwise discriminant function analysis 
showed inadequate BP increase to be an indepen-
dent predictor of mortality. A high-risk group can be 
identified at discharge on clinical grounds in patients 
unable to perform a stress test, whereas interme-
diate- and low-risk groups can be identified by the 
extent of BP increase during exercise. 
(Am J Cardiol1985;55:1313-1318) 
in the prediction of mortality and other cardiac events 
during the first year. 
Methods 
We analyzed the records of 529 consecutive patients ad-
mitted to the coronary care unit of the Thornxcenter between 
March 1, 1981. D.Ild December 31. 1983. with a dia@osis of 
AMI before their discharge. Diagnosis of AMI was bused on 
at least 2 of the following criteria: (1) Typical prolonged chest 
pnin at least 45 minutes in duration. (2) In transmural AMI. 
dynamic electrocardiographic changes such as evolving Q 
waves longer than 0.04 second with ST and T changes or in 
nonttrulllmural AMI. T -wave inversion or ST depression 
persisting-for at least 24 hours without new Q waves. Site was 
classified as undetermined in the case of complete left bundle 
branch block. (3) Typical increase nnd decrease of total serum 
creatine kinase level with a peak level of more than 100 IU/ 
liter (twice the upper limit of normal values in this laboratory). 
Previous AMI was diagnosed by a hb"i.ory of AMI or diagnostic 
Q-wave abnormalities. During their hospital staY 72 patients 
died. Thirty-two patients underwent coronary artery bypass 
grafting and 16 underwent percutaneow transluminal coro-
nary angioplasty before discharge for post-A:M:I angina re-
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1314 RISK STRATIFICATION AFlER MYOCAROIAL INFARCTION 
TABLE I Baseline Characteristics ol Patients PopulaUon, 
Subdivided According to Eligibility lOr Stress 
Testing 
No Stress Test 
No. of pts 
Age(yW 
Men(%) 
Previous AMI (%) 
Anterior AMI(%) 
Kl!!lp class I(%) 
Carolao 
Limitations 
"' 65±9 74 
56 
53 
23 
• Mean ± standard deviation. 
AMI = acute myocardial Infarction. 
Noncardlac 
Limitations 
62 
66± 10 
63 
26 
29 
68 
Stress Test 
Performed 
300 
54± 10 
54 
27 
36 
74 
fractory to medical therapy. FoUl' patients required surgery 
for mechanical myocardial dysfunction. 
To avoid a bias in interpretation of the results, these pa-
tients were excluded from the follow-up results. Of the re-
maining 405 patients participated in the study, 105 patients 
were judged ineligible for the test: 43 because of cardiac lim-
itations (7 with angina and 36 with persistent heart failW"e) 
and 62 for noncardiac limitations (9 with peripheral vascular 
disease, 7 with lung disease, 5 with cerebrovascular disease, 
5 with musculoskeletal disease, 22 with general disability and 
14 for other medical noncardiac limitations). Advanced age 
was not considered a contraindication for the stress test. Some 
clinical characteristics of OW' patients are given in Table I. The 
median hospital stay was 15 days (range 7 to 70). Medication 
usage at dischuxge is detailed in Table II. Metoprolol, 50 or 
100 mg twice daily, was given, when indicated, for angina or 
hypertension and also as a secondary preventive agent pro-
vided there were no contraindications or side effects..9 
Before discharge. on average 13 days after AMI, a symp-
tom-limited stress test with stepwise increments of10 W /min 
was performed on a bicycle ergometer in 300 patients. Three 
Frank leads were constantly recorded and analyzed by a 
computer system_l0 Blood pressW"e (BP) was measured every 
2 minutes during exercise and during the recovery phase. The 
clinicnlly prescribed medication was not discontinued before 
the test. 
One hundred forty-five patients also underwent coronary 
angiography at discharge, 49 electively and 96 because of a 
study protocol, including patients in cardiogenic shock and 
those included in an ongoing randomized trial with intrn.co-
ronary streptokinase.U After hospital discharge all patients 
were followed for 1 year by regular outpatient visits. 
Statistical analysis: Univariate analysis with unpaired 
Student t test for continuous variables and cbi-sqWJie or 
Fisher's exact test, were applied when appropriate, for the 
discrete variables. To compare and visualize the predictive 
value for mortality of different continuous variables. we used 
receiver-operator characteristics curves (ROC curves), In 
these curves, sensitivity vs specificity of a test are plotted, 
where sensitivity is a frnction of positive classification for all 
patients who satisfy the endpoint criteria and specificity is the 
fraction of all negative classifications for all patients who 
satisfy the non-endpoint criteria. These curves. when gener-
ated for different tests. provide a direct comparison of their 
results over the entire range of measUI"ements. 
In patients eligible for stress testing, the B:MPD statistical 
package for stepwise discrimini:IDt analysis (P7M) was used 
to generate classification functions for 3 cl&;ses of information: 
clinical data only. exercise stress test data only. and clinical 
data and exercise stress test combined. The clinical variables 
consisted of age, sex, presence of a previous myocardial in-
24 
TABLE II Medication at Hospital DISCharge 
Olgllalls(%) 
Diuretics{%) 
Vasodl!atOI'S (%} 
/Jblockers{%1 
Antiarrhythmles (%) 
Anticoagulants(%) 
No Stress Test 
Carolao 
Um!tat!ons 
65 
76 
56 
16 
14 
5S 
Noncardlac Stress Test 
Limitations Performed 
27 
4S 
34 
27 
' 29 
16 
31 
29 
52 
3 
14 
farction. anterior location of the index infarction. the worst 
Killip class in the coronary care unit. angina pectoris present 
dW"ing the hospital stay, late sustained ventricular tachy-
cardia. persistence of congestive heart failW"e after the stay 
in the coronary care unit, cardiomegaly on discharge (car-
diothoracic ratio greater than SO'Yo), and indication for digoxin 
or diuretic drugs at discharge The exercise stress test variables 
included percent of predicted work capacity achieved, the 
workload achieved. angina pectoris present during the test. 
ventricular arrhythmias during the test. ST-segment de-
pression, ST elevation (:<=:.1 m.m), extent ofBP change during 
the test and maximal heart rate. The endpoint of major in-
terest was cardiac mortality during the follow-up period. In 
a first pass. stepup analysis was done using an F to enter of 1.0, 
which entered in the discriminant function all variables re-
motely related to the outcome. In the second pass, a stepdown 
analysis was performed on the selected subgroup of variables 
using an F to enter of 4.0. The discriminant functions resulting 
from the stepdown analysis were then used to predict the 
classification of the same group of patients for a range of 
threshold levels in the discriminant function resulting in the 
specificity-sensitivity plots (ROC curves). 
Results 
Follow-up results: Complete follow-up information 
was available in all 405 patients. Mter discharge 49 
patients (12%) died during the f'li'St year: 32 suddenly, 
'8 from a fatal reinfarction, 7 from progressive heart 
failure and 2 perioperatively after coronary artery by-
pass surgery. During the same period 18 patients (4%) 
had a nonfatal reinfarction; 33 underwent eleetive cor-
onary artery bypass surgery, 5 other cardiac surgery and 
5 percutaneous translu.minal coronary angioplasty. 
Prediction of mortality from clinical data in all 
patients: A comparison of medical history and clinical 
data between survivors and nonsurvivors is summarized 
in Table III. Univariate analysis indicates that late 
mortality was strongly associated with clinical variables 
that indicated a more advanced left ventricular dys-
function and less related to angina pectoris. The mor-
tality rate was highest (24 deaths [57%]) among the 43 
patients who could not perform the test because of 
cardiac limitations. The mortality rate among the 62 
patients who could not perform the test for other rea-
sons (5 deaths [8%}) was similar to that in 300 patients 
eligible for the test (20 deaths [7%]). The discriminant 
function analysis {Table N) resulted in 4 independent 
variables predictive of mortality. The strongest pre-
dictor was the noneligibility for stress testing because 
of cardiac limitations, followed by the use of digitalis on 
discharge, a history of a healed AMI and cardiomegaly 
on chest radiograph. 
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Prediction of mortality from stress test data by 
univariate analysis: The stress test results of survivors 
and nonsurvivors are represented in Table V. ST 
changes were not significantly associated with mortality. 
in contrast. the extent of BP increase was; it was twice 
as high in survivors as in nonsurvivors. The predictive 
value for mortality of several stress test results are 
represented in Figure 1 as ROC curves. The distribution 
of mortality in patients eligible and in those not eligible 
for stress testing is su.nuo.arized in Figure 2. The ROC 
curves in Figure 1 suggest that the most "advantageous'' 
cutoff point of BP increase, i.e., that with the highest 
sensitivity and specificity, is 30 mm Hg. In this way a 
subgroup of 212 patients was identified that had a very 
low risk (mortality 3%. n = 6) provided they had a BP 
increase of 30 m.m Hg or more (Fig. 2). 
Prediction of cardiac events in patients eligible 
for stress test from clinical data and stress test re-
sults, by multivariate analysis (Table IV): The 
discriminant function analysis using exclusively the 
clinical information described in the Methods section 
resulted in 2 independent variables predictive of mor-
tality at the 0.05level of significance: history of a healed 
AMI and the use of digitalis on discharge (65% correct 
classifications). Similarly, using exclusively the exercise 
stress test data. only the BP change (the absence of a 
sufficient increase in BP during testing) was associated 
with mortality at the 0.05 level of significance (64% 
correct classifications). Combining both clinical and 
exercise information in the analysis resulted in the in-
clusion of the 3 above-mentioned variables with 76% 
correct classifications. The results of the sensitivity-
specificity analysis with variable decision levels for 
classification are shown in Figure 3 and Table IV. When 
nonfatal reinfarction was added to mortality as the 
endpoint, the stress test lost its independent prognostic 
value relative to clinical information. However. stress 
test results appeared to have independent predictive 
value when other endpoints were added. such as late 
coronary artery bypass surgery. coronary angioplasty 
50 
~ 
" ~ oeok HR.bom 
20 
n;300 
0 
0 20 
" 
50 80 lOO 
SENSITIVITY,:::: 
FIGURE 1. Spl;lCiflclty vs sensitivity for late mortality of ex6fclse test-
Ing-derived data: maximal workload, peak heart rate (1-fl). peak systolic 
blood pressure (BP). systolic BP Increase. ST elevation (STf) and ST 
depression (ST~). 
TABLE Ill Differences In Historical and Clinical Data 
Collected During Hospital Stay Between Late 
Survivors and Nonsurvlvors 
p 
Survivors Nonsurvlvors Value 
No. of ptS 
Men(%) 
Age {yr)• 
Previous angina (%) 
Previous AMI (% J 
Anterior AMI{%} 
Peak CK, IU/lJter• 
Kllllp class Ill or IV(%) 
Late heart failure (%) 
Late vr orVF (%) 
Cardiomegaly (chest x-my) (%) 
Post-AMI angina {%) 
Discharged on digitalis (%) 
Discharged on diuretics(%) 
Discharged on {3 blockers(%) 
• Mean ±standard deviation. 
356 
80 
56± 11 
15 
25 
36 
583 ± 500 
6 
14 
4 
19 
15 
19 
34 
47 
49 
77 
62± 12 
" 65 
41 
586 ± 491 
26 
45 
12 
57 
" 67 
69 
22 
NS 
0.002 
NS 
0.001 
NS 
NS 
0.001 
0.001 
0.02 
0.001 
NS 
0.001 
0.001 
0.001 
AMI = acute myocardial Infarction: NS = not significant; VF = 
ventricular fibrillation; VT = ventrlCtJiar tachycardia 
and persistent congestive heart failure. ST depression 
during stress testing did not provide independent 
additional information for any of the endpoints 
considered. 
Dlscusslon 
Many studies have examined the prognostic value of 
predischarge stress testing after AMI.2 Only a few,6,7 
however. include a detailed description of patients not 
eligible for the test or have tried to determine whether 
stress testing provides independent prognostic infor· 
mation compared with clinical variables alone. In our 
study group. after exclusion of patients who underwent 
coronary artery bypass surgery or percutaneous tran-
sluminal angioplasty for unstable angina (10% of dis-
charge patients). 26% were judged not eligible for the 
stress testing (11% for cardiac and 15% fornoncardiac 
limitations). The percentage of patients not eligible for 
the test in our study is somewhat lower than that pre-
viously reported.6·7 Consistent with the f'mdings of 
Madsen and Gilpin6 and DeBusk et al,7 we also found 
a higher mortality in this group, which was further en-
hanced by subdividing the patients according to the 
contraindication (cardiac vs noncardiac). Patients with 
cardiac contraind.ications, usually heart failure, had a 
mortality rate of 57%. In contrast. the mortality rate of 
0 ounl¥oro (N•3Se) 
- non ounlvoro (N•4Q) 
FIGURE 2. lnclclence of mortality and exercise teSt (X-test) rosults. 8P 
= blood pressure. 
25 
"' 
"' ~ 
~ 
' ~ 
~ 
TABLE IV Predlcllon ol Cardiac Even!& During Follow-Up by Dlscrlmlnanl Funcllon Analysis ~ 
0 
z 
Patients Eligible for Stress Test > 
All Death or AMI Death or RMI or ~ 
" Patients Death Dt!<lth or AMI or CABG or PTCA CABG or PTCA or CHF < 
Death < 
c c X c+x c X c+x c X C+X c X C+X ~ 
" Clinical variables (F ratio) 
Previous AMI 24 31 27 13 13 14 16 11 10 ~ 
Killip class > Hl or IV 12 11 f ~~~~~~~~(~hest x-rays) 5 7 
'i8 Discharged on digitalis 25 ·s·3· 27 34 '34' 18 
" 
20 § Cardiac contralnd, for x-test 47 
X test variables {F ratio) 
BPrlse 14 5 5 8 20 9 
Max. workload 
Ventricular arrhythmias 
ST elevation 5 5 
't'i Angina 8 
No pat~nts 
Total 405 300 300 300 300 
El'ldpolnt 49 20 36 60 80 
Wm endpoint 358 280 264 240 220 
Predicti~e accuracy(%) 
Sensitivlty 69 90 70 85 72 59 72 63 63 65 65 65 65 
Specificity 93 63 63 75 84 57 84 65 66 75 67 61 75 
Pred. value positive 58 15 12 20 21 15 21 31 30 38 42 37 48 
Pred. value negative 96 99 97 98 94 91 
" 
8S 8S 90 
" 
83 8S 
Total COfrect classification 90 65 64 67 65 57 65 65 65 73 
" 
62 72 
High-risk group 
" 
40 38 28 40 45 40 40 40 32 41 46 35 
F ratio Is the relative Importance of each variable. C. X and C + X lmlicate lhatlha predlc11on of the events Is based on clinical Information (C), stress testing results (X) 
or both (C +X). 
Pred. value positive {negative)= predictive value of positive {nega1iva) test. Total correct classillca11on "'number of patients cOfrectly classified/total population. High 
risk group = number of patients with a positive testltotal population. 
AMI = acute myocardial infarction; BP = blood pressure; CABO = coronary artery byfrass grafting; CHF = congestive heart failure; contralnd. = contralndicallons; Max. 
= maximal; PTCA = percutaneous \fanslumlnal coronary angloplasty; AMI = nonfatal re nfarction. 
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patients not eligible for the test for noncardiac limita-
tions and those eligible for the test had a low risk (8% 
and 7%, respectively). During 1-year follow-up. 20 of the 
300 patients eligible for stress testing died. An adequate 
BP increase during exercise •.vas the best single predictor 
of mortality (Tables IV and V): this confirms our pre-
vious observations in a smaller group of 167 patients} 
We did not confirm the association between stress 
test-induced ST depression and late mortality or non-
fatal reinfarctions. contrary to previous findings.1.7.12 
This discrepancy may be a result of many factors, such 
as patient selection. different techniques of stress 
testing (different lead systems. bicycle ergometry vs 
treadmill) and treatment during follow-up. In partic-
ular. the prognostic significance of an ischemic response 
during stress testing may have been underestimated by 
coronary artery bypass surgery or coronary angioplasty 
performed during follow-up. In fact. these patients more 
frequently had stress test-induced angina (p <0.001) 
and ST depression (p <0.02) than patients treated 
medically. However study results have been reported 
that are consistent with our results and fail to show any 
predictive value of ST depression. but emphasize the 
stronger association between mortality and left ven-
tricular function.0·6.l3-l7 Factors such as maximal 
workload. the duration of exercise"'·., or the BP re-
sponse13·1·1 are good indicators ofleft ventricular func-
tion. Scardi et al14 found that a "hypertensive re-
sponse." i.e .. BP in excess of200/100 mm Hg. identified 
a low-risk subset of patients. 
Although the extent of BP increase is related to left 
ventricular function. there was no correlation with 
ejection fraction at rest. This is not surprising because 
left ventricular dysfunction can be often detected only 
during physical exertion. In this series. the 30 patients 
with 3-vessel di..o:;ea.~ had a smaller BP increase than the 
92 with less extensive coronary artery disease (26 ± 22 
vs 42 ± 23 mm Hg. p <0.001). An important finding of 
our study is that only 6 of 212 patients who had a BP 
increase of 30 mm Hg or more died. while none of the 
107 patients with a BP increase of more than 50 mm Hg 
died. This group of patients at very low risk should not 
be considered for special additional investigations. 
The use of !)-blocking drugs in 139 patients who 
performed stress testing could have affected the results 
of our study because of the blunting effect on the in-
crease in arterial pressure. The BP increase was only 
slightly lower in patients taking !)-blocking drugs (38 
± 22 vs 43 ± 25 mm Hg. p <0.04): however. the predic-
tive accuracy for mortality of a BP increase of 30 mm 
Hg or more was higher in patients not using !)-blocking 
drugs during the test (80% correct classifications com-
pared to 65% for the whole group of patients) (Table 
IV). Therefore. an inadequate BP increase when 
P-blocking therapy is not discontinued before the test 
should be interpreted with caution. 
The issue of whether stress testing yields prognostic 
information independent of routinely available clinical 
data is important and controversial.G-S When clinical 
variables and stress test results were combined. the 
predictive accuracy for late mortality was improved 
compared with each variable by itself (Fig. 3, Table IV). 
TABLE V Summary of Stress Test Results 
Survivors Nonsurvlvors p 
(n = 280) (n "' 20) Value 
Reasons for Interrupting the test 
Fatigue(%) 
Angina(%) 
Dyspnea(%) 
Pressure drop(%) 
Max. workload 0N) 
Rest heart rate (beats/min) 
Max. heart rate (003ts/mln) 
Rest BP (mm Hg) 
Max. BP (mm Hg) 
BP rlso (mm Hg) 
Angina pectoris{%) 
ST depression {%) 
Workload at ST depression (W) 
ST elevation{%) 
Ventricular ectopic activity(%) 
75 
6 
17 
2 
115±33 
81 ± t6 
132±23 
121 ± 16 
164± 29 
42±24 
20 
., 
83±43 
., 
20 
ST depression or elevation of 1 mm or more. 
65 
5 
20 
" 98 ± 24 
93±20 
142 ± 26 
122 ± 22 
144±24 
21 ± 15 
20 
40 
96±30 
60 
35 
NS 
NS 
NS 
NS 
0.05 
0.01 
0.01 
NS 
0,01 
0.001 
NS 
NS 
NS 
NS 
NS 
Data are expressod as l)e!'cent of patients or as mann ± standard 
deviation. 
Abbreviations as In Table IV. 
A sensitivity of 85% and a specificity of 76% was thus 
achieved. At variance with our results, Madsen and 
Gilpin., found that the prediction of death was not im-
proved by exercise data. In their study correct predic-
tions ranged from 67 to 71% for survivors and from 60 
to 66% for nonsurvivors. They did not consider the BP 
response, which in our experience and that of Scardi et 
al12 was the single best predictor. DeBusk et al,7 in a 
more recent study, also found that stress testing had an 
independent predictive value for subsequent "hard 
events," including death and reinfarction. The paucity 
of deaths in their group of patients who underwent 
stress testing (7 of 338 patients) did not allow multi-
variate analysis to predict mortality alone. Therefore 
we cannot compare their results with ours. 
When nonfatal reinfarction was added to mortality 
as the endpoint. stress test results lost independent 
N-300 
0,~----------~-----+ 
o 20 40 so ao 1 oo 
% NON SURVIVORS CORRECTLY 
PREDICTED (SENSITIVITY) 
FIGURE 3. Speclflcity vs sensitivity for late mortality of discriminant 
function derived from clinical data alone. exercise test (X-test) alone 
and the combination of clinical and exercise test results. 
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predictive value relative to clinical variables.4 This is 
consistent with previous observations of our group and 
of others8.14•16 while Madsen and Gilpin6 found that 
stress testing provided a slight additional information. 
Stress testing gained again independent information 
when bypass surgery and/or coronary angioplasty were 
included on the endpoint (Table IV). This is not sur~ 
prising, because these are not spontaneous events and 
the decision to perform these interventions is often in* 
fluenced by the results of the stress test itself. 
Implications: Patients who are not eligible for stress 
testing because of cardiac limitations have a high risk 
of dying during the subsequent year. These patients 
require intensive evaluation with other noninvasive 
methods and very careful management. Patients eligible 
for stress testing can be further stratified into low-and 
intermediate-risk groups by a combination of clinical 
and stress testing results: this combination improves the 
accuracy of the prognosis. Patients at very low risk do 
not require further investigation. Such attempts at 
stratification may allow for better utilization of in-
creasingly costly health resources. 
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ERRATA CHAPTER 2 
Page 23: December 31, 1983 should be replaced by: December 31, 1982. 
Page 26: Table IV: Killip class III or IV should be replaced by:Killip 
class III or IV. 
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Relative Value of Clinical Variables, Bicycle Ergometry, Rest 
Radionuclide Ventriculography and 24 Hour Ambulatory 
Electrocardiographic Monitoring at Discharge to Predict 1 Year 
Survival After Myocardial Infarction 
PAOLO RORETfl. MD.* RONALD W. BROWER. PHD.t MAARTEN L. SIMOONS. MD. FACC.* 
HARALD TEN KATEN. BSc.* ANITA BEELEN. BSc.* TACO BAARDMAN. BSc.* 
JACOBUS LUBSEN. MD.* PAUL G. HUGENHOLTZ. MD. FACC* 
Rotterdam, The Netherlands 
The relative vaJue of predischarge clinical variables, bi-
cycle ergomctry, radionuclide veotriculogrnphy and 24 
hour ambulatory electrocardiographic monitoring for 
predicting survival during the first year in 351 hospibl 
survivofS of acute myocardial infarction was assessed. 
Discriminant function analysis showed that in patients 
eligible for stress testing the extent of blood pressure 
increase during ~ercise sJightly improved the predictive 
aceuracy beyond that of simple clinical variables (history 
or previous myocardial infarction. persistent heart fail-
ure after the acute phase of infarction and usc of digitalis 
at discharge). whereas radionuclide ventricuJography and 
24 hour clectroeardiogrnphic monitoring did not. The 
predictive value for mortality was 12% with clinical vari-
ables alone and 15% with the stress test added. 
Left ventricular function is a major prognostic detenninant 
of survival in the first year after acute myocardial infarction 
(1-5), although residual myocardial ischemia (6.7) and ven-
tricular arrhythmias (2.8.9) have also been associated with 
reduced survival. On the basis of these observations dif-
ferent algorithms have been proposed to assess the risk for 
individual patients early after acute myocardial infarction, 
including clinical variables and multiple noninvasive or in-
vasive tests (5.10.11). Stress testing (3.5.7 ,12-15). radio-
nuclide ventriculography (5,16.17) and 24 hour ambulatory 
electrocardiographic monitoring (2.8.9.18-20) are com-
monly perfonned early after myocardial infarction and all 
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Radionudide ventricuJography and 24 hour electro-
cardiographic monitorin~ were slightly additive to clin-
ical information in the whole group of patients indepen-
dent of the eligibility for stress testing (predictive va.l.ue 
for mortality 24% with clinical variables aJone and 26% 
with radionuclide ejection fraction and 24 hour electro-
cardiographic monitoring added). 
n is concluded that the appropriate usc of simple 
clinical variables and stress testing is sufficient for risk 
stratification in postinfarction patients. whereas radio-
nuclide ventricuJography and 24 !Jour electrocardio-
1-:taPhic monitorin~o: should be limited to patients not 
eli~ible for stress testing. 
(JAm CoH CardWl 1986:&40-9) 
have been shown to provide some prognostic infonnation. 
However. as far as we know. their relative merit in pre-
dicting late survival independent of easily obtainable clinical 
infonnation has not been established. because most reported 
data have concentrated on one testing method rather than 
comparing them all. 
We have shown in previous studles on postinfarction 
patients that radionuclide ventriculography and bicycle er-
gometry provide similar prognostic information (5) and that 
bicycle ergometry slightly improves the prediction of Sur· 
viva! during the first year after myocardial infarction beyond 
that of routine clinical variables (15). The aim of the present 
study was to determine whether the results from more ex-
pensive tests. such as radionuclide ventriculography and 24 
hour ambulatory electrocardiographic monitoring, provide 
a further improvement of the prognostic judgment compared 
with the appropriate use of simple clinical variables and 
inexpensive, widely available and practical forms of stress 
testing. 
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Methods 
Patients. The records of 706 consecutive patients ad-
mitted to the coronary care unit of the Thorax center between 
March 1981 and December 1983 with documented acute 
myocardial infarction were reviewed. This population in-
cludes 26% of patients referred from other hospitals for 
complications. The diagnosis of acute myocardial infarction 
was based on at least two of the following criteria: I) Typical 
prolonged chest pain at least 45 minutes in duration. 2) In 
transmural acute myocardial infarction. dynamic electro-
cardiographic changes such as evolving Q waves longer than 
0J)4 second with ST-T changes or. in non-Q wave infarc-
tions, ST-T changes persisting for at least 24 hours. 3) 
Increase of total serum creatine kinase level with a peak 
level of more than 100 IU/liter (twice the upper limit of 
normal values in our laboratory). Previous myocardial in-
farction was diagnosed by a typical history or diagnostic Q 
wave abnormalities. or both. 
Hospital mortality occurred in I 04 patients (I 4%). Coro-
nary artery bypass grafting before hospital discharge was 
performed in 51 patients. percutaneous transluminal coro-
nary angioplasty for postinfarction angina was performed 
in 16 cases and cardiac surgery for mitral insufficiency or 
ventricular septal defect was performed in 9 patients. 
Multiple tests. In hospital survivors. symptom-limited 
bicycle ergometry. rest rad.ionuclide ventriculography and 
24 hour ambulatory electrocardiographic monitoring were 
performed in. respectively. 407. 520 and 389 patients an 
average of 14 days after myocardial infarction. before hos-
pital discharge. Radionuclide ventriculography and stress 
testing were performed as previously described (5). Stress 
testing was symptom limited and medication was not dis-
continued at the time of the test. Drug therapy included a 
beta-receptor blocker in 209 patients (52%) and digitalis in 
66 (16% ). One hundred ninety-one patients were judged not 
eligible for stress testing. because of angina in 55. heart 
failure in 47. a noncardiac limitation in 71 and logistic 
problems in 18. Twenty-four hour ambulatory electrocar-
diographic recordings were centrally analyzed (21) using a 
modified Medilog syStem (MRI4). 
Patient subsets (Table 1). Six of the surviving patients 
were lost to follow-up. while 594 patients were followed 
up for 1 year by regular outpatient visits or. in a few cases. 
by telephone contact with their general practitioner. Cardiac 
death was the primary end point of this study but other 
events. such as nonfatal reinfarction. coronary artery bypass 
surgery and percutaneous transluminal coronary angio-
plasty. were also recorded. 
Prediction of survival was performed first in the 594 
patients who survived hospital stay. including those who 
underwent revascularization procedures before hospital dis-
charge. Two patients who died of noncardiac causes were 
excluded from the analysis. Because of the influence that 
cardiac surgery or perCutaneous transluminal coronary an-
gioplasty could have had on the first year course of events, 
the analysis was repeated after excluding the 76 patients 
who underwent one or both of these procedures. Depending 
on the diagnostic tests performed, different subgroups of 
patients were analyzed: 449 patients were studied with radio-
nuclide ventriculography and stress testing unless contrain-
dicated, while 351 had a complete evaluation including 
radionuclide angiography. 24 hour ambulatory electrocar-
diographic monitoring and bicycle ergometry. unless con-
traindicated. 
Statistical analysis. Univariate analysis with the un· 
paired Student's t test for continuous variables and chi-
square or Fisher's exact test for discrete variables were 
applied when appropriate. Data are expressed as mean and 
standard deviation unless otherwise specified. To compare 
Table I. One Year Swvival in 706 Consecutive Patients Admitted to the Coronary Care Unit of 
the Thoraxcenter With a Proven Diagnosis of Acute Myocardia! Infarction 
32 
T<ltal populatiQn 
H<lspital death 
Discharged alive. with 1 year f<lllow-up 
Lost to f<lllow-up 
Cardiac surgery or PTCA bcf<lre dL,ehatge 
Discharged Qn medical thernpy 
With RV 3DdXT 
With RV 3Dd contrnindicaticm for XT 
With RV, XT and 24 h ECG 
With RV, 24 h ECG and contraindication 
for XT 
N<l. Qf Patients 
706 
"''] 596 706 
6 
76] 596 hospital swvivon; 
520 with I year follow-up 
355 ] 449 .th RV 
" ~ 
293] 351 with RV 
58 + 24hECG 
No. Qf De.:iths at 
1 Year(%) 
176 (25) 
104 (14) J 176 
72(1W 
2(3) J n· 
70 (13)" 
24 (7) ] " 
25 {26) 
19 (6) ] 32 
13 (:U) 
*Including tw<l ooncardiac de:tth:;. PTCA - percu13DeQu.~ tr;Ulsluminal coronary angiQPlasty: RV - rndio-
nuclide venaicul<>grophy; 24 h ECG "' 24 hour ambulatory electrOC!U"diographic m<lnit<lring; XT "' exercise 
test {bicycle ergometry}. 
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the predictive value for mortality of different continuous 
variables. we u:;ed receiver-operator characteristic curves 
as in previous reports from our group (5.15). 
The BMDP st:nistical package for stepwise discriminant 
analysis (P7M) was used to generate classification functions 
for different classes of information: clinical variables only 
and clinical variables combined stepwise with stress testing. 
radionuclide ventriculography and 24 hour ambulatory 
elecrrocardiographic monitoring. to assess whether the com-
bination of the different tests provides additive predictive 
value beyond clinical data alone. 
The clinical variables consisted of age. sex. history of 
previous myocardial infarction. history of previous angina 
more than 4 weeks before the index myocardial infarction, 
anterior location of index myocardial infarction. the worst 
Killip functional class while in the coronary care unit. pres-
ence of angina pectoris during hospital stay. persistence of 
congestive hean failure after the stay in the coronary care 
unit, sustained ventricular tachycardia or fibrillation more 
than 72 hours after myocardial infarction. cardiothoracic 
ratio at discharge greater than 50% and use of digoxin, 
diuretic drugs and beta-blockers at discharge. 
The stress test variables included percent of predicted 
work capacity, maximal work load, occurrence of angina 
during the test, heart rate at peak work load. extent of 
systolic blood pressure rise, ST depression, ST elevation 
and any ventricular arrhythmia. 
Left ventricular ejection fraction was the only variable 
included from radionuclide ventriculography. 
Variables from 24 Jwur ambulatory electrocardiographic 
monitoring in the stepwise analysis included: more than five 
multiform premature ventricular complexes during any min-
ute of the recording, and the presence of any ventricular 
couplet or ventricular tachycardia (runs of three or more 
ventricular complexes with a rate 2': I 00/min) during the 24 
hour recording period. 
The end point of the study was cardiac mortality during 
the first year after myocardial infarction. In a first pass. 
stepup analysis was done using an F value of 1.0, which 
entered in the discriminant function all variables remotely 
related to the outcoiP.e. In the second pass. a stepdown 
:malysis was performed on the selected subgroup of vari-
ables using an F value of 4.0 or more. The discriminant 
functions resulting from the stepdown analysis were then 
used to predict the classification of the same group of pa-
tients for a range of threshold levels of the discriminant 
function. 
Results 
Prediction of survival by univariate analysis in aU 596 
hospitaJ survivors (Tables 2 and 3). During the I year 
follow-up period there were 70 cardiac-related deaths: 37 
sudden, 18 from reinfarction. 13 from heart failure and 2 
perioperative. There were two noncardiac deaths, which 
were excluded from analysis. Death occurred within 3 months 
of the index infarction in 30 cases. between 3 and 6 months 
in 14 cases and between 6 and 12 months in 26 cases. 
All clinical variables reflecting impaired left ventricular 
function were associated with poor survival. In addition. 
late ventricular tachycardia or fibrillation was significantly 
associated with late mortality. Early postinfarction angina 
was not followed by a higher mortality than that in patients 
Table 2. Differences. in Clinical Variables Before Discharge Between Late Survivors and 
Nonsurvivors Among 594 Hospital Survivors 
Clinic:tl V ariabl<:s Survivors Nonsurvivors p V:tluc 
No. of patients 524 70 
Male(%) 79 74 NS 
Ag~ ()T) 57 ::!: 10 62 ::!: 12 0.0005 
Previous angina(%) 36 S3 O.Ql 
Previou~ AMI(%) 
" 
60 0.0005 
Antenor A.W (%) 
" 
38 NS 
Killip cia:>s >II(%} 28 0.0005 
Peak CK (IU!litcr) 564 ::!: 481 590 ::!: 554 NS 
Post-AMI angina(%) 
" " 
NS 
Late heart failure(%) 13 
" 
0.0005 
Late vr or VF (%) 
" 
0.0005 
CTR >SO'k (%) 20 57 0.0005 
Digil.:lli.' at disctw.rge (%) 
" 
56 0.0005 
Diuretic therapy at discharge(%) 
" 
66 0.0005 
Beta-blockers at discharge(%) 
" 
33 0.001 
Cardiac surgery or PTCA (%) 
" 
0.01 
The data of two patients who died of noncarchac cau""" are e;.;cluded. AMI ~ acute myocardial infarction; 
CK "' 'erum creatine kina.,e; CTR "' eardiothorac1c ratio; NS ~ not s1gnifieant; VF ~ ventncular fibrillation; 
vr "' sustained ventneular tachycardia; other abbreviation' as in Table 1. 
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Table 3. Difference~ in Predi~harge Bicycle Ergometry. Rndionuclide Ventriculogrnphy :md 24 
Hour Ambulatory Electrocardiographic Monitoring Between Late Survivors :md Non~urvivors in 
594 Hospital Survivors 
Sun.wors Non.survivor:. p Value 
Radionuclide ventnculogr.1phy 
No_ of p~tient< 
""' " Ejection fraction (0<) 47 :!:: 
" 
32 :!:: 15 0.0005 
Bicycle ergometry 
No. of p~tient' 
'" 
29 
Reason for intermptin!,! the test ('ii:) 
Fatigue 71 62 NS 
Angina 6 NS 
Dyspne~ 18 17 NS 
Pressure drop \3 0.1)01 
Mnximal work load (W) 114 ::': 33 IOO :!:: 23 0.02 
Percent workin),! capacily 79::: 17 66 ::': 
" 
0.0005 
Angina(%) 20 20 NS 
Heart rnte at rest (beat<Jmin) s: ::: 16 89 ::': 18 0.01 
Peak heart rnt~ (bea!Ymin) 130 ± 22 133 = 27 NS 
SBP at rest (mm Hg) 121 = 15 121 = :o NS 
Peak SSP (mm Hg) 163 ::': 28 
"' 
:25 0.0005 
SBP rise (mm Hg) 4Z :o: 23 21 ± 19 0.0005 
ST deprc:...,ion (%)" 
"" 
53 NS 
Work load at ST depreSSIOn (W) 9Z : 31 8Z : 33 NS 
ST elevation(%)" M 53 NS 
Ventricular ectopic activity(%) 
'" " 
NS 
Z4 h ECG moniloring 
No. of patient< 
"' 
39 
Muluform PVCs >5/min (%) 
" 
33 NS 
Ventricular couplet!.(%) 31 58 0.001 
Ventricular tachycardia(%) !3 38 0.0005 
"ST depres&ion or elevation 2: 1 mm. The data of two patient' who died of noncardiac cau.<.es during 
follow-up are excluded. PVCs "' premature ventricular compleJ\eS; SBP "' ,ystolic blood pressure; other 
abbrev1ation.' a.< in Tables I and :. 
without angina; in contrast. a history of stable preinfarction 
angina was associated with a poor prognosis. 
Radionuclide ejection fraction was signific:uuly lower in 
nonsurvivors. consistent with the clinical findings. 
An insufficient maximal work load and an insufficient 
blood pressure rise during the stress rest were predictive of 
mortality. whereas markers of ischemia. such as angina and 
ST depression during exercise. were not predictive. Ven-
tricular ectopic activity was more frequent in nonsurvivors. 
but not significantly so. 
Finally. 24 hour ambulatory electrocardiographic mon-
itoring was also predictive because the incidence of repet-
itive ventricular complexes was higher in nonsurvivors. 
Prediction of survival from clinical vari&bles, radio-
nuclide ventricu.lography and bicycle ergometry in 449 
patients treated medically (Tables 4 and 5). Radionuclidc 
ventriculography was perfonned on 449 of the 520 patients 
treated medically (Table 1). Three hundred fifty-five patients 
were eligible for stress testing. whereas 94 were ineligible. 
Mortality was highest in patients ineligible for the exercise 
test (n = 25: 26%) and was 7% (n = 24) in patients who 
were judged eligible for the test. Baseline characteristics of 
34 
the patients who were and were not eligible for stress testing 
arc reported in Table 4. These data indicate that patients 
not eligible for testing were older. had more severe left 
ventricular dysfunction and a higher incidence of early post-
infarction angina than did patients who completed the test. 
The predictive value of clinical variables. stress testing 
and radionuclide ejection fraction by univariate analysis 
was comparable with that found in the whole group of 596 
patients described in the previous section (Tables 2 and 3). 
Ejection fraction was lower in nonsurvivors than in survivors 
(31 ::!:: 14 versus 47 ::!:: 15%. respectively; p < 0.0005). 
The distribution of radionuclide ejection fraction values in 
the 449 patients is shown in Figure l. Among stress test 
results. the contraindication for the test and the extent of 
blood pressure increase were the best predictors of prog-
nosis. 
The predictive value of radionuclide ejection fraction and 
stress testing (combined with the contraindication for the 
test and blood pressure increase) were comparable (Fig. 2). 
because the sensitivity and the specificity of the two tests 
largely overlap during the whole range of measurements. 
The cutoff points with the highest sensitivity and specificity 
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Table 4. Ba..;;eline Characteristics of 355 Patients Eligible and 94 Pm.ients Not Eligible for 
Exercise Test. Treated Medically 
Eligible for 
S!J"e's Testing 
No. of patienL~ 355 
Age (yr) 54 :': 
" Men(%) 83 
Previous AMI(%) 13 
Anterior AMI(%) 37 
Killip elas.' >ll (%) 
Late heart failure(%) 35 
Post-AMI angina(%) 28 
Lat<:: VT or VF (%) 
' erR >50%(%) 
" Ejection fraction(%) 39 :!: 
" Abbreviation' a.' in Tablelo I and 2. 
to predict survival were a blood pre..;;sure rise of 30 mm Hg 
for stress testing and an ejection fraction of 40%. 
The discrimino.nt function analysis (Table 5) using the 
clinical variables alone in the group of 355 patients eligible 
for stress testing resulted in two independent variables pre-
dictive of mortality at the 0.05level of significance: a history 
of previous myocardial infarction and treatment \.Vith digi~ 
talis at discharge. The predictive accuracy was slightly im-
proved when the result of stress testing. that is. extent of 
blood pressure increase. was included with the clinical vari~ 
abies. In contrast. radionuclide ejection fraction did not 
improve the prediction. 
Not Eligible for 
Stress Testing p Value 
" 64 = 9 0.001 
69 0.005 
"" 
0.001 
,, NS 
" 
0.0005 
" 
0.0005 
" 
0.01 
" 
0.01 
" 
0.0005 
47 .:':: l5 0.0005 
On the other hand. radionuclide ventriculography in pa~ 
tients ineligible for stress testing did provide an improve~ 
ment in the prediction of survival compared with clinical 
variables alone. increasing the predictive value for mortality 
from 50 to 58%. The receiver-operator characteristic curves 
of the discriminant functions derived from clinical variables 
alone and combined \.Vith stress test and radionuclide results 
are shown in Figure 3 (patients eligible for the stress test) 
and Figure 4 (those not eligible). From these curves it ap-
pears that bicycle ergometry provides an improvement on 
the prognostic judgment comfared with clinical variables 
alone in patients eligible for stress testing. while radio-
Table 5. Prediction of Cardiac Morul.ity by Discriminant Function Analysis in 449 Patients Studied With Radionuclide 
Ventriculography and Bicycle Ergometry (unless contraindicated) 
Patients Eligible for Stres.~ Test Patients Not Eligible for Suess Test 
Clinicnl Clinical Variables + Clinical Variables + Clinical Variables + 
Variables Slrel;s Test Stm;s Test + EF Clinical Variables EF 
NQnsurvivQrs (n) 
" 
,, 
" " " Survivor.; (n) 331 331 33l 69 69 
Clinical variables (F value) 
?reviou.~ AMI 18.4 15.4 15.4 5.1 
Discharged Qn digit.ali~ 22.6 18.6 18.6 
CTR >50% 15.3 9.9 
Late Vf or VF 5.8 
Stres testing (F value) 
SBP rise SA 5A 
R.adionuclide ventrieulography 
(F vnlue) 
Ejection fraction ]0.6 
Pn:dictive accuracy 
Sensitivity(%) 71 71 71 
" 
76 
Specificity(%) 67 71 71 70 80 
Predictive vnlue positive(%) 13 15 15 50 58 
Predictive vnlue negative(%) 97 97 97 93 90 
Total com:ct classification(%) 67 71 71 73 79 
High risk group (%) 35 33 33 45 J5 
Risk ratio ... 5.2 5.2 6.5 5.9 
EF "" ejectiQD fractiQn; other abbreviations as in Tables I and 2. 
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Figure 1. Histogram of ejection fnction relative to I year survival 
in 449 p:1tien~ with acute myocardial infarction discharged re-
ceiving medical treatment. 
nuclide ventriculography helps prognosis in those patients 
not eligible for exercise testing. However. it must be em-
ph:lsized that bicycle ergometry and radionuclide ventric-
ulography provide only a slight improvement beyond other 
routine clinical information. 
Prediction of survival from clinical variables, radio-
nuclide ventriculography, 24 hour ambulatory electro~ 
cardiographic monitoring and bicycle e~omctry in 351 
patients treated medically (Tables 6 to 8). The univariate 
analysis of these predictive variables was separately ana-
lyzed in patients eligible and not eligible for stress testing 
(Tables 6 and 7). Radionuclide ejection fraction W<lS lower 
in patients not eligible for the Stress test than in those eligible 
for the test (41 :±: 15 versus 47 :±: 15%. respectively: p < 
0.01). Patients with an ejection fraction of 40% or more 
(n = 235) h.ad a mortality rate of 4% (n = 9) compared 
Figure 2. Predictors of mortality after acute myocardial infarction. 
Spedficity versus &ensitivity for prediction oflatc cardiac mortality 
of radionuclide ejection fraction and cxerci&e (X) testing (con-
traindication for the test or change of systolic arterial blood pres-
sure [BP] during the test). 
# 
,: 
~ 
0 •• 
" 0 SP RISE 
w DURING X-TEST 
• ~ •• 
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N-449 
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Cl.. VAR. +X-TEST 
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\ 
\ 
Figure 3. Specificity versus sensitivity for late mortality afteracutc 
myocardial infarction of discriminant function derived from clin-
ical variables (CL. VAR.) alone and the combination of clinical 
and exercise (X} test result~. EJ. eo ejection. 
with a mortality rate of20% (n = 23) in II6 patients with 
an ejection fraction of less than 40%. 
The presence of repetitive ventricular complexes ( cou-
plers or tachycardia) during 24 hour electrocardiographic 
monitoring was significantly associated with monality only 
in patients not eligible for stress testing. In these patients 
the predictive value for mortality of repetitive ventricular 
complexes w<lS 37%. compared with 9% in patients eligible 
for bicycle crgometry. 
On the basis of the extent of blood pressure increase 
during stress testing. 204 patients at low risk (4% mortality 
Figure4. Specificity versus sensitivity for late mortality after acute 
myocardial infarction of discriminant function derived from clin-
ical variables alone and the combination of clinical variables and 
radionuclide ventriculography. in 94 patients not eligible for stress 
testing. Abbreviations as in Figure 3. 
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Table 6. Univariate Predictors of Mortality in 351 Patients With Complete Evaluation 
No. of patients 
Clinical variable~ 
Age (yr)* 
Males(%) 
Prcviou~ AMI (%) 
Pn:viou~ angma (%) 
Anterior AMI(%) 
Killip class >II(%) 
Post-AMI angina(%) 
L:uc: heart failure(%) 
Late VT or VF (%) 
CTR >50%(%) 
Digitalis at discharge(%) 
Diuretic therupy at di,charge (%) 
Bem-blocken. at di,cbarge (%) 
Radionuclide EF (%)* 
24 h ECG monitonng 
Multiform PVC~ >5/mm (%) 
Ventricular couplcllo ('d 
Ventricular tachyc:rrdia f%) 
Survivor:. 
319 
56 :!: 10 
" ,, 
33 
37 
6 
" 
" 
' 20 
16 
" 56 
47 :': 14 
All P>~ticnt~ 
Non,urv. 
32 
5& :!: 
" 
" 53 
56 
" 
" 
" 50 
16 
50 
59 
72 
37 
33 = 16 
" 59
37 
p Value 
NS 
NS 
0.001 
0.001 
NS 
0.001 
NS 
0.001 
0.005 
0.001 
0.001 
0.001 
0.05 
0.001 
NS 
0.005 
0.001 
P"~ticnt> El•gible ror 
Stfe<.> Te>llng 
54=!0 
86 
20 
31 
36 
5 
" 
" 
' 
" 13 
" 60 
43 = 14 
" 31 
13 
5:! = II 
95 
" 37 
53 
11 
" 
" 11 
" 53 
63 
" 35 = 18 
" 
" 
" 
NS 
NS 
0.001 
NS 
NS 
NS 
NS 
0.001 
NS 
NS 
0.001 
0.01 
NS 
0.001 
NS 
" NS 
Patienb Not Elig1ble for 
Stres.' Te,ting 
65 = 9 67 ::':: g NS 
73 69 NS 
" " 
0.02 
" 
85 0.005 
37 31 NS 
9 46 0.002 
33 31 NS 
" " 
O.OCIJ 
' 
23 0.05 
" 
85 0.001 
" 
69 OJ)() I 
" 
85 0.0:! 
09 31 NS 
45 = 15 30 = 1:! 0.00:! 
" " 
NS 
33 77 0.005 
15 60 0.001 
•Mean = SD. Nonsurv. "' non_,urvivor..; other abbreviation> as in prevtou> table>. 
rate) were identified with a blood pressure increase of 30 
mm Hg or more and an intermediate risk group included 
89 patients with a monality rate of 12% who had a blood 
pressure rise of less than 30 mm Hg. 
The discriminanr function analysis (Table 8) applied !0 
clinical variables only in the entire group of 351 patients 
resulted in three independent variables predictive of mor-
tality at the 0.05 level of significance: use of digit:liis at 
discharge. history of a previous myocardial infarction and 
persistence of heart failure after the acute phase of infarc-
tion. By adding the results of radionuclide ventriculography 
and of24 hour ambulatory electrocardiographic monitoring, 
ejection fraction and the presence of ventricular tachycardia 
improved the predictive accuracy compared with that of 
clinical variables alone. 
When a similar stepwise anal_vsis was repeated in the 
group of patients eligible for the stress test. stress test results 
(the extent of blood pressure rise) slightly improved the 
prediction over that of clinical variables alone. but in thls 
subset of patients ejection fraction and the results of 24 hour 
ambulatory electrocardiographic monitoring did nor provide 
any additional information beyond that provided by the com-
bination of clinical and stress test res:J.lts. 
Discussion 
Left ventricular dysfunction. ventricular arrhythmias and 
residual myocardial isehemia are all important determinants 
of survival during the first year after myocardial infarction 
(1,2,6} when considered separately. Consequently, multiple 
Table 7. Univariate Predictors of Survival in 293 Patients With Complete Evaluation: Stress 
Test Results 
Surv1vors Nonwrvivor.. p Value 
No. of patient:> 274 19 
Max1mal work load (W) 115 = 32 103 ::: 23 NS 
Working capacity(%) 79 = 17 66 ::: 
" 
0.002 
Anginn (%) 15 11 NS 
Heart mte at mol (beatYmin) 81 = 16 93 = 19 0.002 
Peak heart mte (beaWmin) 130 ::: 22 139 = :!5 0.05 
SBP at mot (mm HgJ 121 = 15 120 ::: 18 NS 
Peak SBP (nun Hgl 161 = 26 143 = 27 0.002 
SBP rise (nun Hg) 4() = 22 24 = :!0 0.002 
ST depre~~ion (%) 
" " 
NS 
Any vcmricular arrhythmia(%) 
--
26 
" 
Abbreviation' a..' m previou.' table>.. 
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Table 8. Prediction of Mortallty by Discriminant Function Analysis in 351 Patients With Complete Evaluation 
Non,urvivors (n) 
Survivo~ (n) 
Clinical variable' (F value) 
Di~oeharged on digitalis 
History of previou' AMI 
Lare hean failure 
Radionudide ventriculography (F value) 
Ejection fraction 
24 h ECG monitoring (F value) 
Ventricular tachycardia 
Stress testing (F value) 
SBP rise 
Predictive accurncy (%) 
sen.~itivity (%) 
Spectficity (%) 
Predictive value po"tive (%) 
Predictive value negative(%) 
Total correct das.~ification (%) 
High rbk group(%) 
Risk ratio 
Abbreviation' a' in Table' I 11Jld 2. 
All Pauenh 
Clinical Clinical Variable' ... 
V anabb EF + ::!4 h ECG 
" 319 
20.5 
14.1 
5.5 
59 
" 
" 95 
79 
23 
5.0 
" 
"' 
26.4 
12.7 
5.::! 
7.5 
n 
80 
26 
97 
79 
" 7.7 
PatienL~ Eli~;ible for Stre's Test 
Clinical Variabb + 
Clinical Variable' Stres.' Test 
19 
274 
19.1 
7.5 
63 
67 
" 96 
67 
35 
3.::! 
19 
274 
15.8 
5.8 
5.0 
63 
75 
" 98 
75 
27 
45 
Clinical V ariabb 
+ Stre,s Test + 
EF + 24hECG 
19 
274 
15.8 
5.8 
5.0 
63 
75 
" 98 
75 
27 
45 
tests have been applied to postinfarction patients to improve 
the prediction of clinical outcome obtainable with clinical 
variables only (10.11). The questions now are: which of 
these tests is the most predictive and do we need them all 
in every patient? Indeed. the present study confirms that 
clinical variables. stress testing. radionuclide angiography 
and 24 hour ambulatory electrocardiographic monitoring are 
all useful in predicting late survival. When clinical infor-
mation and these tests indicate left ventricular dysfunction 
and show complex ventricular arrhythmias. late survival is 
reduced (Table 6). 
Surprisingly. early postinfarction angina and ST depres-
sion during the exercise test were not predictive of impaired 
survival. This is largely explained by the f:l.ct that 76 patients 
with more severe early postinfarction angina underwent 
coronary artery bypass or percutaneous transluminal coro-
Figure 5. One year mortality after 
hospital discharge following acute 
myocardial infarction in subsets of pa-
tients based on clinical :md exercise 
tes.t results. AMI = acute myocardial 
infarction; BP = blood pre.">Sure; ECG 
= electrocardiogram. 
38 
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c;J 
DOtlento stualed w!tn rOCflonucllde 
ventrlculogrcphy and 24-h ECG 
with stress test 
I 
no stress test • orevJous AM! 
·on dlgJtalls 
• no orevlous Al'\l • orevJous AMI 
13t 
22 : 
• BP rise aur!ng 
stress test 
<30 rmiH9 
8 t 
17 : 
• no dlgJtalls ·on dJgJtolls 
• BP rise during • BP rlse durJng 
stress test stress test 
<30 nrnHg )30 rnnHg 
' t 
" 
• no orevJous AMI 
• no a!gnol!s 
• BP rise aurtng 
stress test 
~30 rnnHg 
5 ' 
" 
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nary angioplasty before hospital discharge (22.23) and. 
therefore, had to be excluded. However, other studies (24.25) 
have also failed to show ST depression during stress testing 
to have much prognostic relevance. even when patients 
undergoing reva~ula.rization were excluded (24). 
Clinical variables versus multiple tests. Also consist~ 
ent with previous studies (2,26), stress testing. radionuclidc 
ventriculography and 24 hour ambulatory electrocardio-
graphic monitoring do provide additional prognostic infor-
mation to that provided by clinical data (Table 8). However, 
when multivariate analysis was restricted to those patients 
who completed a stress test, only the extent of blood pres-
sure rise during exercise improved the prediction based on 
clinical data alone. where:).s radionuclide ejection fr.Jction 
and results of 24 hour ambulatory electrocardiographic mon-
itoring were not additive. The failure of the ejection fraction 
determination to provide supplemental information is prob-
ably related to the better left ventricular function of the 
patients selected for stress testing compared with that of 
patients who were not eligible for stress testing (Table 4). 
Complex ventricular arrhythmias also added little new prog-
nostic information in this group of patients. This finding 
also is consistent with the observations of many other in-
vestigators ( 1.27) who found that the prognostic relevance 
of complex ventricular arrhythmias is secondary to the as-
sessment of ejection fraction. 
Taken together. our results show that a large percentage 
of patients at low risk of mortality can be identified with 
easily obtainable and low cost techniques (Fig. 5). These 
findings are similar to those recently published by Krone et 
a!. (12). who found a lo/c mortality rate during the first year 
after acute myocardial infarction in patients with no signs 
of pulmonary congestion and a systolic blood pressure of 
110 mm Hg or more during exercise. Such patients. who 
represent a subst:mtial percentage of postinfarction patients. 
therefore do not require further noninvasive or invasive di-
agnostic procedures. which by itself will reduce the overall 
cost of postinfarction evaluation. 
Our results point out that low risk patients can be effi-
ciently identified by clinical information and stress test re-
sults; in contrast. the predictive value for mortality in pa-
tients undergoing stress testing is low even with the optimal 
combination of different tests. being 15% at best in our 
experience (Tables 5 and 8). 
Limitations of the study. Some limitations of our study 
have to be acknowledged. Medications were not withdrawn 
before stress testing; this is particularly important in relation 
to the patients using beta-blockers. because the damping 
effect of these agents on blood pressure rise during exercise 
lowers the predictive value of blood pressure response. as 
we observed previously (15). Therefore. in the presence of 
a low blood pressure increase in patients receiving beta-
blocker therapy. the result should be interpreted cautiously 
and the test eventually repeated after discontinuation of the 
beta-blocking agent. Furthermore. our results might have 
been influenced by the exclusion of some patients from 
analysis because of incomplete evaluation or early revas-
cularization procedures. 
Conclusions. We recommend a careful clinical assess-
ment during hospitalization of patients with acute infarction. 
A history of previous myocardial infarction or requirement 
of digitalis on discharge by itself categorizes a high risk 
profile. A symptom-limited stress test should nevertheless 
be carried out at discharge as a routine procedure. Additional 
tests. such as radionuclide angiography and 24 hour am-
bulatory electrocardiographic monitoring. should be cJ.rried 
out only in patients with contra.indications for stress testing 
or in those who complete the test OJld have an equivocal 
risk profile. In the low risk group it is unllkely that. unless 
indicated by symptoms. any particular medical treatment or 
any procedure of revascularization can significantly improve 
prognosis during the first year. although this should be pro-
spectively verified. Long-term follow-up is required to de-
termine whether the benign clinical course is maintained in 
these low risk patients. On the other hand. in the higher 
risk group. the appropriate treatment will also depend on 
the results of coronary arteriography. This procedure can 
be recommended with conviction on the basis of the pre-
dictive value of the noninvasive tests. 
W~ gratefully acknowledge A. Petene and S. Schenderling for the mter-
pretation of 24 hour ambulatory elcetrO<:ardiogr~phie monitonn~,: d.J.ta and 
H. de Wolf for a.'~istin& m the preparation of the d.J.mba..\e. 
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ABSTRACT 
The prognostic value of QRS score (Selvester ), ST-depression, ST-eleva-
tion, premature ventricular contractions, P terminal force in V 1 and QTc 
from predischarge 12 lead electrocardiogram, has been assessed in 474 
patients after myocardial infarction without ventricular conduction 
defects and/or hypertrophy and/or atrial fibrillation. These results were 
compared with other usual clinical data for risk assessment. During 
follow-up 45 patients died. 
By logistic regression analysis, QRS-score, ST-depression and QTc were 
independently predictive of cardiac mortality. However, when multivariate 
analysis was applied to clinical and electrocardiographic data, the 
12-lead electrocardiogram did not provide independent information above 
other usual clinical and laboratory findings, such as a history of pre-
vious myocardial infarction, clinical signs of persistent heart failure, 
indication for digitalis or antiarrhythmic drugs at discharge, and en-
larged heart on X ray. In conclusion, the electrocardiogram has important 
prognostic value, however it is not powerful enough to further improve the 
risk assessment of post-infarction patients. 
Key words: 12 lead electrocardiogram, risk assessment after myocardial 
infarction. 
INTRODUCTION 
In the last few years cardiology has witnessed increased emphasis on 
a number of non-invasive as well as invasive tests which assess many 
different aspects of cardiac function. Some of these tests, (mainly 
related to the detection of myocardial ischemia, the quality of left 
ventricular function or the occurrence of ventricular arrhythmias) have 
been utilized to assess the risk of patients after myocardial infarction. 
However, it is apparent that there is considerable redundancy in infor-
mation (1). Futhermore, since that many hospitals cannot support all these 
tests, which are costly and in some cases risky for the patient, it has 
become increasingly desirable to employ the usual clinical and laboratory 
findings in an optimal fashion. 
Recently, different studies have shown that the 12 lead electro-
cardiogram has important prognostic value in patients after myocardial 
infarction (2-7). However, few studies have also included in their ana-
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lysis, other clinical findings (2) or utilized a multivariate analysis for 
the prediction of survival. The routine 12 lead electrocardiogram could be 
a a very attractive tool for risk assessment in postinfarction patients, 
as it provides information on the extent of myocardial damage (8), left 
atrium overload (7,9), presence of myocardial ischemia (2,10) arrhythmias 
(3) and electrical instability (4,5). 
The aim of this study was to analyze the power of different variables 
extracted from predischarge electrocardiogram to predict one year survival 
after myocardial infarction, and to establish whether they provide additio-
nal information beyond the routine clinical findings and tests. The study 
was based on 474 hospital survivors of myocardial infarction, without 
ventricular conduction defects, ventricular hypertrophy or atrial fibril-
lation. 
PATIENTS AND METHODS 
From March 1981 to December 1983, 706 consecutive patients were 
admitted to the coronary care unit of the Thoraxcenter with a confirmed 
diagnosis of acute myocardial infarction. Out of 602 hospital survivors, 
474 patients formed the data base for this study (table 1). All these 
patients were followed up for one year with cardiac mortality as the end 
point. To predict mortality, we utilized different sets of information, 
derived from predischarge 12 lead electrocardiogram and from the other 
clinical and laboratory findings obtained during the different phases of 
hospitalization. 
Electrocardiographic variables. 
Standard 12 lead electrocardiogram was obtained at discharge on a 
three channel Hewlett Packard 1513. A recorder at a paper speed of 25 
mm/s. The following electrocardiographic variables have been measured: the 
presence of premature ventricular contractions, QRS score developed by 
Selvester (8), ST-depression (horizontal or downsloping) or elevation of 
one mm or more, P terminal force in V 1 (7, 9), and QT-interval corrected 
for heart rate (QTc) (4,5). The measurements were performed by one cardio-
logist, blinded to the clinical outcome of the individual patients. In a 
previous study we showed a good agreement when QRS score was measured by 
two independent observers (6). 
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TABLE 1 Patient population. 
N 1-zear mortalitz 
Admitted with acute 
myocardial infarction: 706 174 (25%) 
Study group: 474 45 (9%) 
E......_cluded from the study: 
Hospital mortality 104 104 
Lost to follow-up 6 
Non-cardiac death 2 2 
Missing or bad quality 
pre-discharge ECG 36 3 (8%) 
With ventricular conduction 
defects or hypertrophy 8 19 (24%) 
Atrial fibrillation 6 3 (50%) 
Abbreviation EGG 12 lead electrocardiogram 
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Other clinical variables 
The other "routine" variables consisted of age~ sex~ history of 
previous myocardial infarction~ pre-infarction stable angina pectoris~ the 
anterior location of the index infarction (Q-wave infarction)~ the worst 
Killip class while in the coronary care unit, early post-infarction 
angina~ ventricular fibrillation any time before hospital discharge, 
"late" (72 hours or more after the infarction) ventricular fibrillation, 
"late" sustained ventricular tachycardia or supraventricular tacharrhyt.h-
mias, persistent heart failure after discharge from the coronary care 
unit~ resting heart rate at discharge, medication at discharge~ cardio-
megaly at discharge (cardiothoracic ratio> 50%) and radiological signs of 
pulmonary congestion. These variables were selected based on clinical 
experience and previous studies in our clinic. Other tests performed 
before discharge included radionuclide resting ventriculography in 417 
patients, symptom limited bicycle ergometry in 340 patients and 24-hour 
ambulatory electrocardiographic monitoring in 310 patients, as previously 
described (1). 
Cardiac catheterization with coronary arteriography was additionally 
performed in 235 of these patients for elective indications or as part of 
a randomdzed trial with intracoronary streptokinase (11-13). Medication at 
discharge included betablockers in 270 patients~ digitalis in 94, diure-
tics in 166, antiarrhythmics in 17~ nitrates or other vasodilators in 180 
and calcium blockers in 128. Coronary artery bypass surgery was applied in 
46 patients, and transluminal coronary angioplasty in 15 patients, before 
hospital discharge. 
Statistical analysis 
Univariate analysis for the different electrocardiographic and 
clinical variables was performed. Continuous variables were trichotomized. 
The 95% confidence interval (CI) for the respective risk ratio's (RR) were 
calculated according to Miettinen and Nurminen(10) with the first tertile 
considered as the reference group. If the 95% confidence interval exceeds 
1, the association of the respective variable with the risk of dying 
within one year is statistically significant at the 5% level. For multi-
variate analysis the logistic regression model was used in order to 
predict mortality. Thus the objective was to find any combination of 
variables that predicted mortality to its nearest accuracy. As a general 
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principle~ indicator variables were used. These are variables which assume 
the value of 1 if the property considered is present and 0 if absent. 
Continuous variables were trichotomized, so that indicator variables 
for the middle and high risk categories were considered for inclusion into 
the model. The BMDP package was used which selects stepwise predictor 
variables based on the maximum likelihood ratio (MLR). This provides is a 
measure of significance and has an asymptotic chi-square distribution. 
Thus variables were included into the model, if they led to a substantial 
improvement of the log-likelihood (P<0.10)~ or if their removal led to a 
substantial decrease (p<0.15). Forward selection and backward elimination 
of the variables into the model yielded the same models. 
Two models were developed, one based on the 12-lead electrocardiogram 
variables alone and the other on the clinical variables alone. 
The regression coefficients of each model have a direct epidemiologic 
implication: each coefficient represents the log odds of dying while 
controlling for the other variables in the model. Its antilogarithm is the 
relative risk for the property considered. As an example, if the regres-
sion coefficient for old myocardial infarction is l, its antilogarithm 
e
1) is 2.7. This means that the risk of dying within one year for patients 
with a previous infarction is 2. 7 times as high as that for patients who 
suffered no prior myocardial infarction. In fact~ the coefficients concern 
relative odds, which are a good approximation for the relative risk, since 
mortality is a relatively_ rare event (45 out of 474 died, 9.5 %). 
RESULTS 
Prediction of mortality by univariate analysis 
Table 2 gives the results of univariate analysis for the percent mortality 
and the risk ratios of the 474 patients included in the study. Of the 
12-lead electrocardiographic variables~ QRS score and ST depression gave 
significant values, while QTc and P terminal force in v1 were less pre-
dictive. Of the clinical variables, previous myocardial infarction, 
pre-infarction angina ~ Killip class III or IV, late paroxysmal supra-
ventricular tachycardia or fibrillation, late heart failure, heart rate at 
discharge greater than 75 beats/minute, predischarge cardiothoracic ratio 
greater than 50% and pulmonary congestion on X-rays all revealed sig-
nificant risk ratios. From the medications administered at discharge, 
three reached significance: digitalis, diuretics and antiarrhythmic£. 
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TABLE 2 Mortality~ risk ratios and confidence intervals for the different 
electroeardiograhic and clinical variables~ by univariate analysis 
95% Confidence 
N Mortalit:z (%) Risk Ratio Interval. 
12-lead electrocardiogram 
QRS SCORE 
< 2 144 9 (6. 3%) 
2-5 140 10 (7 .1%) 1.1 0.5-2.7 
> 5 190 26 (13. 7%) 2.2 1.1-4.5 
ST-SEGMENT DEPRESSION 
no 414' 34 (8.2%) 
yes 60 ll (18.3%) 2.2 ).2-4.0 
ST-SEGMENT ELEVATION 
no 306 28 (9.2%) 
yes 168 17 (10.1%) 1.1 0.6-1.9 
PVCs 
no 455 43 (9.5%) 
yes 19 2 (10.5%) 1.1 0.3-3.5 
PTF 
< 10 mm msec 190 14 (7.4%) 
10-20 mm msec 131 12 (9. 2%) 1.2 0.6-2.6 
> 20 mm msec 153 19 (12.4%) 1.7 0.9-3.2 
QTc 
< 400 msec 147 12 (8.2%) 
400-440 msec 182 13 (7 .1%) 0.9 0.4-1.8 
> 440 msec 145 20 (13.8%) 1.7 0.9-3.3 
Other clinical variables 
AGE 
< 50, years ll6 ll (9.5%) 
50-60. years 165 ll (6. 7%) 0.7 0.3-1.5 
> 60, years 193 23 (11.9%) 1.3 0.6-2.5 
SEX 
female 102 12 (11.8%) 
male 372 33 (8.9%) 0.7 0.4-1.4 
PREVIOUS AMI 
no 331 21 ( 6. 3%) 
yes 149 24 (16.8%) 2.6 1.5-4.6 
PREVIOUS ANGINA 
no 301 23 (7. 6%) 
yes 173 22 (12. 7%) 1.7 l. 0-2.9 
PEAK CK 
< 300, IU/1 194 14 (7. 2%) 
300-600, IU/1 121 16 (13.2%) 1.8 0.9-3.6 
> 600, IU/1 159 15 (9.4%) 1.3 0.7-2.6 
KILLIP CLASS 
I-II 439 36 (8. 2%) 
III-IV 35 9 (25.7%) 3.1 1.6-5. 7 
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TABLE 2.3 c:ontinued 
95% Confidence 
N Mortalit:z: (%) Risk Ratio Interval. 
EARLY POST MI ANGINA 
no 351 32 (9 .1%) 
yes 123 13 (10. 6%) 1.2 0.6-2.1 
LATE VF OR VT 
no 460 40 (8. 7%) 
yes 14 5 (35. 7%) 4.1 1.8-7.8 
LATE SVT OR AF 
no 452 40 (8.8%) 
yes 22 5 (22. 7%) 2.6 1.1-5.3 
LATE HEART FAILURE 
no 411 27 (6.6%) 
yes 63 18 (28. 6%) 4.3 2.5-7.3 
HEART RATE AT DISCHARGE 
< 65 bpm 185 12 (6.5%) 
65-75 bpm 144 12 (8.3%) 1.3 0.6-2.7 
> 75 bpm 145 21 (14.4%) 2.2 1.2-4.3 
PREDISCHARGE CTR >50% 
no 379 24 ( 6. 3%) 
yes 95 21 (22.1%) 3.5 2.0-5.9 
PULMONARY CONGESTION 
no 445 39 (9%) 
yes 29 6 (20.7%) 2.3 1.1-4. 7 
MEDICATION AT DISCHARGE: 
DIGITALIS 
no 383 24 (6.3%) 
yes 91 21 (23.1%) 3.7 2.1-6.2 
DIURETICS 
no 312 19 (6.1%) 
yes 162 26 (16.0%) 2.6 1.5-4.6 
BETA-BLOCKERS 
no 205 24 (11.7%) 
yes 269 21 (7.8%) 0.7 0.4-1.2 
ANTIARRHYTIIMICS 
no 459 40 (8.7%) 
yes 15 5 (33.3%) 3.8 1.7-7.4 
ANTICOAGULANTS 
no 384 32 (8.3%) 
yes 90 13 (14.4%) 1.7 0.9-3.1 
Abbreviations: 
PVCs =premature ventricular complexs; PTF= P terminal force in v1; AMI = acute 
myocardial infarction; CK = serum creatine phosphokinase; VF= ventricular 
fibrillation; VT = sustained ventricular tachycardia; SVT= paroxysmal 
supraventricular tachycardia; AF=paroxysmal atrial fibrillation or atrial 
flutter~ CTR = cardio thoracic ratio. 
.. 
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Prediction of mortality by multivariate analysis 
The results of stepwise logistic regression of one year mortality on the 
12-lead electrocardiogram variables are shown in the upper part of table 
3. QRS score>S, presence of ST depression and QTc> 440 msec were found to 
be of predictive value. In particular, the presence of a QRS score>S or of 
QTc > 440 msec yields a 1. 8 fold increase in the patient 1 s risk of dying 
within one year and the presence of ST-depression multiplies the risk by 
2.2. 
The lower portion of table 3, summarizes the logistic regression 
results for the clinical variables. The presence of previous myocardial 
infarction, late heart failure, indication for digitalis at discharge or a 
cardiothoracic ratio >50% and an indication for antiarrhythmic drugs (RR 
4.0) were of independent predictive value. The construction of the model 
is not straightforward here as there are three variables related to pump 
failure: clinical signs of late heart failure, use of digitals and cardia-
thoracic ratio> 50%. The regression model assumes multiplicity of the 
different factors. That is, if tv.ro factors are present each with a re-
lative risk of 3, then the combined relative risk will be 3 x 3 9. As 
the three above variables measure to a large the same phenomenon, one may 
question the assumption of multiplicity. We investigated this using 
interaction terms in our model. We concluded that digitalis and a cardia-
thoracic ratio> 50% can be combined yielding a satisfying yet parsimonious 
model. The consequences are that. the relative risk of a patient using 
digitalis or with cardiothoracic ratio> 50% remains 4. 0. However, if 
clinical signs of late heart failure are present, the relative risk 
increases to 12.0, v.rhich is also the case if the lat.ter is present with 
either of the other risk factors. 
The addition of the 12-lead electrocardiogram variables to the model 
already containing the other clinical variables yielded only a marginal 
better fit to the data; the improvement of the log likelihood is 0. 32 
(X2 =0.64, p > 0.60). From this we concluded that the 12-lead electro-
cardiogram variables do 
prediction of one year 
variables alone. 
not make an independent 
mortality over that of 
contribution to the 
the other clinical 
On the other hand, if such data are not availabe the 12 lead electro-
cardiogram can, to a certain extent subtitute them. The mean predicted 
probability of dying for patients who actually died is 0.12, based the 
electrocardiographic model, and 0.23 based on the clinical model. This 
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TABLE 3 Variables eventually retained in the logistic function of the risk of 
dying within one year. 
coefficient 
12 lead ECG 
QRS SCORE> 5 0.6 
ST SEGMENT DEPRESSION 0.8 
QTc > 440 msec 0.6 
CONSTANT -2.9 
Clinical variables 
PREVIOUS llMI 1.1 
LATE HEART FAILURE 1.1 
DIGITALIS OR CTR > 50% 1.4 
ANTIARRHYTHMICS 1.4 
CONSTANT -3.7 
standard 
0.3 
0.4 
0.3 
0.3 
0.3 
0.4 
0.4 
0.6 
0.3 
relative risk N 
1.8 
2.2 
1.8 
3.0 
3.0 
4.1 
4.1 
190 
60 
145 
474 
143 
63 
148 
15 
474 
log-likelihood 
(-142.2 
1-122.7 
Abbrevations: N = number of patients in whom the property considered was present. 
AMI= acute myocardial infarction; CTR = cardio thoracic ratio; 
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demonstrates the greater ability of the clinical variables to identify 
patients who are going to die. The mean predicted probability of surviving 
( l-predicted probability of dying) for patients who actually survived is 
0.91 based on -:he electrocardiographic models and 0.92 based on the 
clinical model, demonstrating that survival can equally well be predicted 
from the electrocardiographic and clinical variables. 
DISCUSSION 
Due to the proliferation of non-invasive and invasive tests, the 
armamentarium ava:...lable to the cardiologist for assessing the risk of 
patients after my~-,cardial infarction has considerably grown. Due to the 
overlap of information provided by different tests, the selection ot the 
most efficient strategy (with the highest ratio of information to cost or 
risk to the patient) in an individual patient is not obvious. 
In previous studies we addressed the problem of the prognostic value 
of tests which are not universally performed at discharge, like exercise 
testing, radionuclide ventriculography and the 24-hour ambulatory electro-
cardiogram compared to other clinical variables (1). 
In this study, we assessed the prognostic value of the predischarge 
12-lead electrocardiogram, which is not costly and is usually performed in 
order to establish whether it provides additional information beyond the 
known clinical information and tests. 
As far as we know this is a unique study for the following reasons: 
l. it includes a consecutive series of patients admitted to the same 
coronary care unit, which was sufficiently large to allow a multivariate 
analysis based on predischarge clinical and electrocardiographic 
variables; 2. it focusses on relatively low risk patients since those with 
conduction defects, ventricular hyper-trophy and atrial fibrillation were 
excluded; 3. its electrocardiographic variables include among others the 
QRS score by Selvester (8) which in the last few years has become very 
popular for the assessment of the extent of myocardial damage and prog-
nosis. However, its prognostic value has not been compared in other 
studies to that of other electrocardiographic or clinical variables by 
multivariate analysis. The only large study which addressed the relative 
prognostic value of clinical and electrocardiographic variables in post-
infarction patients is that of the Coronary Drug Project (2). In this 
study, which includes 2035 patients followed for three years, it was 
concluded that ST-depression of l nnn or more of the r ischemic r type was 
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the most important independent risk predictor of all clinical and electro-
cardiographic findings studied~ including~ Q-waves~ ventricular conduction 
defects, atrial fibrillation and premature ventricular complexes. 
In our study we confirm that many electrocardiographic variables are 
predictive of survival (tables 2 and 3). The highest risk ratios for 
mortality at 2.2 were obtained for ST segment-depression. These figures 
are rather similar to those reported by the Coronary Drug Project (2). 
However, in contrast to their findings we did not confirm the predictive 
value of premature ventricular contractions and of ST-elevation. This 
could be relat:ed to the different population in the two studies. In fact 
the entry in the Coronary Drug Study was late (at least 3 months after the 
most. recent infarction)~ and included also patients with ventricular 
conduction defects and atrial fibrillation. Also patients were followed 
for a longer period, up to three years. In contrast, our study was based 
on a consecutive series of patients evaluated at hospital discharge 
without conduction abnormalities and atrial fibrillation and the follow-up 
was for one year. When we recall that for hospital survivors of myocardial 
infarction, the mortality is highest in the first 3 to 6 months (1), it is 
clear that the two studies deal with a completely different population, 
particularly since early mortality is excluded in the Coronary Drug 
Project. In table 4 some predischarge variables of the 474 patients in the 
study group are compared to those of patients excluded from the study 
because of ventricular conduction defects, hypertrophy or atrial fibril-
lation. These data clearly indicate that patients with normal QRS pattern 
had much less extensive myocardial damage, consistent with a lower 
mortality during follow-up. It also means, that for the electrocardiogram 
to be helpful it must be dichotomized into either an electrocardiogram 
without conduction disturbance or hyperthropy in a relatively low risk 
group after myocardial infarction or when conduction defects are present 
be considered to carry highly significant prognostic information. The 
QRS-score and, to a lesser extent., P terminal force in v1 and QTc were 
also predictive of mortality (table 2). 
As QRS-score is directly related to the extent of myocardial damage 
(8), it has been shown to have a fair correlation with left ventricular 
ejection fraction. In the present series the correlation coefficient 
between radionuclide ejection fraction and QRS-score was -0.53 (SEE 11%) 
in 417 patients. The correlation coefficient was similar (r=-0.57, SEE 
11%) when the analysis was limited to 296 patients with a first myocardial 
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infarction. These data are very close to previous findings by our group in 
a smaller population (6). 
P terminal force measured from precordial lead V 1 has been shown by 
others to correlate to left atrium overload (9). Siltanen et al (7) 
recently described that P terminal force was the strongest independent 
predictor of mortality from predischarge electrocardiogram in 457 post-
infarction patients, followed by ST-segment abnormalities. 
However, these authors did not measure the Selvester QRS score. Their 
population was also different. In fact they did not exclude patients with 
ventricular conduction abnormalities or ventricular hypertrophy. In our 
study these patients had a greater P terminal force in V l, indicating a 
more severe left ventricular dysfunction. Accordingly~ these patients had 
also more frequently clinical signs of heart failure and a lower ejection 
fraction (table 4). 
Mortality was higher in patients with prolonged QTc: Schwartz et al 
(4) found in 55 patients with a recent infarction that the finding of 
prolonged QTc (>440 msec) during serial electrocardiographic measurements 
constituted a 2.1 greater risk of sudden death, during a seven year 
follow-up. More recently, Ahnve et al (5) confirmed that a prolonged QTc 
is predictive of mortality in post-infarct patients. By using a cut-off of 
440 msec, they found that QTc yielded a sensitivity of 77% and a specifi-
city of 84%, limited to patients not on medical therapy, which might 
influence the QTc interval. 
In contrast to QRS score and P terminal force in V 1 , which are 
related to pathophysiological phenomena such as the extent of myocardial 
damage and left atrium overload, ST-depression and QTc interval are 
difficult to interpret. In our study both were predictive of mortality. 
However the clinically prescribed medication was not discontinued. It is 
well known that medication is one of the many factors which affect both 
variables (5,11) 
When multivariate analysis was applied to the different electro-
cardiographic variables, ST-segment depression, QTc and QRS score were 
independent predictors of mortality (table 3). Of the clinical data the 
independent prognostic variables were persistent heart failure, a history 
of previous myocardial infarction, cardiomegaly from X-rays, the use of 
digitalis and antiarrhythmics at discharge. These variables all relate 
directly or indirectly to poor ventricular function, which is the stron-
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TABLE 4. Differences of selected baseline characteristics between patients 
in the study group and those excluded from the study. 
number of patients 
age, years, mean(SD) 
previous AMI, n(%) 
late heart failure, n(%) 
CTR >50%, n(%) 
EF, %, mean(SD) 
ElectrocardiograPhic variables 
PVCs, n(%) 
PTF rom msec, mean(SD) 
Follow up 
one year mortality, n(%) 
study grou:e 
474 
57 (11) 
146 (30) 
66 ( 14) 
100 (21) 
47 (14) 
22 (5) 
20 (15) 
45 (9) 
excluded 
84 
61 (10) 
26 (33) 
27 (35) 
34 (44) 
37 (17) 
6 (8) 
26 (18) 
23 (27) 
:e-value 
0.002 
ns 
0.0005 
0.0005 
0.0005 
ns 
0.0005 
0.001 
Abbreviations; AMI= acute myocardial infarction; CTR= cardia thoracic 
ratio; EF= left ventricular ejection fraction; PVCs= premature ventricular 
complexes; PTF= terminal force of P-wave in v1• 
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gest prognostic factor. Therefore~ several clinical and electrocardio-
graphic variables provided useful prognostic information~ however when 
multivariate analysis was applied to the combination of clinical and 
electrocardiographic variables, electrocardiographic variables were not: 
strong enough to improve the prognostic information of the clinical data. 
It is concluded that, predischarge electrocardiogram per se provides 
important prognostic information for post-infarction patients without 
conduction abnormalities, ventricular hypertrophy or atrial fibrillation, 
in whom clin1cal prescribed medication is not discontinued. From these 
electrocardiographic variables, persistent ST-segment depression, the 
Selevester QRS-score (8) and QTc are the independent predictors of sur-
vival. However, electrocardiographic variables by themselves are not 
sufficiently powerful to improve risk assessment when added to other 
information routinely collected during hospital stay. 
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The extent to which patients with low peak serum creatine kinase (CK) at their first myocardial infarction 
differ from patients with high CK levels in terms of risk for subsequent ischaemic events was investigated 
in 266 patients who survived the first 48 h from the onset of infarction. All patients were followed up for 
one year. Four groups were formed based on peak CK~200, 201-400, 401-800 and >800 IU r 1 • During 
follow~up the incidence of mortality was 15% (N=39). non-fatal re~infarction 9% (N=23). and angina 
53% ( N = 140). Hospital mortality was significantly higher ( P < 0·02) in the highest CK~group ( 16%), but 
the incidence of non-fatal re~infarction, angina pectoris and late mortality was similar in the four groups. 
In hospital survivors, ischaemic ST~changes during pre~discharge symptom limited bicycle stress test and 
multiple vessel disease were equally distributed in all four groups. 
We conclude that while hospital mortality is directly related to peak CK, there is no relationship between 
peak CK and late mortality, non-fatal re~infarctions, or recurrent angina. Accordingly, diagnostic and 
therapeutic procedures in the individual patients are not influenced by the amount of serum CK released 
during acute infarction. 
Introduction 
Serial measurements of serum creatine kinase 
(CK) in the first few days after acute myocardial 
infarction is a routine procedure for proving the 
existence of infarction and is also used to estimate 
the extent of myocardial damage[1l. It has been 
repol}:ed that this simple measurement also pro~ 
vides prognostic information since patients with 
high peak serum CK were found to have higher 
early mortalicyl2l. However, it is uncertain to 
what extent patients with low peak CK levels at 
their first infarction differ from those with high CK 
levels in terms of their risk for other ischaemic 
events, such as angina and recurrent infarction. 
Small myocardial infarctions are more often 
"non Q~wave' infarctions and some investigators 
have reported that these patients carry a worse 
prognosis than patients with Q~wave infarctions[JJ. 
If this could be confinned from enzyme studies, 
Received for publication on 17 December 1984 and in revised fonn 
18 Ma.rc:h 1985. 
a more aggressive diagnostic and therapeutic 
approach would be justified in these patients. 
However, other authors have not found any clini~ 
cal differences between the two forms of infarction 
and have also failed to demonstrate that the 
concept of Q-wave versus non Q~wave infarction 
implies a pathologic distinction[4 l. 
To darify the significance of the enzyme levels, 
we studied 266 consecutive patients with a first 
acute myocardial infarction and subdivided them 
into four subgroups with increasing peak serum 
CK levels. They were followed during the acute 
phase and during the year after recovery from the 
infarction. 
The aims of this study were to determine the 
relation between peak serum CK and other clinical 
information reflecting infarct size. and to deter~ 
mine whether patients with a low peak serum CK 
have a different incidence ofischaemic events than 
those with larger infarctions. based on peak serum 
CK levels. 
Address for corrcsrxwknct>: Paolo Fioretti, MD. Thoraxcenter, Patients and methods 
University Hospital 'Dijkzigt". Dr. Molewaterplein 40. 3015 GD 
Rotterdam. The Netherlands. The records of 361 conse 
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admitted to the coronary care unit of the Thorax-
center with a proven diagnosis of acute first 
myocardial infarction between I March 1981 
and 31 December 1982 were considered for the 
study. The diagnosis of myocardial infarction was 
made in presence of at least 2 of the following 
criteria: 
1. prolonged chest pain of at least 45 min; 
2. dynamic electrocardiographic changes defined. 
in case of transmural infarctions. as evolving 
QR-complexes. Q-waves >0·04s or R>S in 
V1-V2 with ST-T wave changes. or in case 
of non-transmural infarction. as ST- and/or 
T-wave changes persisting for at least 24 h with-
out loss ofR-wave voltage or new Q-waves. Site 
of infarction was defined as undetermined in 
case of complete left bundle branch block; 
3. a typical rise and fall of total serum CK with a 
peak level > 100 IU I- 1 (twice the upper limit of 
the normal range). 
Patients were graded in 4 groups according to 
peak CK<200IU1- 1 (N=71. median 123. range 
91}-200), 20!-4001Ul-' (N=49. median 290, 
range 221}-400), 40!--8001UI-' (N=84, median 
583. range 403-795) and >8001Ul-' (N=62, 
median 1373. range 814-2994). Serial serum CK 
was sampled every 6 h during the first day of 
admission and thereafter once a day for seven 
days. The CK was measured both in our center and 
in the referring hospital with the same method[sJ. 
The precision of the method is monitored by fre-
quent analysis of commercially available control 
serum. Coefficients of variation in these lyophilized 
materials are in our laboratory 7-10%. When 
repeated analysis of fresh human serum is con-
sidered. variation coefficients are 3-6%. 
Twenty three patients with a :first myocardial 
infarction who died within 2 days from the onset of 
symptoms were excluded as the peak level of CK 
was possibly not reached. We also excluded from 
the study 19 patients admitted longer than two 
days from the beginning of symptoms and fifty 
three patients treated with intracoronary strepto-
kinase. as part of an ongoing randomized clinical 
trial[6 l. since t:he treatment with streptokinase is 
known to modify the patterns of enzyme release. 
The treatment during hospital stay followed the 
guidelines recently described[71• The data base 
therefore consisted of266 patients. 
At hospital discharge 188 patients were evalu-
ated with a symptom limited bicycle stress test and 
217 undenvent a radionuclide ventriculography at 
rest[81. Stress testing was not performed in 58 hos-
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pi tal survivors: in 14 because of recurrent angina. 
in 14 for persistent heart failure and in 30 for other 
limiting diseases or general disability. Eighty four 
patients underwent a coronary arteriography. 
elective in 58% of cases and in the others as part 
of a study protocol. After discharge patients were 
followed at the outpatient clinic. One year follow-
up was complete. Mortality, recurrent infarction, 
persistent heart failure and typical angina pectoris 
were the end-points of the study. 
Differences among grouPs of patients were 
assessed with analysis of variance for the contin~ 
uous variables and with the Cochran modification 
of the chi square test for trend assessment of dis-
crete variables. 
Results 
CK LEVELS. BASELINE CLINlCAL DATA AND PRE-
DISCHARGEEVALUATION (TABLES I AND 2) 
Patients with a large infarction (CK>800) were 
slightly younger than those in the smaller infarc-
tion groups. but age was similar in the other 
groups. Sex and history of angina pectoris were 
evenly distributed. The percentage of patients 
referred from other hospitals for complications 
was 23% on average. being highest in patients with 
the largest infarcts (40%). As expected, the preva-
lence of non-transmural infarction was highest in 
the lowest CK-group (62%). while in the highest 
CK-group there was a prevalence of anterior 
infarctions (65%). left ventricular ejection frac-
tion progressively declined in the four CK-groups. 
and was on average 57. 56.47 and 37%. 
Stress testing could be performed in a similar 
fraction of each group-in 76% of patients on 
average. The maximal workload and the preva-
lence of ST-segment depression were equally dis-
tributed. Patients with the highest CK level had 
the lowest incidence of angina pectoris. but had the 
highest incidence of ST -segment elevation. the 
highest maximal heart rate and the lowest 
increment of systolic blood pressure. all indicators 
of impaired left ventricular function. 
Coronary arteriography was performed in 37% 
of patients on average. and showed an even dis-
tribution of patients with multiple vessel disease in 
the four groups. 
CLINICAL COURSE (TABLES 3 AND 4) 
The in'cidence of mortality and severe heart 
failure during the hospital phase was significantly 
higher in patients with the highest peak CK-levels. 
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Table 1 Historical and clinical data in groups with different peak serwn CK levels 
Peak CK (IUI~ 1 ): ~200 201--400 401-.800 >800 ?value 
Number of patients 71 49 84 62 
Age (yrs: mean±SD) 60± II 57±12 60±11 53±11 0·01 
Males(%) 76 71 76 77 NS 
Previous angina(%) 38 35 25 31 NS 
Referred from other hospitals.(%) 14 18 18 
"" 
0·01 
Site of infarction 
anterior('%) 15 16 32 65 0·0001 
inferior(%) 22 49 56 34 0·0001 
non-transmural(%) 62 35 10 2 0·0001 
unknown("/.,) 0 0 2 0 
Peak a-HBDH (IUI~ 1 ) 190±96 360±173 598±254 1048±430 0·0001 
(N=64) (N=47) (N=78) N=56) 
If not specified. data are expressed bymean±SD. 
Tah!e 2 Pre-discharge evaluation by radionu.clide ventriculography. stress testing and coronary 
arteriography 
Peak CK (IU 1~ 1 ): ~200 201-400 401-.800 >800 ?value 
Ventriculograpy 
performed(%) 76 88 80 85 NS 
LVEF(%) 57± 11 56±Il 47±16 37±17 0·001 
Stress testing 
performed(%) 66 75 62 84 NS 
max. workload (W) 119±38 122±43 112±33 109±28 NS 
max. HR (bpm) 124±25 133±22 132±21 141±21 0·001 
SAP rise (mmHg) 47±25 45±24 47±27 34±22 0·02 
ST-depression (%) 40 52 48 25 NS 
ST-elevation (%) 16 37 48 65 0·0001 
angina(%) 28 40 19 3 0·002 
Coronary angiography 
performed(%) 2S 20 35 63 0·005 
3:2VD(%) 65 80 72 64 NS 
Abbreviations: LVEF=left ventricular ejection fraction: HR=heart rate; SAP=systolic arterial 
pressure. ST -depression and -elevation ~ I mm. If not specified. data are expressed as mean± 1 SD. 
Tahle3 Hospital clinical course 
PeakCK (JU 1- 1): ~200 201-400 401-800 >800 Pvalue 
Mortality N 2 7 10 
% 4 8 16 0·02 
Non-fatal re-infarctions N 6 0 5 0 
% 8 0 6 0 NS 
Angina N 18 II 16 10 
% 25 22 19 16 NS 
Killip class III-IV N 2 2 9 17 
% 3 4 11 27 0·0005 
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Table 4 Clinical course after hospital discharge during one yeQT follow-up in 246 hospital 
survivors 
PeakCK(IUl- 1) ::;;200 201-400 401-SOO >800 Pvalue 
Number of patients 70 47 77 52 
Mortality N 4 4 7 4 
% 6 8 9 8 NS 
Non-fatal re-infarctions N 3 0 2 7 
% 4 0 3 13 NS 
Angina N 25 17 23 15 
% 36 36 30 29 NS 
Heart failure N 2 2 4 17 
% 3 4 5 33 0·0001 
CABG/PTCA N 5/1 3/0 4/1 0/1 
% 9 6 6 2 NS 
CABG - coronal)' artery bypass grafting; PTCA- percut:lneous transluminal 
coronary angioplasty. 
TableS Treatment at hospiral dischQTge 
PeakCK(IUI- 1) ::;;;:200 201-400 401-SOO 
Number vf patients 70 47 77 
Beta blockers N 45 27 31 
% 64 57 40 
Nitrates N 25 15 21 
% 36 32 27 
Calcium blockers N 21 12 15 
% 30 26 !9 
Digitalis N iO 5 20 
% 14 II 26 
Diuretics N !9 10 30 
% 27 21 39 
Anticoagulants N 5 2 16 
% 7 4 21 
Antiarrhythmic:; N 3 7 
% 6 9 
No medication N 10 9 II 
% 14 !9 14 
CABG/PTCA N 7/3 1/1 3/2 
% 17 4 6 
In contrast non-fatal re-infarctions and angina 
pectoris were similar in all groups. After hospital 
discharge. the follow-up data showed no differ-
ences in mortality, re-infarctions or angina pectoris 
during the first year. However. patients with the 
highest CK levels had the greatest incidence of per· 
sistent heart failure. which occurred in 33% of 
cases. 
64 
>800 Pvalue 
52 
10 
!9 0·0005 
23 
44 NS 
6 
46 NS 
24 
46 0·0005 
30 
58 0·005 
23 
31 0·0005 
2 
4 NS 
3 
6 NS 
2/0 
4 NS 
Infarct size is well established as an important 
determinant of Iongterm outcome in patients who 
survive a first myocardial infarctionl1•2•9 ·101. Peak 
serum CK is a simple measurement related to the 
extent of myocardial damage. which is routinely 
carried out in most coronary care units111. 
Peak s::rum CK is a less accurate method to 
estimate the extension of myocardial necrosis than 
the calculation of total CK release11l. However. 
total CK release is not practical for routine 
work and certainly more expensive. Furthermore. 
Thomson et afPl. found a fair correlation between 
the two methods. 
We found that peak serum CK is inversely 
related to left ventricular function as detected by 
clinical variables. pre-discharge radionuclide ven-
triculography. and stress testing. Left ventricular 
ejection fraction at discharge was inversely cor-
related with peak CK. The extent of blood pressure 
rise during the bicycle ergometry test. an index of 
left ventricular function18l, was lowest in the 
highest CK-group. Also the incidence of ST -eleva-
tion during ergometry. an index of left ventricular 
dyskinesia, was highest in the highest CK-group. 
Therefore we confirm that peak CK. despite its 
limitations11l, is for practical purposes a reliable 
indicator of residual left ventricular function 
and early prognosis after acute first myocardial 
infarction. 
Other serum enzymes like CK-MB or a-HBDH 
have been reported to provide more specific infor-
mation on the amount of myocardial necrosis 
than total serum CKI11l. In the present study total 
CK was utilized since it was determined also in 
all referring hospitals. Furthermore, peak CK 
paralleled peak a-HBDH (Table 1). and therefore 
the use of total CK should not have invalidated 
our :findings. 
Hospital mortality and the incidence of advanced 
heart failure during the early phase was signifi-
cantly higher in the highest CK-group (Table 3). 
In contrast. mortality after discharge during the 
:first year follow-up was independent of peak CK. 
· ranging from 5 to 8% in the four groups (Table 4). 
This is in partial agreement with the results of 
Thomson et af.12l. who found that peak CK was 
more closely related to immediate than to late 
mortality. These investigators also found that the 
mode of death during follow-up was related to 
infarct size: patients with high peak CK died 
mostly from progressive heart failure while death 
was more often sudden in patients with a smaller 
infarction. In our series we could not confirm this 
last observation. since most of our patients who 
survived during follow-up died suddenly; however 
the incidence of heart failure was highest (25%) in 
the highest CK-group. 
Another important issue is the relative incidence 
of angina pectoris and/or non-fatal re-infarctions 
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since it is uncertain whether their incidence is 
higher in patients with small infarctions, which 
would justify more aggressive management of 
these patients. Our results indicate that the 
incidence of angina andre-infarction is not related 
to peak CK either during the acute phase or during 
late follow-up (Tables 3 and 4). This is consistent 
with the similar frequency of ischemic electro-
cardiographic changes during stress testing and 
that of multiple vessel disease in the different 
CK-groups (Table 2). 
Our results could have been biased by the many 
patients referred to us from peripheral hospitals 
because of complications. This would overestimate 
the severity of the disease compared to an unselec-
ted population. In fact. the prevalence of patients 
with multiple vessel disease in our series was higher 
than that described by Abraham et al. in a conse-
cutive series of unselected patients with a first 
myocardial infarction who underwent coronary 
arteriographyl12l. This difference could also be due 
to the selection for coronary arteriography. mostly 
elective in our series. 
The follow-up results could have been influenced 
by the treatment applied to the different CK-
groups (Table 5). In particular, coronary artery 
bypass surgery and coronary angioplasty for the 
treatment of postinfarction angina were more 
frequently applied in the group of patients with a 
small CK rise. However, a recent study of our 
groupl13l. partially based on the population of the 
present study. showed that coronary artery bypass 
surgery early after myocardial infarction did not 
influence survival or re-infarctions compared to a 
matched group treated medically. 
As expected. at the other end of the spectrum, 
patients with the largest infarctions (CK> 
800 IU- 1) were more frequently treated with 
digitalis. diuretics and anticoagulants and less 
frequently with beta blockers. because of the 
higher incidence of heart failure. However. most of 
these differences disappeared by excluding from 
the comparison the group with CK greater than 
800 IU- 1 • It is therefore unlikely that treatment 
different influence on the clinical outcome in those 
patients with a small or intermediate CK rise. 
In summary. we confirm that in patients with 
first myocardial infarction. residual left ventricular 
function is inversely correlated with peak serum 
CK. Accordingly. patients with highest CK levels 
have the highest incidence of hospital mortality 
and heart failure. On the coronary.late mortality. 
non-fatal re-infarctions and angina were not 
65 
478 P. Fioretti et aL 
related to peak CK levels. Therefore. in patients 
with a first myocardial infarction. the diagnostic 
procedures and therapeutic policy should not 
be influenced by peak serum CK. In particular. 
patients with a small enzyme rise. do not require a 
more aggressive approach. unless indicated by 
persistent symptoms. Our results also indicate 
that when interventions are planned during the 
acute phase of infarction to salvage myocardium. 
beneficial effects on survival can be expected dur-
ing the early phase. but not during the subsequent 
year. 
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Oorspronkelijke stukken 
Prognose van het ongecompliceerde eerste hartinfarct bij patienten jonger dan 
6o jaar: reden tot hartcatheterisatie? 
J.W.OECKERS, P.FIORETTI, R.W.BROWER, J.A.J.M.SEELEN, T.BAAROMAN EN M.L.SIMOONS 
IN LEIDING 
Onrangs beschreven Veenbrink et al. in dit tijdschrift 
de bevindingen bij coronairangiografie en in-
spanningselektrocardiografie na een eerste myocard-
infarct.1 Bij So patii!nten zonder ernstige angina 
pectoris of decompensatio cordis, met een gemiddel-
de leeftijd van 48 jaar. vonden zij correlatie tussen 
daling van bet ST-segment tijdens inspanning en een 
zogenaamde high risk-coronaria-aandoening. Hun 
conclusie luidde dat coronairangiografie beperkt zou 
kunnen biijven tot patii!nten bij wie het inspannings-
onderzoek na bet eerste infarct in deze zin positief 
uitvalt. 1 Het artikel bevatte evenwel geen gegevens 
over de prognose van de onderzochte populatie. 
Onlangs hebbcn wij bij 338 niet-geselecteerde 
patii!nten die een infarct hadden doorgemaakt. de 
prognostische waarde nagegaan van het voor ontslag 
verrichte inspanningsonderzoek.: Daarbij bleek dat 
niet de ST-segmentdaling. maar de linker-kamertunc-
tie bij inspanning van prognostisch belang was. Om 
deze reden hebben we de prognose onderzocht van 
aile patienten jonger dan 6o jaar. die in een periode 
van 22 maanden in ons centrum werden opgenomen 
wegens hun eerste ongecompliceerde infarct. De duur 
van het na-onderzoek bedroeg een jaar. 
PATIENTEN EN METHODEN 
Tussen I maart 1981 en 31 december 1982 werden 529 
achtereenvolgende patienten opgenomen wegens een 
myocardinfarct. De diagnose werd op de gebruikelij-
ke wijze gesteld met behulp van anamnese. typi.sche 
ECG-veranderingen en enzymbeloop. Op grond van 
het ontbreken van de kenmerkende Q-golven in het 
eerste ECG van een gedocumenteerd infarct in bet 
verleden kon bij 418 patii!nten worden vastgesteld 
dat het een eerste infarct betrof. Van hen overieden48 
in bet ziekenhuis. Van de 370 overlevende patiCnten 
waren 2r3 jonger dan 6o jaar. Bij 94 hunner werd bet 
herstel gecompliceerd door dccompensatio cordis, 
angina pectoris dan wei door late. ktinisch manifeste 
ritmestoornissen. Bij de overige I 19 patiCnten. jonger 
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SAMENVATTING 
In dit artikel wordt ecn onderzoek beschrcven naar de 
prognose in bet eerste jaar na ontslag uit het ziekenhuis 
wegens een ongecompliceerd vcrlopen eerste hartinfarct 
van II9 achtereenvolgende patii:nten jonger dan 60 jaar. 
Sleehts ~Gn patii:nt overleed plotseling binnen o;:en jaar; bij 
ro patii:nten ontstond een recidiefinfarct. De da.g voor 
ontslag wcrd door 110 patiCnten een insnanningstest ver-
richt. Er bleek verband te bestaan tussc~ bet v66rkomen 
van angina p<:ctoris en ST-segmentdaling tijdens het inspan-
rringsonderzoek en het optreden van angina pectoris in de 
periode van na-onderzoek. Bij de belft van de patii!nten 
ontstond bij de inspanningstest een ST-segmentdaling van 
ten minste O,I mY. Inspanningsvariabelen bleken ecbter 
geen waarde te hcbben voor de voorspelling van een 
recidiefinfarct. Geconcludeerd wordt dat ST-segrnentdaling 
tijdens inspanningsonderzoek in deze groep patii!nten geen 
indicatie is voor coronairangiografie. 
dan 6o jaar met ecn eerste infarct. verliep hct herstel 
van bet infarct ongecompliceerd. Deze groep bestond 
uit 98 mannen en 2! vrouwen, in leeftijd variCrend van 
22 tot 59 jaar. gemiddeld 49 jaar. Van hen hadden 37 
een voorwandinfarct. 54 een onderwandinfarct en 28 
een niet-transmuraal infarct. 
Aan het einde van de ziekenhuisopname vond bij 54 
patiCnten hartcatheterisatie ptaats. Dit onderzoek 
gebeurde bij 39 patienten in verband met een geran-
domiseerd onderzoek naar het effect van de toedie-
ning van streptokinase en bij rs patienten om electie-
ve redenen. 3 Een diametervernauwing van meer dan 
so% in een of meer coronairanerien werd ais signifi-
cant beschouwd. 
De dag voor ontslag. gemiddeld 9 dagen na het 
infarct. verrichtten IIO patii!nten een inspannings-
proef op de fietsergometer. waarbij de belasting met 
ro watt per minuut werd opgevoerd. Bij geen van de 
patii!nten ontstonden ritmestaornissen. repolarisa-
tiestoomissen of veranderingen in de bloeddruk, die 
noodzaakten tot beCindigen van bet onderzoek. Het 
ECG werd met het afleidingsysteem van Frank voort-
durend geregistreerd en door een computer geanaly-
seerd. 4 De bloeddruk werd om de minuut met een 
manchet gemeten. De voorgeschreven medicatie 
werd op de dag van het inspanningsonderzoek gecon-
tinueerd. Wegens niet-cardiale comra-indicaties of 
om organisatorische redenen konden 9 patienten. 
onder wie 4 gecatheteriseerde patienten. bet inspan-
ningsonderzoek niet ondergaan. Na ontslag uit het 
ziekenhuis bezochten de patienten regelmatig de 
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TABEL 1. R"'u1t:>Icn van in~punningc:.ondcrzock na onge«>mp1icccrcl vcrlo-
pcn ccnac infnrcr 
a!fc patil!ntcn 0-1-w.ksafw. 2-3-taksafw. 
(n " JJO) (n = 41)) (n = 10) 
A. vench•;ns.-lcn 
~ngina pectoris(%) 16 (IS) 6 (IS) 2 (20) 
vcntricul~irc ritmC"!.lOOr-
ni''""" (%) 21 (19) 7 (17) 1 (10) 
S. orukrzoeksbcvmdint:en 
bchaaldc max. tx:1a,tin)! 
(%;SO) ~1 (15) 78 (13) 78 (13) 
0.1 mV ST-d~ling (%;SOl 40 (36) 15 (37) 5 (50) 
0.2 mV ST...:!~ling (%;SO) 13 (12) 4 (10) 1 (10) 
0.1 mV ST·•tijgmg (':'".,;SO) 30 (!7) 12 (30) 3 (30) 
02 mV ST-,t•JW"l': (%; SO) 17 (15) 7 (17) 
max. h~nfrcq. (,;Umm; SO) 136 (:!3) 141 (24) 129 (:!5) 
max. ,y,t. blocddruk 
(mmHg;SO) 110 c:m 164 (24) 163 (27) 
!O<:n~mc syst. blocddruk 
(mmHg;SO) 45 (22) 45 (18) 36 (:!3) 
polikliniek. Van aile patienten waren de gegevens 
over een periode van een jaar na opname beschik-
baar. 
Bij de statistische bewerking werd de univariante 
analyse met Students Hoets voor continue variabelen 
en met Fishers exacte toets voor de discrete variabelen 
toegepast. Een p-waarde < 0.05 werd bescbouwd als 
significant. 
RESULT A TEN 
Slechts een patient overleed in bet eerste jaar na bet 
infarct. terwijl bij 10 patienten een recidiefinfarct 
optrad. Angineuze klachten ontstonden bij 39 patien-
ten in de periode van na-onderzoek. In verband met 
de ernst van deze klachten werd bij 5 patienten een 
bypass-operatic (CABG) uitgevoerd en bij 2 een 
percutane transluminale coronaire angioplastiek 
(PTCA). 
Geen van de 54 patienten bij wie hartcatheterisatie 
en coronairangiografie werd verricht aan het einde 
van de ziekenhuisopname. had een belangrijke ver-
nauwing van de hoofdstam; 42 patienten hadden een 
een-taksafwijking en 12 een twee- of drie-taksafwij-
king. 
De bevindingen van het inspanningsonderzoek bij 
110 patienten zijn weergegeven in tabel I. De inspan-
ningsgegevens van de gecatheteriseerde pati¢nten 
waren vergelijkbaar met die van de niet-gecatheteri-
seerde patii!nten. De gemiddelde bebaalde belasting 
bedroeg ongeveer So% van de voor de leeftijd en 
Iengte vastgestelde norm. Bij r6 patiCnten ontstond 
tijdens de test angina pectoris en bij 53 een ST-
segmentdaling van ten minste o.r mV. 
In de gecatheteriseerde groep waren geen signifi-
cante verschillen in behaalde belasting. mate van 
ST-segmentafwijking. maximale hartfrequentie en 
systolische bloeddruk tussen patii!nten met 2- of 
3-taksafwijkingen vergeleken met patit!nten met 
afwijkingen in een tak van de coronairarterien (zie 
tabel 1). Tabel 2 geeft het verband weer tussen het 
optreden van angina pectoris en ST-segmentdaling 
tijdens bet inspanningsonderzoek bij ontslag en het 
kliniscbe beloop in de periode van na-onderzoek. 
Gecn van b;eide kenmerken bleek van waarde voor 
het voorspellen van een recidiefinfarct: wei bestond er 
verband tussen angina pectoris en ST-segmentdaling 
tijdens de test en het later optreden van angineuze 
klachten. 
BESCHOUWING 
Onze resultaten Iaten zien ~t de eenjaarssterfte van 
jonge overlevenden na een ongecompliceerd verlopen 
eerste infarct bijzonder laag is. Van de 119 patienten 
overleed slechts een in het eerste jaar na ontslag. Deze 
!age eenjaarssterfte bij patienten jonger dan 6o jaar 
wordt ook door anderen gevonden: zo vermeldden 
Abraham eta!. een eenjaarssterfte van 3% bij 197 
niet·geselecteerde patiCnten die een eerste infarct 
overleefden.5 Deze bevinding is niet zo verrassend. 
indien men bedenkt dat patii::nten met klinische 
tekenen van decompensatio cordis van ons onderzoek 
werden uitgesloten. ~ Deze selectie verklaart ook bet 
geringe aantal patiCnten met ernstige coronairaan-
doeningen. 5 In een poging om onze onderzoeksgroep 
zoveel mogelijk vergelijkbaar te maken met die van 
Veenbrink et al. werden de patiCnten die angineuze 
klacbten in het ziekenhuis badden, uitgesloten. Niet-
temin kregen 16 patienten nieuwe angineuze klachten 
tijdens bet inspanningsonderzoek en in de periode van 
na-onderzoek was er sprake van angina pectoris bij 39 
patiCnten. Veenbrink et al. namen bij 20 van de So 
patiCnten angina pectoris waa.r. 2 tot 4 maanden na het 
infarct.1 zodat ook in dit opzicbt de patientengroepen 
goed overeenstemmen. 
Wij hebben bij het inspanningsonderzoek bij onge-
veer de helft van de patiCnten een ST .-segmentdaling 
r ... on ~- Voorspcllcndc wa~rdc vun angin~ pectoris en ST....cgmcntd~ling tijdcn~ in~panning~ndcrlock 
klinisch bdoop in periodc 
van na-ond~rzO<'k. 
ovcrhjdcn 
reC!didinfarc:t (% J 
angin~ pectoris(%) 
CABG of PTCA (%) 
gcen comp~Cllti<;) (%) 
70 
inspanrunpondcrzO<'k. 
angina pectons 
(aant. pmi<'ntcn) 
+ 
In " 11>) (n " 94) 
0 J(J) 
3 (18) 5 (5) 
11 (69) 25 (27) 
3 (19) 3 (3) 
5 (31) 65 (69) 
p 
NS 
NS 
0,003 
0,08 
0.01 
ST-scgnu-ntdalins angina en ST·s~gmemdaling 
laatU. pat•enten) (aant. putii'nten) 
+ 
rn =53) In '"'57) p rn = I2! In = 98) 
0 1(1) NS 0 l(l) NS 
3 (6) 5 (10) NS 0 8 (::1) NS 
:!3 (38) 13 {23) 
'·" 
9 (75) "Z7 (28) 0.00-< 
4 (8) 2 (4) NS 3 (25) 3 (3) O.o3 
29 (55) 41 (72) NS 3 (25) 67 (6$) O.Ql 
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van ten minste o.r mY kunnen vaststcllen: dit getal is 
ook door anderen gevonden.7·~ Veenbrink et a!. 
namen een significante ST~segrnentdaling waar bij 
22% van hun patienten: dcze Jagere incidentie wordt 
wellicbt verklaard door een andere interpretatie van 
ECG~afwijkingen in de oude infarctgebieden. alsook 
door bet latere tijdstip waarop de inspanningsproef 
werd uitgevoerd. De door Veenbrink et al. gevonden 
correlatie tussen de coronairangiografiscbe en elek~ 
trocardiografische bevindingen was in ons onderzoek 
minder duidelijk. Hct is ccbter de vraag of deze 
verschillen van zoveel belang zijn. De prognostischc 
waardc van ST~segrnentdaling tijdens inspanning na 
een doorgemaakt infarct wordt immers door velen 
bctwijfeld. Hoewel Theroux et al. destijds verband 
hcbben gevonden tusscn ST-segmentdaling en pro~ 
gnose,q is dit door latcre onderzoekers niet beves-
tigd.n~Jo.J~ Bij eerder eigen onderzoek naar de 
prognostische waarde van de inspanningstest bij 338 
ongeselecteerde overlevenden van een myocardin~ 
farct blcek de eenjaarsprognose het bestc gecorrc-
leerd te zijn aan de toename van de systoliscbe 
bloeddruk tijdens de test.~ Andere onderzoekers zijn 
eveneens van mening dat de uitkomsten van bet 
inspanningsonderzoek die de mechaniscbe functie van 
de linker kamerweergeven. de grootste prognostiscbe 
betekenis bebben. Geringe inspanningstolerantie en 
lage maximale waarde van de systolische bloeddruk 
tijdens inspanning correleren volgens recente onder~ 
zoekcn bet beste met de sterfte na bet infarct.nl0· 1~ 
Hier dringt zicb de vergelijking op met de angiogra-
fische gegevens: ook daar is de functie van de linker 
kamer. be halve bij patienten met ceo aandoening van 
de boofdstam, prognostisch van groter belang dan de 
ernst van de anatomische afwijkingen in de coronair~ 
arterien. 13 
Gezien de zeer !age eenjaarssterfte na een onge-
compliceerd myocardinfarct, is bet niet verrassend dat 
de bijdrage die inspanningsonderzoek kan leveren 
aan de prognostische indeling van deze patienten. 
slechts gering is. Niettem.in heeft bet onderzoek ook in 
deze groep zijn waarde: zo is, bij afwezigheid van 
angina pectoris tijdens de test. de kans op cardiale 
complicaties tijdens bet na-onderzoek zeer gering. 
Hoewel uit de sterftecijfers van ons onderzoek de 
indruk zou kunnen ontstaan dat het doormaken van 
een ongecompliceerd infarct op jonge leeftijd niet 
zoveel betekenis beeft. mag niet uit bet oog verloren 
worden dat een recidiefinfarct de prognose op tangere 
termijn zeker nadelig zal belnvloeden. In ons onder-
zoek ontstond bij 10% van de patienten een niet-
dodelijk recidiefinfarct binnen een jaar. Geen van de 
inspanningsgegevens bleek van waarde voor de voor-
spelling van deze gebeurtenis: resultaten van andere 
studies en eigen gegevens uit een andere populatie 
bevestigen deze slechte voorspelbaarheid.~ 14 
Tenslotte:moet met enige nadruk vermeld worden 
dat bet niet duidelijk is welke waarde gehecht moet 
worden aan hct vinden van een zogenaamde high 
risk-coronaria-aandoening bij patiCnten met geen of 
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weinig klachten. Veenbrink et al. wezen bier reeds 
op. 1 Er is inmiddels aangetoond dat een bypass~ 
operatic de prognose van deze patienten niet verbe-
tert. 1 ~ Hiermee vervalt de noodzaak om door middel 
van niet-invasief onderzoek patienten te selecteren 
die ondanks de afwezigheid van klacbten toch een 
uitgebreide coronaria-aandoening hebben. 
CO!"CLUSIE 
De uitkomsten van dit onderzoek bevestigen bet 
goede eenjaarsoverlevingscijfer voor patienten jon~ 
ger dan 60 jaar. die hun eerste infarct overleven en bij 
wie geen recidiefinfarct, decompensatie. late ritme-
stoornissen of angina pectoris ontstaat in bet zieken-
huis. Het verricbten van een inspanningstest v66r 
ontslag heeft dus prognostisch niet veel waarde, maar 
lijkt zinvol om andere redenen. De test kan het 
zelfvertrouwen van de patient doen toenemen. dan 
wei angineuze klachten provoceren die aanleiding 
kunnen zijn tot medicamenteuze tberapie of even-
tueel coronairangiografie: bovendien kan bet resul-
taat van de test een ricbtlijn zijn voor latere revalida-
tie. Het optreden van uitsluitend ST-segmentdaling 
tijdens de inspanning vormt echter geen reden tot 
coronairangiografie over te gaan. 
SUMMARY 
Prognosis of the uncomplicared first myocardial infarction in 
patientS under 6o: an indication for cardio.c catheterization?-
A follow-up study of I 19 consecutive patients younger than 
6o years one year after their discharge following hospitali-
zation for an uncomplicated first myocardial infarction. 
Only one patient was found to have died suddenly within 
one year; lO had had reinfarctions. 1 ro patients had been 
subjected to effort ECG one day before discharge. A 
correlation was observed between occurrence of angina 
pectoris and ST segment depression during the effort test 
and angina during the follow-up period. One-half of the 
patients had shown at least o. 1 m V depression of the ST 
segment. The effort test results proved to be irrelevant for 
prediction of reinfarction, however. It is concluded that 
depression of the ST segment during effort testing in this 
group of patients does not constitute an indication for 
coronary angiography. 
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Table 1, page70 : the first column should be as follows: 
A Verschijnselen 
angina pectoris, n (%) 
ventriculaire ritmestoornissen, n (%) 
B Onderzoek bevindingen 
behaalde max. belasting, % (SD) 
0. I mV ST-daling, n (%) 
0.2 mV ST-daling, n (%) 
0. I mV ST-stijging, n (%) 
0.2 mV ST-stijging, n (%) 
max hartfrequentie, sl/min (SD) 
max syst bloeddruk, mmHg (SD) 
toenamse syst bloeddruk, mmHg (SD) 
Table 2, page 70: the first column should be as follows: 
overleden, n (%) 
recidief infarct, n (%) 
angina pectoris n (%) 
CABG of PTCA n (%) 
geen complicaties, n (%) 
Ned Tijdschr Geneeskd 1986: 130. nr 5 
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SUM.MARY Of 510 patients admitted to hospital with acute myocardial infarction, 34 had coronary 
artery bypass grafting before discharge ( 6-43 days (median 20) after infarction). The patien'[S who 
were given grafts generally had a smaller infarction with less functional impairment than the 476 
patients who were not. The outcome of coronary artery bypass grafting was investigated in a 
retrospective matched pair study. Patients were matched on the basis of the presence of post-
infarction angina, left ventricular ejection fraction, location of the infarction, peak creatine kinase 
activity, Killip clinical class, and severity of coronary disease with 34 patients who were given 
medical treatment only. At one year follow up fewer of the operated patients had symptoms than 
did the matched non-operated patients. Survival at one year in the operated and non-operated 
groups respectively was 94% vs 91 %; angina within one year occurred in 3% vs 68%; congestive 
heart failure in 3% vs 6%,; and 0% vs 32% were referred for later bypass grafting or coronary 
angioplasty. 
It is concluded that coronary artery bypass grafting can be performed safely soon after myo-
cardial infarction provided that left ventricular function is not seriously compromised. Such 
trearment is more effective than medical treatment for relief of angina during the first year after 
infarction. 
Referral for coronary artery surgery early after acute 
myocardial infarction presents a dilemma to the car-
diovascular team. It has long been maintained that 
surgery at this stage carries substantial operative 
risks; recent reports, however, suggest that suches-
timates of operative mortality and complications 
may be unduly pessimistic. 1 - 3 DeWood etal and 
Berg et al have reported that surgery can be safely 
performed in the acute phase of infarction with ex-
cellent results. 14 When pharmacologically uncon-
trolled angina indicates the likelihood of further 
deterioration, the indication for surgery is clear, es-
pecially since it may be possible to salvage the jeop-
ardised myocardium. The possibility that surgery 
will improve long term survival or prevent rcin-
farction in this group of patients, however, has not 
been proven. 
For the past few years we have referred patients 
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for coronary bypass surgery when recurrent angina 
was refractory to pharmacological treattnent, in 
some patients soon after acute myocardial infarction 
and in others when angina was induced by mild ex-
ertion and associated with severe coronary lesions. It 
has been our impression that this could be done at 
low risk and with good long term results. 
We have compared results in a group of patients 
operated on soon after infarction with results in all 
other patients seen over the same period who re-
ceived only pharmacological treattnent. We have 
also compared them with a matched pair series of 
patients at similar risk and with similar symptoms 
who were not operated on. Over a one year follow up 
we compared mortality, reinfarction, late referral to 
bypass surgery or coronary angioplasty, and recur-
rence of complaints. 
The sole criterion for inclusion in the surgery 
group was that the patient had isolated coronary ar-
tery bypass grafting soon after an acute infarction 
and before hospital discharge. Most had angina pec-
toris at r'est that was resistant to intensive medical 
treattnent. There are always exceptional cases, how-
460 
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ever, generally those with angina during mild exer-
tion or advanced proximal lesions or both. In this 
study we have chosen to include all cases referred to 
surgery before hospital discharge after an acute 
myocardial i."'lfarction. 
Patients and methods 
Myocardial infarction was diagnosed when at least 
two of the following were present: typical prolonged 
chest p:ain lasting at least 45 minutes; evolving QR 
complexes or Q waves of more than 0·04 s duration 
with ST and T wave changes in the case of trans-
mural infarction~ or T wave inversion or ST depres-
sion persisting for at least 24 hours without loss of 
the R wave or development of new Q waves in the 
case of non-transmural infarction; a typical rise and 
fall of total creatine kinase with a peak activity 
greater than 100 IU/1 (twice the upper limit for nor-
mal in our clinic). 
From March 1981 to February 1983 there were 
529 admissions with acute infarction. Hospital treat-
ment followed the guidelines described by Simoons 
et al. 5 Four cases were referred for surgery because 
of mitral valve incompetence, ventriC".J.lar septal de-
fect, or free wall ventricular rupture, and fi...~een 
were treated by elective percutaneous transluminal 
angioplasty before discharge. These nineteen pa-
tients were excluded. 
Of the remaining patients, 34 had coronary 
surgery during the admission for myocardial in-
farction and 476 did not. In 27 patients the indi-
-:ation for operation was persistent angina pectoris at 
rest, refractory to medical treatment including beta 
blockers, calciu."ll. antagonists, and nitrates. Three of 
these patients were in Killi.p class III or IV during 
the acute phase of infarction. No patient was in 
severe heart failure or cardiogenic shock at the time 
of operation. The seven other patients did not have 
persisting angina at rest; three of them had .angina 
during mild exenion and they were found to have 
severe proximal lesions, and four bad severe prox-
imal lesions in the infarct related artery after 
anempted intracoronary thrombolysis with strep-
tokinase. Table I summarises the clinical data at en-
t.ry to the trial. The coronary score0 was 15·5 (8·8) 
(mean(SD)), 'three patients were classified as having 
proximal three vessel disease, none had exdusivelv 
distal vessel disease. · 
Seventy three (15%) oft.1.e 476 patients who were 
not referred to surgery also had post-infarction an-
gina, but they were not offered surgery for various 
reasons: angina became responsive to medication; 
there were contraindications to surgery because of 
severe non-cardiac disease; some refused surgery; 
and in a few the coronary anatomy was not suitable. 
Poor left ventricular function was not regarded as a 
contraindication to coronary bypass operation. 
A subgroup of 34 non-operated patients was 
tnatched to the operated patients on the basis of age, 
presence of angina during the hospital stay, Killip 
class, !.eft ventricular ejection fraction (radionuclide 
ventriculography) at discharge or before surgery, lo-
cation of the infarction, peak serum creatine kinase 
activity, and anatomical severity of coronary artery 
disease (greater than 50% diameter stenosis, coded 
Table: I Key prognostic variables used to select matcJ-.cd pairs from the larger series of rum-operated patients ro match the 
group of operated patients 
Variable OJXrated Maxd-.ul non-operated p All TUm•·<JfN:,.ated p 
No. of cases 34 34 476 
Age(yean;) 60·7(6·1) 55·5 (8·9) 0·01 58·3(ll·6) NS 
Post-mfarction angi.n.:l at rest Z7 (79" 0 ) 25 (74° 0 ) NS 73 (lS~o) 0·0001 
Ejection fr;tction 0·48 (0·14} 0·49 (0·11) NS 0·45 (0·16) 
(31 cru;es} (34-cases) (35Scru;es) 
Location of MI: NS 0·025 
Tnm:m1uml :mterior 9 (26° 0 ) 10 (29°0 ) 189 (40~") 
Tr:msmlll':l.l inferio,- 10(29"0 ) 9 (20~0 ) ln(37~o) 
Non-o:::msmur21 15 (44°0 ) 15 (44"0) 102(21%) 
Undefinable/unknown 0 0 8 
Peak SC1:1m1 CK (IU/1) 420 (390) 420 (320} NS 610 (530) 0·05 
Killip cbss: NS 0·025 
I 25 (74~·0 ) 25 (74° 0 ) 278 (58~ 0 ) 
II 6 (18" 0 ) 6 (18°~) 113 (24~(,) 
lil or JV 3 (9<;;,) 3 (9°:o) 85 (18",0 ) 
An.:l.tomical severity: NS 
1 or 2 vessel d.ise~se 15 (44" 0 ) 18 (53° 0 ) Ill (23° 0 ) 3 vessel or left main vessel disease 19 (S<J";,) 10 (47°~) 43 (9° 0 ) 
Unavailable 0 0 322 (68~0 ) 
Data_a.~ repone<! as events and pac=w.ge of ca,;cs o,- as me:m (SD). Sw.o~ticnl eomparisons: noo-opc:r::ne<! vs ope::atc:d.; NS, difference 
not SJ.gnificam at the 0·05 levd. 
•No ~tatisrical comparison Oc:cluse large number.; of ouries were missing. 
Ml, myoc::u-dial infarction~ CK, creatine klrul:\e. 
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as (a) one or mo vessel disease or (b) three vessel 
disease or worse) (Table 1). Mean' (SD) coronary 
score0 was 12·5(6·5), one case was classified as hav-
ing proximal three vessel disease and five cases h::~.v­
ing exclusively distal vessel disease. 
Medication in the operated patients (at referral to 
surgery) was compared with that in the non-
operated matched pairs: beta blockers in 85% of 
operated vs 80% non-operated, calcium antagonists 
in 85% vs 60%, nitrates in 85% vs 70%, digoxin in 
18% vs 15%, and diuretics in 29% vs 33%. Treat-
ment at discharge for all 476 non-operated patients 
included beta blockers in 44%, calcium antagonists 
in 19%, nitrates in 33%, digoxin in 25%, and di-
uretics in 38%. The median duration from onset of 
the infarction to operation was 20 days (range 6 to 43 
days); 97% were operated on within 35 days. For 
those patients referred for operation, treatment with 
analgesics and sedatives had already been started, 
hence additional premedication was usually not re-
quired. Intravenous fentanyl 15 Ji&/kg was used for 
induction of anaesthesia and 0·1 mg/kg pan-
curonium was given to facilitate intubation. Treat-
ment with intravenous glyceryl trinitrate and 
inotropics was determined on the basis of arterial 
pressure monitoring and in principle drug treatment 
continued until extracorporal circulation was estab-
lished. The patient was ventilated with a servo-
ventilator with a mixture of oxygen and nitrous 
oxide (40:60). Additional intravenous fentanyl and 
possibly pancuronium were given as required before 
sternotomy and later duri..ng operation. 
Coronary artery bypass grafting was performed 
with moderate systemic hypothermia (28°C) and 
cardioplegic arrest in combination with topical cool-
ing by means of a saline solution (4°C). Cardioplegic 
arrest was accomplished by use of at least 500 m1 of 
StThomas's solution (sodium chloride 91·6 mmol/1, 
potassium chloride 14·8 mmol/1, magnesium sul-
phate 1·2 mmol/1, magnesium chloride 15 mmol/1, 
potassium d.ihyd.rogen phosphate 1·2 mmol/l, cal-
cium chloride 1·2 mmol/1, and hydrochloride pro-
Table 2 Clinical infomuuion.lxforc discharge from hcspital 
caine 1·0 mmol/1). This was administered through 
the aortic root after cross clamping. If cross clamp-
ing lasted more than one hour after the initial in-
fusion, cardioplegia was repeated every 60 minutes 
to maintain a fiat electrocardiogram. 
A jump graft was constructed with a saphenous 
vein graft to all coronary arteries which had stenosis 
of 50% or more. One sequential vein graft was rou-
tinely used and all distal anastomoses were made 
during cardioplegic arrest. The proximal anas-
tomosis was made after removing the cross clamp 
during rewarming. The average revascularisation 
rate was 3·5 grafts per patient (6 cases with 5 grafts, 
11 with 4, 10 with 3, and 7 with 2). Sinus rhythm 
usually returned spontaneously. The left ventricle 
was always vented by means of a left ventricular 
drain. 
Ventilation in the postoperative period was con-
tinued until the patient awoke and was hae-
modynamically stable. Hypertension was treated 
with nitroprusside. The patient was extubated on 
the same day as operation or the next morning. 
Results 
Compared with the 476 non-operated cases, the 34 
operated cases had a greater frequency of non-
transmural infarction, were more often in Killip 
class I, and had lower mean peak serum creatine kin-
ase values, indicating less myocardial damage from 
the acute infarction. The ejection fraction, however, 
appeared to be similar in both groups, but it was not 
known in 61 of 70 (87%) of patients who died in 
hospital compared with 60 of 44:4 (14%) hospital 
survivors. The mean(SD) ejection fraction of 
0·45 (0·16) for non-operated cases, because it is de-
rived from the group containing the larger fraction 
of deaths, may therefore overestimate the true ejec-
tion fraction for this group. Finally, the in-hospital 
mortality rate was 3% for operated cases vs 14% for 
all 476 non-operated cases (Table 2). All these 
Variable Operated Matched ntm-<>pcra.ud p Allntm-operaud p 
No. of cases 34 34 476 
Mol~ 27(79%) 29 (85%) NS 377(79%) NS 
History of a.oginu of more than 4 weeks 22(65%) 11 (32%) 0·01 164(34%) 0·0005 
History of old. MI 17(50%) 17(50%) NS 145 (30%) 0·02 
W cd.ge pressure {mm Hg) at admission 9·8 (6·1) 11·1 (4·5) NS 13·3(6·6) 0·05 
Cardiac ind.ex in CCU at admission 3-l (1·1) 2·8 (0·7) NS 2·6 (0·8) 0·05 
Systemic arteria) pressure 119 (20) 126(23) NS 121 (25) NS 
Length of hospital stay 22 (10) 18 (15) NS 12 (10) 0·0001 
Recurr=t Ml in hospital 4(12%) 3(9%) NS 24(5%) NS 
Death in hospital 1(3%) 1(3%) NS 69(14%) 0·07 
Data are reported as events and percentages of cases or as rnc:m (SD). Statistical cornparisons: non-operated vsopcr.ued.; NS, d.ifference 
not signi£cnnt at the 0·05\cvel. 
MI, myocardial infarction; CCU, coronary care unit. 
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results indicate that patients referred for coronary congestive heart failure in a 67 year old man (ante-
artery bypass grafts were generally in a better condi- rior infarction, peak serum creatine kinase activity 
tion overall after their myocardial infarction than 130 IU/1, ejection fraction 0·24, history of previous 
were the non-operated patients. Therefore some infarctions, three vessel disease). 
form of matching is required to obtain a meaningful Among the survivors at one year (32 operated, 31 
comparison between the operated and non-operated matched non-operated, and 356 non-operated cases) 
patients. there were several highly significant differences. 
The size of the infarction appeared to have a bear- Cardiological events were infrequent in the operated 
ing on the timing of operation; when peak serum cases; only one patient had angina and another had 
creatine activity was < 400 IU /1 the median delay symptoms of congestive heart failure. Of the 356 
from date of myocardial infarction to operation was survivors in the non-operated group, 143 reported 
14days compared with 26 days when creatine kinase angina by one year (43% of survivors), 57 had had 
was ~400 IU/1. an episode of congestive heart failure (16% of sur-
One year survival in the operated cases was 94% vivors), and 30 were eventually referred to coronary 
compared with 91% in matched non-operated cases artery bypass graft surgery (8% of survivors). The 
(Table 3). Two patients in the operated group died; comparison of operated survivors with the matched 
both had had post-infarction angina and were in non-operated patients is even more striking. Of the 
congestive heart failure in the acute phase of in- 31 matched non-operated survivors, 23 (74%) had 
farction. The first death, in a man aged 65, occurred angina by one year (five with angina Killip class IV, 
in the perioperative period and 7 days after the in- six with class III, and twelve with class II) and 10 
farction. He had an inferior infarction with peak se- were referred for late coronary artery bypass surgery 
rum creatine kinase activity of 530 IU/1, an ejection (32%). The frequency of recurrent infarction and 
fraction of 0· 37, and three vessel disease. Death was congestive heart failure, however, is similar to that 
caused by low cardiac output syndrome. All grafts in the operated cases. 
were found to be thrombosed. The second death, in Since the indication for coronary artery bypass 
a man aged 64, occurred 5 months after infarction grafting shonly after an acute infarction is recurrent 
and was caused by congestive heart failure. He had angina resistant to medical treatment, it is pertinent 
had an extensive inferior infarction with peak serum to ask whether these cases differ in any other im-
creatine kinase activity of 1595 IU/1. portant way from those without post-infarction an-
There were three deaths in the matched non- gina. To avoid a selection bias, we considered only 
operated group. The first occurred 26 days after in- those patients who survived the first 72 hours after 
farction due to cardiac rupture in a 60 year old man the acute event. Ninety eight patients presented with 
(inferior infarction, peak serum creatine kinase ac- such post-infarction angina (21% of 472 patients 
tivity 400 IU/1, ejection fraction 0·41, three vessel surviving three days or more) (Table 4). There were 
disease, and with congestive heart failure in the no significant differences in the distribution of age, 
acute phase). This patient did not have post- sex, or history of a previous infarction, although 
infarction angina in the acute phase but the other cases with recurrent angina do have a longer history 
two did. The second death occurred at 70 days due of angina before the acute event. Ventricular func-
to progressive cardiac failure in a 50 year old man tion is virtually identical in the two groups as is one 
(anterior infarction, peak serum creatine kinase ac- year survival. At discharge beta blockers, nitrates, 
tivity 1360 IU /1, ejection franction 0·18, three vessel and calcium antagonists were more frequently being 
disease). The third death occurred at 67 days due to given to patients with post-infarction angina. 
Table 3 Follow up of patients after dischargejr(Wl hospital 
Vario.bk Operated Marched non--operated p All TUmoo(Jpt:rated p 
No. of cases 34 34 476 
Death after discharge 1(3%) 2(6%) NS 51 (11%) NS 
Survival at 1 year 32(94%) 31 (91%) NS 356 (75%) 0·02 
Recurrent MI by 1 year 0(0%) 0{0%) NS 27(6%) NS 
Angina by 1 year 1{3%) 23(68%) 0·0001 153 (32%) 0·0001 
CHFwi:thin 1 year 1(3%) 2(6%) NS 57 (12%) 0·05 
CABG within 1 year 0(0%) 10(29%) 0·001 30(6%) NS 
PTCA within I year 0(0%) 1(3%) NS 5(1%) NS 
Dat:J. rq)Orted as events and petCC:Otage of ca:>es. Statistical comparisons: non-operated '!IS operated; NS, difference not significant at the 
0·05\evel. 
MI, myocardi.al iofaxcrion; CHF, congestive heart failure; CABG, coronaey nnery bypass graft: :surgery; PTCA, percutaneous 
mms1uminal coronaey angioplascy. 
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Discussion 
Earlier repons on the outcome of bypass operations 
peformed soon after acute myocardial infarction 
were not encouraging. In 1974 Dawson et al re-
ported a hospital mortality rate of 14·5% in 145 pa-
tients operated on within two months of an acute 
myocardial infarction and a rate of 38% in those 
operated within one week. 7 At that time hospital 
mortality for elective coronary anery bypass graft 
surgery in patients without a recent myocardial in-
farction was 6·2°,Q at the same hospital. Because this 
latter figure is considerably higher than that cur-
rently reported8 q (less than 2~0 at most hospitals), it 
is likely that the surgical mortality for patients with 
acute infarction has also fallen, and, indeed, recent 
reports clearly demonstrate this fact. In 1985 Will-
iams et al reported a hospital mortality rate of2% in 
patients operated on within 30 days of infarction, 1 
and Nunley er al reported a 3°'o operative mortality 
rate in those operated on within rn-o weeks of in-
farction; this was in a subgroup of 66 patients with 
threatened extension of infarction. 3 In our series the 
operative monality is one case out of 34 (3%) while 
the one year survival (94°,0 ) accords with the recent 
reports mentioned above. The current operative 
mortality rate at our institution for all aortocoronary 
bypass surgery is 1·2~o with a 5 year survival of 
93·5°~. 10 Wh;le surgical mortality after acute in-
farction has apparently improved greatly over the 
past decade, it still falls somewhat short of the excel-
lent results of elective surgery. 
Brower, Fioretti, S£moons, Haalebos, Rulf, Hugenholt:: 
infarction is small or caused relatively liule func-
tional impairment or both. Such patients would be 
expected to have a better prognosis whether or not 
they were operated on early, and this assumption is 
supported by the results in the matched pair series. 
It should be borne in mind that our results are 
based on a retrospective study with all u~e lim-
itations inherent in such an approach, and despite 
matching major differences remain betWeen the rn-o 
groups-these are responsiveness to medical treat-
ment, unsuitable coronary anatomy for bypass 
surgery, and important non-cardiac disease. For ex-
ample, five patients in the non-operated group had 
exclusively distal vessel disease whereas none of the 
operated group did. 
There has been a substantial improvement in sur-
gical technique and postoperative care since the 
early 1970s, and we agree with Nunley eraP that 
current results do mitigate the concern about at-
tempting an early operation in patients with post-
infarction angina. Nevertheless, we should continue 
to exercise caution. Because the current policy gen-
erally excludes patients with extensive ventricular 
dysfunction, much of the risk of surgery has been 
eliminated at the outset. This is borne out by the fact 
that the two deaths in the operated group, one at 7 
days and the other at 5 months, occurred in patients 
with poor left ventricular function. Furthermore, it 
has been our policy to select patients in whom the 
We found no significant difference in survival be-
rn-een patients with or without post-infarction an-
gina (Table 4), nor was there a significant difference 
in survival between those operated on and the 
matched non-operated patients. It is doubtful 
whether operation would materially affect one year 
survival in any event since it was carried out too late 
to influence the primary infarct size itself. 11 
De Wood et a/1 and Berg et a/4 have reported that 
operation at a sufficiently early stage of infarction 
may limit infarct size and improve survival, al-
though this can not be taken as proven since their 
patients formed a consecutive series without concur-
rent controls. The major benefit of surgery in our 
Table 4 Comparison of patients withcur and with 
post-infarction angina who survived the first 72 hours after 
myocardial infarction ( 4 72 patien.ts) 
Variable Ncpcst*MI Post*MI p 
an~:~na angina 
Noofca:sc:s 374 98 
A~(yc:ars) 57 (12) t.O (10) NS 
Mol~ 301 (80° 0 ) 75 (77" 0 ) NS 
Length of stay (days) 12·9 (8·8) 18·8 (10·7) 0·001 
Ejection fraction 0·45(0·16) 0·46 (0·13) NS 
(303casc:s) (86casc:s) 
History of old MI 114(30°0 ) 36 (37°.,) NS 
History of AP for more 
61 (62° 0 ) 0·001 than 4 wc:d:.s 110(29"ol 
Location of MI: NS 
Transtn1.1r::tl anterior 144(38°0 } 31 {32"0 ) 
Transm1.1ra! inferior 139 (37"·o) 34 (35":,} 
Non*transrmrral 85(23" 0 ) 32 (33" 0 ) 
Unknownlundc:tin<lbk 
' 
I 
Peak serum CK (IU/1) 620 (540) 520 (420) NS 
Killip clinical class; NS 
I 237 (63"·0 ) 64 (65";,) 
II 90 (24" 0 ) 24 (24° 0 ) 
Ill 23(6"0 ) 6(6"ol 
IV 24 (6° 0 ) 4 (4"o) 
Wed~ prc:s1.1re C= Hg,l 12·9 (6·5) 11·3(6·0) NS 
Cardlllc: index (ljminlm•) 2·8(0·8) 2·b (0·8) NS 
Mean nnc:rial prc:ssu.rc: 
NS C=Hg) 123(22) 123 (20) 
Death in hospital 27 (7" 0 } 5 {5"o) NS 
Death after disc:hargc: 
13 (13'\,) NS within one: yc:ar 39 (10" 0 ) 
Non*fatal rc:infarction 43(ll"oi 12(12"0 ) NS 
Total one: year survival 317(85"0 ) 83 (85"ol NS 
MOOication at discharge: 
NS Anticoag\ll.ants 74 (20".0 ) 19 (I9"ol 
Beta blockers 147{39"o) 63 (64"uJ 0·001 
DiSQXin 88(24" . .,) 18 (18" ol NS 
Di1.1rctics 129 (34".,,) 3i(38"ol NS 
Nitratc:s 91 (24" 0 ) 73 (74°,.) 0·001 
Calcium anragonists 46(12° 0 ) 60 (61 "o) 0·001 
A.ntiarrhythmics 18 (5° 0 ) 4 (4":0 ) NS 
Data reponed as events and perc:c:ntagc: of casc:s or as mean (SD). 
All perc:c:ntagc:s c:ompl.ltc:d over entire series of374 and 98 cases 
rc:spectivc:ly. NS, ditfc:r_c:nc:c: not siKD.i:ficant at the 0·05 lc:vd. 
Ml, myoc:u:dial infarroon; AP, angina pectoris; CK, crc:arine 
kinase:. 
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series thus is the effective management of refractory 
post-infarction angina. Nevenheless, the decision to 
perform bypass grafting for this indication soon af-
ter infarction remains a matter requiring careful 
judgment in each patient. 
These data were gathered during a period when 
percutaneous transluminal coronary angioplascy 
started to gain acceptance at our institution. It is 
clearthat-angioplasty is having an impact on our pol-
icy to refer patients for operation; more patients re-
ceive angioplasty first, and those with unsatisfactory 
results or complications are later referred for oper-
ation. 12 Meyer et al have reported that angioplascy 
can be carried out at low risk and with good early 
and late results in patients with unstable angina pec-
toris. 1 :> But results from randomised trials designed 
to evaluate the long term success rate of this policy 
have not yet appeared. Also it remains to be seen 
what effect the widespread availability of throm-
bolytic agents such as recombinant tissue type plas-
minogen activator14 will have on the management of 
these patients. 
In summary, the results presented here for coro-
nary anery bypass surgery after acute myocardial 
infarction show that this procedure can be carried 
out with low operative mortality and one year mor-
tality. In patients with post-infarction angina in 
whom an extension of infarction is threatened oper-
ation should be considered provided that the infarct 
is small and that left ventricular function is good. 
We must emphasise, however, that if angina can be 
controlled by medical treatment early after in-
farction, then this remains the preferred approach. 
The most striking difference between the operated 
and non-operated matched pairs is the recurrence of 
angina within one year that required aggressive 
medical treatment, angioplasty, or coronary bypass 
graft surgery. 
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The identification of high and low risk subjects among those who have 
recovered from acute myocardial infarction is a major aim in clinical car-
diology~ now that so many therapeutic modalities are available. It is 
logical that this should be done in the most efficient way, that is, as 
was pointed out in the introduction, with a strategy which provides the 
greatest information at the lowest possible cost and discomfort to the 
patient. 
In order to make such risk assessment and provide therapeutic recommen-
dations, it is essential to have a knowledge of the mortality risk of the 
disease. Only then does it makes sense to stratify patients in different 
risk subsets. Numerous studies have shown that the time course of mor-
tality in hospital survivors of myocardial infarction is characterized by 
a first year mortality of 10 to 15% as an average~ with a subsequent 
annual mortality rate of 3 to 5%. In particular the first six months after 
hospital discharge represent a high risk period 1 ~ 2 Our findings are 
consistent with the data reported in the literature~ since overall one 
year cardiac mortality was 11 ~ 7% ( 70 out of 596 hospital survivors). 
Thirty patients died during the first three months after discharge, an 
additional 14 patients between 3 and 6 months. Thus, of the one year 
cardiac mortality after discharge, 63% occurred in the first 6 months. 
More than one half of these patients (53%) died suddenly, that is within 
one hour from the onset of symptoms or were found dead unexpectedly. All 
these factors underscore the importance of an early risk assessment of 
post infarction patients. 
Prognostic stratification can be based on variables related to the 
amount of myocardial damage, the extent of coronary artery disease, or re-
sidual myocardial ischemia, and to the presence of ventricular arrhyth-
mias. 
Adequacy of left ventricular function or the extent of myocardial 
damage can directly or indirectly be judged from simple clinical signs 
2,4 
or can be quantified by non-invasive or invasive methods, such as 
hemodynamic monitoring5 • 7 , serum enzyme levels8 , radionuclide studies9 ' 10 , 
11 . 12 13 
echocardiography , 12 lead electrocard~ography , chest X ray or 
1 . h 14, 15 cardiac catheterization, including left ventricu ar ang~ograp y 
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- 16-19 Residual myocardial ischemia can be shown by exercise stress test~ng 
20 pharmacological interventions, like dipyridamole test atrial pacing 
stress testing21 and by ST changes from 24-hour ambulatory electrocardio-
graphic analysis22 
Finally, ventricular arrhythmias can be detected by telemetry, 24-hour 
ambulatory electrocardiographic monitoring23 or by provocative tests such 
as exercise24 or electrophysiological testing25 •26 
Based in part on these observations, it has been suggested that an 
algorithm be developed to identify patients at high and intermediate risk 
in whom a more aggressive management would be indicated~ as well as low 
risk group where multiple tests and special management are not war-
ranted27~28. Such an algorithm should use the most sensitive and specific 
tests and eliminate or obviate those which are costly and redundant. 
Furthermore~ low risk patients should not undergo invasive evaluation. 
Although a great amount of information is available on the prognostic 
value of the individual tests, little information is available on the 
relative prognostic value of tne different tests and on their additive 
value beyond that of usual clinical information and tests29- 32 • Therefore 
the question which tests, in which sequence and for whom in the evaluation 
of post-infarction patients remained open for debate as recently as 
198533 . 
Accordingly we investigated in the same patients recovered f;:-om myo-
cardial infarction the prognostic value of symptom limited bicycle ergo-
metry, resting radionuclide ventriculography and 24-hour electrocardio-
graphic monitoring since these provide information on left ventricular 
function~ myocardial ischemia and ventricular arrhythmias and since they 
are among those tests who are most commonly applied in post infarction 
patients. We then coiDpared this information to the cheapest method of them 
all, the medical history and the in-hospital course. 
Exercise electrocardiography 
Exercise testing can detect a myocardial ischemia in difterent ways~ 
such as the provocation of angina and the induction the induction of ST 
segment changes. At variance with the findings of Theroux34 and those of 
30 the Stanford Cardiac Rehabilitation Program , an "ischemic" response to 
exercise testing has in our experience not been a significant factor in 
identifying patients with increased mortality risk after hospital dis-
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TcibZe 1 RevascuZarisation procedures in the first year after myocardiaL 
infarction in patients who underwent predischarge stress t~"":st. 
stress test 
results 
ST depression yes 
~ 1 rom 
Angina 
Total 
no 
yes 
no 
number of 
patients 
191 
213 
85 
323 
408 
revascularisation 
procedure 
N % 
41 
17 
30 
28 
58 
21 
8 
35 
8 
14 
p-value 
0.0005 
0.0005 
* missing data in 4 patients with intra ventricular conduction 
abnormalities. 
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charge (Chapters 2 and 3 and Figure 1). 
This apparently surprising negative finding is consistent with several 
other recent reports14 , 29 , 31 , 32 , 35- 38 The reason for such differing 
findings is not immediately apparent. It is probably related to a variety 
of factors, the most important. of which is the selection of patients for 
exercise testing (fig 1). In our population 191 patients (32%) were judged 
not eligible for the exercise test, in 55 cases due to severe angina. 
These patients may have formed an important section of the patients 
34 described by Theroux Furthermore many patients with exercise induced 
angina and ST depression underwent coronary artery bypass surgery or 
percutaneous transluminal coronary angioplasty at discharge or during 
follow-up (table 1). These factors could have had biased the results by 
underestimating the prognostic value of an ischemic response to exercise 
testing (Fig 1). On the other hand, the studies more corresponding to 
ours, reported by Jennings et a137 Birk Madsen and Gilpin29 and Saunamaki 
and Anderson35 also did not show a relationship of ST segment depression 
to mortality. It was significant that in their series no patient underwent 
a revascularisation procedure during follow-up. Even though we cannot draw 
definitive conclusions about the lack of association between ST segment 
depression during exercise and cardiac mortality in our hands, our policy 
remains not to refer asymptomatic patients to coronary angiography when ST 
segment depression is the only abnormal finding during the exercise test. 
In contrast to the absence of the "ischemic response", as a significant 
prognostic factor, the hemodynamic response (and in particular the extent 
of systolic blood pressure rise by cuff measurement) and the maximum 
workload, achieved during bicycle ergometry, were highly predictive of 
mortality (chapters 2 and 3). The extent of blood pressure rise was the 
single best prognostic variable and it was the only one which by multi-
variate analysis provided more information than the other usual clinical 
variables. 
This finding is in good agreement with recently published results of the 
Multicenter Postinfarction Research Group32 , who found in 655 patients who 
underwent a submaximal treadmill test early after myocardial infarction, 
that the duration of exercise and the maximal blood pressure were the best 
prognostic variables which identified a large percentage of low risk 
patients. In this study 57 intermediate risk patients were found with a 
maximal blood pressure of less than 110 mmHg (10 deaths, mortality of 17%) 
and 598 low risk patients (20 deaths, mortality of 3%). They conclude, 
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heart failure47 
non cardiac 
causes 71 
other 18 
Fig. 1 Exercise test results and cardiac mortality during follow up in 594 
hospital survivors of myocardial infarction. 
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like we, that it is very unlikely that drug therapy or revascularisation 
procedures will be of any value (unless indicated by symptoms) in such a 
low risk group. Also the execution of multiple tests is not indicated in 
h I d l .k h f K 13 2 · t is group. n our stu y, l. e in t at o rene et a , patJ.ents were 
identified to be at high, intermediate and low risk based on the com-
bination of their eligibility for exercise testing, a history of previous 
myocardial infarction,the indication for the use of digitalis at hospital 
discharg2 and the extent of blood pressure rise during exercise (see 
chapters 2 and 3). It appears that 40% of this population could be 
characterized as being eligible for the exercise test, not having sponta-
neous angina during exercise and with an "adequate" blood pressure respon-
se (30 mmHg or more) during exercise (Figure 2). This 40% had a very low 
mortality (3%), similar to the results described by Krone el a132 . This is 
a subgroup of patients, for whom other tests and specifically invasive 
tests are not indicated. 
Radionuclide ventriculography 
Radionuclide ventriculography was confirmed to provide strong prog-
nostic information (chapter 3) in agreement with many other studies9• 14 ,lj,-
17,27,39 The most efficient cut-off point, that is the point which 
provided the highest sensitivity and specificity, to stratify high and low 
risk patients was an ejection fraction of 40%. In agreement with the 
results of the Multicenter Postinfarction Research Group, we found that 
the risk of cardiac mortality progressively increased when the resting 
ejection fraction decreased below 40%. 
However, an important finding of our study is that in patients who com-
pleted for exercise testing, the radionuclide ejection fraction 
did not provide additional prognostic information beyond that provided by 
clinical information and bicycle ergometry. This issue, as far as we know, 
has not been earlier addressed in the literature, and implies that the 
performance of a radionuclide study is only indicated in patients not 
eligible for stress testing, where it does provide inde~endent information 
beyond clinical data (chapter 3). It is also helpful in those patients who 
appear at intermediate risk from clinical and exercise test results or in 
whom the test is equivocal. Even so, given the cost of this test in terms 
of apparatus and manpower requirements, it is an important conclusion that 
radionuclide testing can be reserved for a relatively small subset (about 
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Fig. 2 Exercise test results and cardiac mortality during follw up in 
hospital survivors of myocardial infaretion. 
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30%) of patients at the time of their discharge. 
24-hour ambulatory electrocardiographc monitoring 
With regard to the association between ventricular arrhythmias and sub-
sequent cardiac mortality~ the literature is virtually unanimous. In fact 
several studies have demonstrated a significant association between 
premature ventricular depolarizations (both in terms of frequency and 
patterns) and subsequent cardiac mortality1 ~ 23 , 39-42 In particular, 
couplets and runs (3 or more complexes) of premature ventricular complexes 
. 41 40 
are associated with the highest mortal~ty Schultze et al and Bigger 
et a141 found that the mortality was most elevated in patients with 
ventricular arrhythmias and left ventricular dysfunction. In particular, 
the results of the Multicenter Post-Infarction Research Group41 show that 
left ventricular dysfunction, assessed from ejection fraction and ventri-
cular arrhythmias detected by 24-hour ambulatory electrocardiograms are 
independently related to mortality risk. 
These data underscore that the clinical relevance of ventricular 
arrhythmias is dependent on the substrate, i.e. the degree of ventricular 
dysfunction. In keeping with these observations we found that ventricular 
arrhythmias were not significantly predictive of mortality in patients 
eligible for exercise testing (chapter 3, table 6), but were predictive in 
those not eligible for exercise testing, in whom the ejection fraction 
compared to that in patients eligible for exercise test was much lower (39 
~ 16% vs 47 ± 15%, chapter 3, table 4). 
Even when arrhythmias are found, the question remains whether reduction 
of ventricular arrhythmias can improve survival, particularly in those 
patients with decreased left ventricular function. Thus far, despite a 
consistent suppression of ventricular arrhythmias, no trial with anti-
arrhythmic agents has demonstrated a reduction of cardiac mortality in 
post myocardial infarct patients41 ' 42 Different hypothesis have been 
formulated to explain this negative finding 41 •43 . The first hypothesis is 
that the suppression of ventricular arrhythmias does not improve prognosis 
at all. The second possible explanation is that the treatment of ventri-
cular arrhythmias may prolong life, but that its benefit cannot be demon-
strated since methodological limitations in the design of the trials and 
the relatively small number of patients participating prevent a small 
benefit from becoming evident. The last explanation is that no overall 
effect has 
benefit some 
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been found as the control 
. 45 pat~ents but harm others , 
of ventricular arrhythmias may 
thus cancelling each other. 
In fact, 
described46 , 
ventricular 
a pro-arrhythmic effect of anti-arrhythmic drugs has been 
which may occur more frequently in patients with malignant 
. 46-49 
arrhythmias and poor left ventricular dysfunct1on 
Accordingly our policy remains to treat ventricular arrhythmias, only 
when they are symptomatic, hence their systematic detection or induction 
has become less relevant. 
Limitations of study 
There are some limitations of this study, which should be discussed. 
Among these are the incompleteness of data, specifically regarding 24-hour 
ambulatory electrocardiographic monitoring and radionuclide ventriculo-
graphy. Other problems are the relatively small number of end-points 
especially in the group of patients with complete tests (chapter 3) and 
the absence of an independent population to test the performance of the 
prognostic variables that were found. 
The prognostic value of a low blood pressure response in patients on 
beta-blockers should be judged with some caution, because of the "blunting 
effect" of beta blocking on blood pressure rise. In these patients. The 
results of the test should be evaluated in the context of other variables 
of exercise tests related to left. ventricular function or one might. 
consider to repeat. the test after withdrawl of beta blockers, if the 
clinical conditions of the patients allow this. 
In chapter 5 the peak serum creatine kinase level was chosen as an 
indirect marker of infarct size. This has been done because this measure-
ment is usually performed in most coronary care units. However, we acknow-
ledge that this is a very crude measurement of myocardial damage. Other 
more specific enzyms like CK-MJ3 or a-HBDH provide more specific infor-
mation about myocardial necrosis and probably about prognosis, especially 
if time-concentration curves are derived from serial measurements4 • 9 . 
Furthermore, the use of thrombolytic agents in the treatment of acute 
myocardial infarction is increasing. Since they modify the pattern of 
enzyme release by including a rapid washout in cases of coronary reper-
fusion, it is likely that in an era where early coronary recanalisation 
will be increasingly applied, the clinical relevance of the peak serum 
enzyme levels will diminish. 
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Conclusions 
Our current view is that the assessment of risk should be carried out 
in the least invasive way and in the most cost effective manner. 
It should begin by an accurate interpretation of the usual clinical 
variables supplemented by a symptom limited exercise test (figure 3). This 
can be performed on average 2 weeks after infarction in about 3/4 of the 
patients who do not present persistent heart failure, angina refractory to 
medical therapy or non-cardiac limitations. Exercise test should be 
symptom limited, since if patients are carefully selected, this is a safe 
procedure and is more accurate to detect signs and symptoms of myocardial 
ischemia than "submaximal" heart rate limited tests51- 54 . 
Additionally the symptom limited nature of the exercise protocol was 
crucial in our study, since the most valuable prognostic variables were 
the extent blood pressure rise from resting values to peak workload, and 
maximal working capacity itself. These data are consistent to recent 
findings of the Cardiac Rehabilitation Group in Standford55 . 
Patients not eligible for stress testing who have recurrent angina 
pectoris, marked heart failure, late sustained ventricular tachycardia or 
ventricular fibrillation, represent a very high risk subset with a mor-
tality during the first year of up to 60%. In these patients multiple 
tests are indicated, according to the specific individual problem with the 
aim of detection ventricular malfunction. Cardiac catheterisation is 
recommended in all patients with angina pectoris. In patients with heart 
failure a non invasive evaluation with echocardiography and/or radio-
nuclide ventriculography may be performed first and cardiac catheteri-
sation should be limited to those in whom there is evidence of left 
ventricular aneurysm, ventricular septal defect or mitral regurgitation, 
lesions which might surgically be corrected. In this regard echocardio-
graphy with the recent addition of Doppler echocardiography may be 
superior to radionuclide studies for tb.e more complet information, its 
repeatibility and the lack of harmful radiation. However a drawback of 
this technique is that it allows less frequently than radionuclide ventri-
culography a quantification of ventricular function. Twent:y four hour 
ambulatory elect:rocardiographic monitoring is recommended in patients with 
late symptomatic ventricular tachy-arrhythmias for t:he assessment of the 
effect of antiarrhythmic treatment. 
Out of the 75% of hospital survivors eligible for the exercise test~ 
more than 50% with an 11adequate" systolic blood pressure response (of 
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Fig. 3 Flow chart proposed for the evaluation at discharge of patients 
after myocardial infarction. 
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30mmHg or more) during exercise, represent a low risk subset (1 year 
mortality of 3%) and do not require additional tests, unless indicated by 
symptoms. 
Patients with lower blood pressure response, even in absence of angina 
pectoris, represent an intermediate risk group, with an average mortality 
of 15 to 19% during the first year. Of this group of patients, which are 
asymptomatic, but still have an increased risk, it is unclear whether and 
which special tests or interventions are indicated. In fact it is reason-
able to perform additional tests only if they can guide therapeutical 
procedure. For instance if coronary artery bypass surgery or percutaneous 
transluminal angioplasty are entertained, coronary angiography should be 
the additional first choice test without other tests before. 
It is our opinion that the guidelines described above are preferable in 
practise because exercise testing is so effective in delineating low risk 
patients. As it is inexpensive and has similar prognostic information to 
that of radionuclide ventriculography, while provinding inforamtion on 
myocardial ischemia, exercise tolerance and arrhythmias it is the most 
valuable approach for risk assessment. It also allows for the estimation 
of the amount of activity patient should be allowed after discharge and 
for developing a schedule of rehabilitation. Finally, it considerably 
improves the self confidence of patients recovering from myocardial 
infarction 56. 
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CHAPTER9 
Samenvatting 
Summary 

SAMENVATTING 
Het doel van deze studie is het geven van een zo compleet mogelijke 
beschrijving van de gegevens van na-onderzoek gedurende 1 jaar, verkregen 
bij een achtereenvolgende groep van 706 patienten ontslagen uit het 
Thoraxcentrum gedurende de periode maart 1981 tot december 1983. 
In het bijzonder hebben wij getracht de relatieve waarde van de gebruike-
lijke klinische variabelen, die van belang zijn voor de overleving na 
ontslag uit het ziekenhuis, vast tel eggen. De waarde van deze klinische 
variabelen is bovendien vergeleken met het voor ontslag verrichte inspan-
ningsonderzoek, met metingen van de linkerk.amerfunctie door middel van 
radionuclide-angiografie en met 24-uurs-elektrocardiografie. Wij hebben 
laten zien dat bij patienten, die in aanmerking kwamen voor de inspan-
ningstest, de stijging van de bloeddruk gedurende de inspanning additio-
nele prognostische informatie verschafte ten opzichte van de reeds bekende 
klinische gegevens. De meting van de functie van de linkerkamer en lang-
durige registratie van het ECG bracht in de aldus gegeven prognostische 
indeling bij deze groep patienten geen wijziging, ook niet indien er 
electrografische registratie sprake was van ventriculaire tachycardieen. 
Patienten, die in staat waren de inspanningstest te verrichten, hadden een 
veel lagere mortaliteit dan patienten bij wie het onderzoek op cardiale 
grond gecontrai.ndiceerd was (8% versus 56%). Op grond van klinische en 
inspanningsgegevens kon een groep patienten geindentificeerd worden met 
een zeer laag risico voor overlijden (mortaliteit 3%). Deze patienten, 40% 
van alle patienten ontslagen na het doorgemaakt.e myocardinfarct, zijn 
gekenmerkt door stijging van de systolische bloeddruk met meer dan 30 mmHg 
tijdens inspanning. Hieruit. kan geconcludeerd worden dat in een omvang-
rijke groep patient.en het. risico voor overlijden geschat. kan worden op 
basis van een zorgvuldige klinische evaluatie en de gegevens van de 
inspanningstest. Aanvullende testen in deze patienten lijken dan ook over-
bodig, tenzij bijkomende klachten deze onderzoeken zouden rechtvaardigen. 
Bij de patienten bij wie het inspanningsonderzoek gecontraindiceerd was, 
verschaften metingen van de functie van de linkerkamer en langdurige 
registratie van het ritme additionele prognostische informatie, ook indien 
er rekening werd gehouden met reeds bekende klinische gegevens. In deze 
groep patienten lijken deze onderzoekingen zeker zinvol. 
In een groep patienten met relat.ief laag risico, gekenmerkt door de 
afwezigheid van intraventriculaire geleidingsstoornissen en/of ventri-
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culaire hypertrofie en/of atrium fibrillatie, werd de prognostische waarde 
van het 12 afleidingen ECG voor ontslag beoordeeld. Hoewel bij deze 
analyse bevestigd werd dat sommige variabelen van het 12 afleidingen ECG 
prognostisch van belang zijn, bleek bij multivariate analyse alleen de 
QRS-score als beschreven door Selvester, als ook persisterende ST segment 
daling en verlengd QT interval onafhankelijk geassocieerd met mortaliteit 
volgend op het infarct. De associatie van klinische variabelen met morta-
liteit was echter veel sterker, zodat de toevoeging van de electrocardio-
grafische gegevens de prognostishe indeling van deze patienten niet 
beinvloedde. 
De invloed die de maximale waarde van de creatine phosphokinase (CK) heeft 
op de prognose werd onderzocht bij patienten, die een eerste infarct 
doormaakten. Er bleek een correlatie te bestaan tussen de PCK waarde's en 
de hoogste mortaliteit in het ziekenhuis. Gedurende bet na-onderzoek werd 
echter geen relatie gevonden tussen maximale CPK waarde en mortaliteit, 
recidief infarct en angina. Hieruit kan geconcludeerd worden, dat men in 
deze groep patienten het verdere diagnostisch of therapeutisch handelen 
niet van de maximale waarde van CK moet laten afhangen. 
De betekenis van de voor ontslag verichtte inspanningstest bij 119 
achtereenvolgende patienten die een ongecompliceerd infarct doormaakten en 
die jonger waren dan zestig jaar, werd duidelijk in het jaar volgend op 
het myocard infarct. Gedurende het na-onderzoek overleed slechts 1 pa-
tient, terwijl 10 een niet fataal recidief infarct doormaakten. De aanwezig-
heid van angina pectoris, en/ of ST segment depressie tijdens inspanning 
bleek niet van waarde voor de voorspelling van het recidief infarct, maar 
deze variabelen correleerden wel met het optreden van late angina pec-
toris. Geconcludeerd wordt dat in deze- groep patienten coronaire angio-
grafie niet noodzakelijk is op grond van de aanwezigheid van ST segment 
daling tijdens inspanningsonderzoek, daar de prognose van deze groep 
uitstekend is. 
Tenslotte bestudeerden wij bet effect van vroege bypass operatie na 
een doorgemaakt myocard infarct bij 34 geopereerde patienten, die verge-
leken werden met 34 anderen, medicamenteus behandeld. De twee groepen 
kwamen overeen voor wat betreft klinische, ventriculaire en coronaire 
angiografische gegevens. Indicatie voor operatie werd gevormd door post-
infarct angina in 30 patienten en doorgemaakt infarct in aanwezigheid van 
ernstige multiple proximale vatafwijkingen in de vier overige pat:ienten. 
De operatie vond plaats na een mediaan interval van 20 dagen na bet 
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infarct. Aan de directe gevolgen van de operatie overleed 1 patient. 
Tijdens het na onderzoek werd geen verschil gevonden in overleving of in 
het optreden van een niet fataal reinfarct tussen de geopereerde en niet 
geopereerde groep. De geopereerde patiEEnten hadden echter een lag ere 
incidentie van angina pectoris. Op grond van de kleine aantal patiEEnten is 
het moeilijk hieruit een definitieve conclusie te trekken. Wel kan gesteld 
worden~ dat een bypass operatie vroeg uitgevoerd na een myocard infarct 
een veilige procedure is die voor wat betreft het optreden van angina 
pectoris in het jaar na het myocard infarct effectiever lijkt dan behande-
ling met medicamenten. 
In hoofdstuk 8 worden onze ervaringen vergeleken met de resultaten 
uit de literatuur~ in het bijzonder wat betreft de waarde van de klinische 
variabelen en veelvoudige niet-invasieve methoden om het risico en het 
ontslagbeleid ten aanzien van hartinfarct patienten te bepalen. Voorzich-
tigheid is geboden bij het schatten van het risico op basis van klinische 
variabelen; het doen van een fietstest wordt altijd aanbevolen. Patienten~ 
bij wie een fietstest gecontraindiceerd is hebben de hoogste l jaar 
mortaliteit (20%). De mortaliteit is nog hoger (50%-60%) indien de contra-
indicatie gebaseerd is op recidiverende angina of decompensatie cordis. In 
deze groep patienten moeten meerdere tests worden uitgevoerd, zoals 
echocardiografie, radionuclide ventriculografie, 24-uurs electrocardiogram 
of hartcatheterisatie, afhankelijk van het individuele probleem van de 
patient. Van de patienten, die een jaar na het hartinfarct nog leven, 
heeft 75% een inspanningstest ondergaan. De patienten met een inspannings-
test hebben 10% minder risico om te overlijden gedurende een jaar na het 
infarct. Een stijging van de systolische bloeddruk met meer dan 30mmHg 
representeerde een lage risicogroep (3%), die 40% van alle overlevenden 
omvatte, terwijl patienten met een mindere stijging van de bloeddruk in de 
middelste risicogroep terecht kwamen (19 %). Patienten in de lage risico-
groep moeten geen additionele tests ondergaan, tenzij geindiceerd door 
klachten. Verdere studie zou verricht moeten worden in de intermediaire 
risico groep, om de beste diagnostische en therapeutische strategie voor 
de individuele patient te bepalen. 
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SUMMARY 
The aim of this study is to provide a comprehensive description of 
follow up data during the first year after myocardial infarction in a 
consecutive group of 706 patients discharged from the Thoraxcenter during 
a three year period, from March 1981 to December 1983. 
In particular we wanted to assess t.he relative value of the usual 
clinical variables to predict survival after hospital discharge, compared 
to that of symptom limited bicycle ergometry, resting radionuclide ventri-
culography and the 24-hour ambulatory electrocardiogram. 
It was shown that in patients eligible for predischarge exercise 
testing, blood pressure rise during exercise provided additive prognostic 
information beyond clinical data. Radionuclide ventriculography and 24 
hour ambulatory electrocardiogram even when demonstrating ventricular 
tachycardia, did not further refine the risk assessment in patients who 
completed for stress testing. Patients Yho were eligible for exercise 
testing bad a much lower mortality than patients judged ineligible for the 
test for cardiac limitations (8% vs 56%). A low risk subset (3% mortality) 
was identified, encompassing 40% of hospital survivors, including patients 
who underwent bicycle ergometry and had an "adequate" blood pressure 
response during exercise (greater than 30 mmHg). From this it follows that 
in a substantial percentage of post-infarction patients a careful clinical 
evaluation and exercise testing are adequate for risk assessment, and that 
other tests are redundant, unless indicated by symptoms. 
In contrast to patient eligible for exercise test, it was shown that 
radionuclide ventriculography and 24 hour ambulatory electrocardiography, 
did provide additional prognostic information beyond clinical data and 
were therefore useful for risk assessment. 
The value of the predischarge 12 lead electrocardiogram, compared to 
other usual clinical variables and tests to predict survival, was assessed 
in "low risk" patients without intra-ventricular conduction defects and/or 
ventricular hypertrophy and/or atrial fibrillation. While it was confirmed 
that several variables from the 12 lead electrocardiogram provided prog-
nostic information, by multivariate analysis only the QRS score by Sel-
vester, persistent ST segment depression and prolonged QT interval cor-
rected for heart rate proved to be independent predictors. Since clinical 
variables were much stronger predictors than electrocardiographic varia-
bles, even the addition of electrocardiographic variables failed to 
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improve the risk assessment. 
The clinical course of patients with different levels of peak serum 
creatine phosphokinase (CK), after their first myocardial infarction, 
showed that those with the highest peak CK value (> 800 IU1-1) had the 
greatest hospital mortality. However, during follow up after hospital 
discharge, different levels of peak CK were not associated with dif-
ferences in mortality, recurrent infarction or angina. It is concluded 
that peak CK in patients after the first myocardial infarction should not 
influence the decision for further diagnostic or therapeutical procedures 
before hospital discharge. 
The value of predischarge bicycle ergometry in 119 consecutive 
patients with uncomplicated first myocardial infarction younger than 60 
years became evident in the first year after myocardial infarction; only 
one patient died while only 10 had a non fatal reinfarction. Exercise 
induced angina and/ or ST depression were not predictive of non fatal 
reinfarction, but they predicted recurrent angina. It is concluded that 
coronary arteriography in this grcup of patients is not indicated even 
when there is exercise induced ST depression, since this subgroup has an 
excellent prognosis. 
Finally, to study the effect of "early" coronary artery bypass 
surgery after myocardial infarction 34 patients were compared with 34 
others treated medically. They were matched by clinical, ventriculographic 
and coronary arteriographic data. The indication for surgery was post 
infarction angina in 30 cases and infarction with severe proximal multiple 
vessel disease in four other patients. Patients were operated upon at a 
median interval of 20 days after the infarction and there was only one 
perioperative death. During one year follow up there was no difference in 
survival or non fatal reinfarctions between the operated and not operated 
group, however operated patients had a much lower incidence of angina 
pectoris. Because of the small numbers it is tentatively concluded that 
early coronary artry bypass surgery after myocardial infarction is a safe 
procedure which is more effective than medical treatment for the relief of 
angina pectoris during the first year after myocardial infarction. 
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APPENDIX A INVENTORY OF THE DATA BASE 
1-1. PATIENT N1\ME 
No entry : o, valid = 706 
1-2. SEX ( l=MALE, 2=PEMALE) 
No entry = o, va~id = 706 
Distribution: 554 152 
1-3. BIRl'H DATE (DDMMYY) 
No entry = o, val.id - 706 
1-4. DATE ADMI'l'TED CCU { DDMMYY) 
No entry = 0, Val.id - 706 
1-5. DATE OP DISCEIARGE (DDMMYY) 
No entry = 66, Valid = 640 
l-6. DATE OF lATEST POLIDW-UP ( DDMMYY) 
No entry = s, val.id = 701 
1-7. DATE OF HOLTER RECORDING (DDMMYY) 
No entry = 316, val.id = 390 
1-8. DATE OF EXERCISE -rEST ( DDMMYY) 
No entry = 298, Valid = 408 
l-9. DATE OP RAOIONUCL.VENTR.ICUIDGR.(DDMMYY) 
No entry = 216, val.id = 490 
1-10. DATE CARDIAC CATBETERISATION ( DDMMYY) 
No entry = 403, val.i.d = 303 
1-l.L DATE OP DEATH ( DDMHYY) 
No entry -= 531, vab.d = 175 
l-12. DATE OP POST-DISCHARGE 
RECURRENT NON-FA~ MI (DDMHYY) 
No entry = 670, Val.:id = 36 
2-1. DATE ADMITTED CCU ( DDMMYY) 
No entry = 0, vaJ.id = 706 
2-2. REFERRING INSTITtrl'ION 
1= not referred 
2= referred from other hospital. 
No entry = 1, val.id = 705 
Oistributi.on: 519 186 
2-3. OLD MYOCARDIAL INFARCTION (O=N, 1-=Y) 
No entry = 2, Val~d = 704 
DiStribution: 478 226 
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2-4. HISTORY AP >4 WEEKS ( O=N, l=Y) 
No entry = 21 Valid = 704 
Distribution: 431 273 
2-5. BEGIN OF MI SYMPTOMS 
2-6. 
1= at rest 
2= exercise 
3~ normal activity 
4= other 
&=unknown 
No entry = 1, Valid= 
Distri.but:i.on: 580 31 
PREVIOUS 0\BG SURGERY 
No entry= 2, Valid= 
Distribution: 671 33 
705 
63 21 
(O=N, 
704 
2-7. PREVIOUS CHF (O=N, l=Y) 
No entry = 2 1 Valid = 704 
Distribution: 690 14 
2-S. PREVIOUS PTCA (Q::=N, l=Y) 
No entry = 2, Valid = 704 
Distribution: 702 2 
lO 
l~Y) 
2-9. PREVIOUS OTHER HEARl' OPF:RATION ( O=N I 1-=Y) 
No entry = 2, ~:id = 704 
Distribution: 702 2 
2-10 . DATE OF M'!OCARDIAL INFARCTION ( ODMMYY) 
No entry = o, Val.:id = 706 
2-ll.. LOCATION OF MI 
2-12. 
2-1.3. 
l= transmural anterior 
2= transmural in£jpost 
~ unknown ( LBBB) 
4= non-transmural 
.s.= undefinable 
No entry = o, ~id = 706 
Distr~ution: 268 266 a 159 5 
PEAK HBDS: 
No entry= 95, Val.:i.d = 611. 
Range= 74 TO 2500, Mean± SD = 542 
PEAK CPK 
No entry= 48, val.id = 658 
Range = 14 TO 3500, Mean± so = 610 
2-14. MIRU CLASS, H:EM:JDYNAMIC 
No entry = 313, Valid = 393 
Distr:i.bution: 143 131 67 52 
2-1.5. KILLIP CLASS 
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No entry = 1, Valid = 705 
Distril::lut:ion: 401 169 60 75 
± 389 
± 539 
2-16. HR ( BPM), A'£ ceo ADMISSION 
No entry = 259, Vali.d = 447 
Range = 40 •ro 160 I Mean ± so = 85 ± 2~ 
2-~7. WEDGE PRESSURE {tm:nHg) 1 AT CCU ADM. 
No entry = 311, Valid = 395 
Range = 1 TO 351 Mean± so = 13 ± 6 
2-lB. CARDIAC INDEX (L/mi.n/1112), AT CCU ADM. 
No entry = 333, valid = 373 
Range = 0.8 TO 5.9, Mean± so = 2.6 ± 0.8 
2-1.9. MIXED VENOUS 02 ('%), AT CCU .ADM. 
No entry = 3621 val.i.d = 344 
Range = 40 TO 84, Mean ± so = 68 ± 8 
2-20. SYSTEMIC ARl'ERIAL P (mmBg), CCU ADM. 
No entry = 262, Val.i.d = 444 
Range = so TO 200, Mean ± so = 120 ± 24 
2-21. HEMODYNAMIC PROGNOSTIC INDEX, CCU ADM. 
No entry = 350, vali.d = 356 
Range = 1 TO 215 I Mean ± so = 42 ± 36 
2-22. ANGINA DURING CCU STAY (O=N, ].:Y) 
No entry = o, valid = 706 
Di.stributi.on: 621 85 
2-23. VP (O=N, 1=Y:<=72h, 2=Y:a£ter 72 h) 
No entry = o, vali.d = 706 
Distribution: 660 38 8 
2-24. RECURREN'l' NON-PATAL MYOCARDIAL INPARCTION 
0= none 
1= transmural anterior 
2= transmural i.n£/post 
3= unknown ( LBBS) 
4= not transmural 
5= undefi.nable 
No entry = 1, Vali.d = 705 
D:i.stri.but:i.on: 681 10 9 o 2 3 
2-25. DATE OF RECORRENT MI(DDMMYY) 
No entry = 683, Vali.d = 23 
2-26. PEAK HBDH 
No entry = 690, Vali.d = 16 
Range = 154 ro 978, Mean ± so = 405 
2-27. PEAK CPK 
No entry = 681, valid = 25 
± 212 
Range = o TO 1461, Mean ± so = 352 ± 4.14 
2-28. STREP'l'OKINASE INTERVENTION (O=N, l=Y) 
No entry ~ o, Vali.d = 706 
DiStribution: 644 62 
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2-29. S'l'REP'l'OKINASE AND P'l'CA IN'I'ERV. ( O=N, l=Y) 
No entry ~ o, va~id = 706 
D:Lstri.bution: 681. 25 
2-30. STREl?'lQKINASE CONTROL GROuP ( O=N, l:=Y) 
No entry = o, valid = 706 
D:i.Stribution: 639 67 
2-3L IABP INTERVENTION (O=N,l=Y) 
No entry = 0, Valid = 706 
D:i.Stribution: 640 66 
Z-32. DESTINATION AFTER CCO 
1= CARDIOLOGY DEPT: 1200 
2= CARDIOLOGY DEPT: 3 zuid 
3= other hospital department 
4= thorax surgery 
5= home 
6= morta.J:ity 
7= other 
No entry ~ 2, va~id 704 
Distribution: 545 42 24 9 0 82 2 
3-1. AP DORING SPONTP.NEOUS EX ( O=N, l=Y) 
No entry = 83, Valid = 623 
Distr1bution: 575 48 
3-2. AP AT REST {O=N, l=Y) 
No entry = 83, ~id = 623 
Distribution: 534 89 
3-3. DUBIOUS AP (O=N,~=Y) 
No entry = 83, valid 623 
Distribution: 604 19 
3-4. CHF (O=N, l=Y) 
No entry~ 83, Valid= 623 
Distribution: 505 1.18 
3-5. RECURRENT NON-FATAL MYOCARDIAL INFARCTION 
0= none 
l= transmural anterior 
2= transmural in£jpost 
3= unknown ( LBBB) 
4= not t~ral 
5= unde£:inab~e 
No entry = 84, valid 622 
Distribution: 60S 4 4 0 5 1 
3-6. DATE OF RECURRENT NON-FATAL MI ( DDMMYY) 
No entry = 694, Valid = 12 
3-7. PEAK HBDH 
No entry = 698, valid = a 
Range = o TO 350, Mean ± so = 178 ± 123 
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3-8. PEAK CPK 
No entry ~ 692, val~d = 14 
Range = o TO 4:20, Mean ± so = 170 
3-9. LATE Vf! (<PN, l~Y) 
No entry = 84, Valid 622 
Distribution: 606 16 
± 191 
3-1.0. SO'S'l'AINED VT, >72 HRS APTER MI {O--N,1=Y) 
No entry = 83, valid : 623 
Distribution: 599 24 
3-1.1. SUS'r. SVT/AF >72 HRS APTER MI (O=N,l=Y) 
No ~ntry = 83, Valid = 623 
Distribution: 587 36 
3-12. CARDIOMEGALY,CTR>SO ON DISCH.(O--N,1"•.Y) 
No entry = 84, Val~d = 622 
Distribution: 4:62 160 
3-l.3. PULMONARY CONGESTION ON DISCH.(Q.=N,1=Y) 
No entry = 85, valid = 621. 
Di.stribut:ion: 569 52 
3-14. ECG ON DISCHARGE 
1-= si.nus rhythm 
2= atrial fibrillation 
3= other arrhythmia 
No entry = 2, Valid = 704 
Distribution: 690 1.4 o 
3-J.S. ECG ON DISCHARGE 
1= LSH 2= RBBB 3= LBBB 4= none of these 
No entry = 2, Val:id = 704 
Distribution: o 53 32 13 606 
3-16. ECG ON DISCHARGE 
1= AV bloCk grade 1. 
2~ 2 
3 
.... RBBB & LSB 
s~ RBBB & LIB 
6- none of these 
No entry = 3, VaJ.id 
Distribution: 10 1 
703 
.. 13 1 674 
3-1.7. Q WAVES PRESENT (Q.=N, l.=Y) 
No entry= 7, valid= 699 
Distribution: 152 547 
3-18. ST ELEVATION ( 0--N I l.=Y) 
No entry = 1.76, Valid = 530 
Distribution: 326 204 
3-19. ST DEPRESSION {O=N, l=Y) 
No entry = 1.76, Valid = 530 
Di.Stributi.on: 444 86 
lll 
3-20. P.V.C. 'S ( 0--N, 1=Y) 
No entry.., 45, valid 661 
Distribution: 624 37 
3-21.. P TERMINAL FORCE 
No entry = 79, valid = 627 
Range = o TO 80, Mean± SD 21 ± 16 
3-22. CONDUCTION DEFECTCS, LVH 
1-"LBBB 
2=RBBB 
3-=RBBB, LSB 
4=RBBB, LIB 
S=LSH 
6=LIH 
7=LVB 
S=PACE MAICER 
No entry = 572, Valid= 134 
Distribution: 28 27 14 140 6 144 
3-23. CORREC'ffiD QT 
No entry = 1.79, valid = 527 
Range = 0.298 TO 0.602, Mean± so = 0.424 ± 0.044 
3-24. BEAR!' RATE 
No entry = 179, valid = 527 
Range = 38 TO 1.67, Mean ± SD -= 73 ± 17 
3-25. SELVESTER ECG SCORE 
No entry = 1.79, Valid 527 
Ra."lge = o TO 20, Mean ± so s ± 3 
3-26. DESTINATION ON DISCHARGE 
1= home 
2= dept thoracic surgery 
3= other hospital department 
4= mortality 
5= other 
No entry = 82, valid = 624 
Dl.stributi.on: 533 51 1.3 22 5 
3-27. ANGINA 
1= no EOG changes 
2= i.sch. infarct zone 
3= i.sch. at a distance 
4= i.sch. at diStance and reci.proc 
5= no ECG recording or BBB 
6= No Angina 
No entry = 5, valid = 701 
Distribution: 24 47 42 0 1.4 574 
4----- THERAPY ON DISCHARGE ######################################### 
4-l. DATE OP .DISCHARGE (DDMMYY) 
No entry = 66, valid = 640 
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4-2. ANTI -coAGULANTS ( O=N I l.=Y) 
No entry = 1.01., valid = 605 
Distribution: 467 139 
4-3. BETA-BLOCKERS 
No entry = 101., Valid ~ 605 
Distributi.on: 29l. 314 
4-4. D.IGOXIN 
No entry = 101, valid = 605 
Di.stributl.on: 470 135 
4-5. DIURETICS 
No entry = 1.01, valid = 605 
Distribution: 375 230 
4-6 • NITRATES OR VASODILATORS 
No entry = 101, Valid = 605 
Distribution: 373 232 
4-7. CALCIUM ANTAGONISTS 
No entry = 101, valid 605 
Distribution: 447 158 
4--8. ANTI -ARRHYTBMICS 
4-9. 
4-10. 
4-11. 
4-12. 
4-1.3. 
No entry = 101, Vall.d 605 
D:istri.bution: 578 27 
!?ACE MAKER 
No entry= 101, valid 605 
Distrihution: 603 2 
REPERRED C>\BG 
No entry = 100, Valid 606 
Distribution: 550 56 
REF. OTHER liEART SURGERY 
No entry = 1, Valid = 705 
Distribution: 696 9 
REPERRED l?TCA 
No entry = 101, Valid 605 
Distribution: 589 16 
NO THERAPY 
No entry= 102, Valid 604 
Distribution: 547 57 
5-- ONE YEAR FOLlOW UP OF PATIENTS ############################### 
5-1. RECURRENT NON-PNrAL MI ( O=N, l=Y) 
No entry= 107, Valid= 599 
Distribution: 563 36 
5-2. DATE OF POST-DISCHARGE 
NON-FATAL RECURRENT MI ( ODMMYY) 
No entry = 670, valid = 36 
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5-3. LOCATION MI 
1= transmural anter~or 
2= transmural ~nt;post 
3= unknown ( LBBB) 
4= non-transmural 
s-= undefined 
No entry = 670, Val~d 36 
Di.Stribut~on: 9 13 o a 6 
S-4. PEAK CPK 
No entry = 681, val~d = 25 
Range = 79 TO 1.550, Mean ± so 539 
5-5 • PEAK BBDH 
No entry = 691 1 vaJ..j_d = J.S 
Range = 1.38 TO 1.200 I Mean ± so 
5-6 • ANGINA PECTORIS ( O=N I 1=Y) 
No entry= 1.07, valid= 599 
D~stribution: 385 21.4 
5-7. CHF ( D-N, l~Y) 
No entry = 1.07 1 valid 599 
DiStribution: 518 81. 
5-S. CABG (O=N1l.=Y) 
No entry= 107 1 Valid 599 
DiStribution: 564 35 
5-9. DNl'E OF CABG ( DDMMYY) 
No entry = 668, Valid = 38 
5-lO. PTCA (D-N, l=Y) 
No entry= 107 1 valid 599 
Distribution: 588 11 
5-ll. DATE OF PTCA ( DDMMYY) 
No entry = 695, Valid = 11 
5-12. OTBER 6EARl' SURGERY ( O=N, l.=Y) 
No entry= 107, valid= 599 
Distribution: 596 3 
5-1.3. DATE OF OTfiER H SURGERY ( DDMMYY) 
No entry = 703, Valid = 3 
5-1.4. SUSTAINED VT ( D-N, 1=Y) 
No entry= 107, Valid 599 
Dl..Stributi.on: 592 7 
5-lS. VF (D-N,l~Y) 
No entry = lOS, Valid 598 
Distribution: 596 2 
4S5 
5-16 . DATE OP LATEST POLLOW-UP ( DDMMYY) 
No entry = 5, valid = 701 
114 
± 41.7 
± 321 
5-17 . DATE OP DEATH ( DOMMYY) 
No entry = 531, Valid = 175 
5-18. CAUSE OF DEA'l'H 
1= Sudden, unexpected (<1 Hour) 
2= Myocardial infarction 
3= Non-cardiac 4= Peri-operative 
5= Congestive heart failure 6= other 
7= Unknown 
No entry = 634, Valid = 72 
Distr1bution: 37 18 2 2 11 2 0 
5-19. SOURCE OF MOR'I'ALITY INFORMA.TION 
1= General practitioner 2= Hospital 
4= other (ENTER ONE CODE ) 
No entry = 633, valid = 73 
Distribution: 31 19 2 21 
5-20. ANY COMPLICATION ( O=N, 1=Y) 
No entry = o, valid = 706 
Distribution: 300 406 
5-21. LOST TO FOLLOW-UP (O=N, l.=Y) 
No entry a 103, Valid 603 
Distribution: 597 6 
5-22. CARDIAC REHABILITATION 
0= Not performed 
1= Drop out because of death 
2= of other cardiac reason 
3= of medical non cardiac reason 
4= of non medical reason 
5= Rehabilitation completed 
No entry = 532, valid = 174 
Distribution: 2 4 5 S 13 1.42 
5-23. DATE OF ST.ART REHABILITATION 
No entry = 533, Valid = 173 
5-24. DATE END REBABILITATION 
No entry = 536, valid = 170 
5-25. BETA SI.DCKERS, AT END REHAB. (O=N,1=Y) 
No entry = 563, Valid = 143 
Distribution: 67 76 
5-26. MAX. WORKLOAD AT END REHABILITATION 
No entry = 564, valid = 142 
Range = 60 TO 260, Mean ± SD = 165 
5-27. % MAX. WORKLOAD, % 
No entry = 565, valid = 141 
Range = 30 TO 160, Mean ± so = 105 
5-28. ANGINA DURING THE TEST ( O=N, l=Y) 
No entry = 564, Valid = 142 
Distribution: 121 21 
3= AUtopsy 
± 41 
± 21 
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5-29. 
5-30. 
5-3L 
5-32. 
RESTING HR, DURING EST Ar"l'ER REHAB. 
No entry == 566, va.J.:id -= 1.40 
Range = 45 TO 1.16, Mean± SD -= 71. 
REST:WG SBP DURING EST 
No entry = 566, valid "" 140 
Range = 1.00 TO 200, Mean± so ""' 1.33 
PEAK HR DORING EST 
No entry= 567, Valid == 1.39 
Range = 53 TO 1.91, Mean± SD -= 1.41. 
PEAK SBP DURING EST 
No entry ~ 568, Valid = 1.38 
Range -= 1.25 TO 240, Mean ± so 175 
5-33. BP RISE ooraNG EST AFTER REHAB 
No entry = 568, Valid = 1.38 
Range = -20 TO 12.0, Mean ± SD = 41. 
5-34. :&EASONS FOR IN'l$RRUPTING THE EST TEST 
1.-= Fatigue 
2= Angina 
.3= Dyspnoe 
4=: other symptoms 
5= HR too high 
6= Pressure drop 
7= ST Changes 
s-= P.rrhythmi.as 
9= other reasons 
l.Q.=>Onknown 
No entry= 567, valid 1.39 
Distribution: 1.05 9 1.4 4 0 1 0 0 3 3 
± 13 
± l7 
± 23 
± 27 
± 23 
6---- BOLTER T.APE ANALYSIS ######################################### 
6-1.. DATE OF RECORDING 
No entry = 31.6, ~i.d = 390 
6-2. PVC ONF <5/MIN 
0= geen 
J.= som.s 
2= ma.tig veel 
3= veel 
4= continu 
No entry ~ 31.6, valid = 390 
Distr~ution: 281. 97 1.1. 1. 0 
6-3. PVC ONF >5/MIN 
No entry = 31.6, valid 390 
Distribution: 356 23 s 3 0 
6-4. VNT BIG 
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No entry = 316, valid = 390 
Distribution: 312 67 11 0 0 
6-5. PVC MI'P <5/MIN 
No entry = 316, Valid = 390 
D:istril:::lution: 104 202 66 15 3 
6-6. PVC MrF >5/MIN 
No entry = 316, valid = 390 
Distr~ution: 293 57 23 15 2 
6-7. PVC R OPT 
No entry= 317, Valid= 389 
Distribution: 385 4 0 o 0 
6-8. VNT DBL 
No entry = 316, Valid = 390 
Distribution: 257 123 8 1 1 
6-9. VNT RIT (>100) 3-10 
No entry = 316, valid 390 
Distribution: 335 51 4 o o 
6-10. VNT RIT (>100) >10 
No entry = 316, Valid = 390 
Distribution: 385 5 0 0 0 
6-11. SLOW VT (<100) 
No entry = 316, Valid 390 
Di.stri.bution: 354 35 0 1 0 
7-1.. TEST STATUS 
1= test performed 
2= not performed due to AP 
3~ ow 
4=" extra-cardiac med contral.ndication 
5= unknown or organizational problem 
No entry = 96, valid = 610 
Distribution: 408 59 52 73 18 
7-2. DATE OF STUDY (ODMMYY) 
No entry = 298, va.J..id = 408 
7-3. DIGITALIS USED (O=N, l=Y) 
No entry = 298, valid = 408 
Distribution: 342 66 
7-4. BETA-Bux::KER USED ( O=N, l=Y) 
No entrY = 296, valid = 408 
Distribution: 196 212 
7-S. PERCENT MAX WORK CAPACITY ( %) 
No entry = 298, Va.l.id = 408 
Range = 32 TO 129, Mean ± so = 78 ± 17 
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7-6. REP.SON FOR STOPPING TEST 
.1= fatigue 
2= AP 
3= dyspnoe 
4= other symptoms 
5= HR. to high 
6= pressure drop 
7= ST changes 
8= arrhythm:i.as 
9= other medical reason 
No entry = 298, valid = 408 
DistrLbution: 284 25 75 0 0 13 S 2 1 
7-7. SYMPTOMS DURING TEST 
~= AP 
2= dyspnoe 
3= other 
4= none 
No entry = 298, valid = 408 
Distr~ution: as 10 1 312 
7-8. Ml.\XIMDM WORK LOAD ACHIEVED 
No entry = 298, Val.i.d = 408 
Range = 40 TO 240, Mean ± so = 113 
7-9. RES'r HR. 
7-10. 
7-l.L 
7-12. 
7-13. 
No entry 298, Val.id = 408 
Range = 44 TO 142, Mean ± so 
REST SYS'l'OLIC BP (mm!!g) 
No entry = 298, valid = 408 
Range = so TO 175, Mean± SD 
Ml\XIMUM !IR 
No entry = 298, val.id = 408 
Range = 76 TO 195, Mean ± so 
RECOVERY HR. 
No entry = 374, valid = 332 
Range = 47 TO 176, Mean± so 
RECOVERY HR./REST HR. RATIO 
No entry = 374, Valid == 332 
82. 
~2l 
= J.30 
Ul ± 
± 32. 
± 16 
± 16 
± 22 
2l 
Range = 0.48 TO 1.11, Mean± SD 0.85 ± o.oa 
7-14. MAXIMUM SYSTOLIC BP 
No entry = 298, Valid = 408 
Range = 100 TO 250, Mean± SD 162 ± 28 
7-15. RECOVERY SYS'roLIC BP 
No entry = 374, Vali.d = 332 
Range = 100 TO 230, Mean± so l50 ± 24 
7-16. RECOVERY SYST BP/SYST BP RATIO 
No entry = 374, Valid = 332 
Range = o.Gs TO 1.23, Mean± so 0.93 ± 0.08 
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7-17. INSUFFICIENT INCREASE PRESSURE (O=N, l=Y) 
No entry = 298, Val~d ~ 408 
Di.Stributl.on: 345 63 
7-18. ST SEGMENT CHANGES {O=N 1 l...,Y) 
No entry -= 302 1 valid = 404 
D~stribution: 117 287 
7-19. IP ST CBANGES I X ISCHAEMIC (mm) 
No entry = 302 1 val.id = 404 
Range -= o TO 3, Mean ± so = 0.4 
7-20. IF ST CHANGES I Y ISCSl\E!fiC ( lmll) 
No entry = 302, vaJ.id = 404 
± 0.7 
Range= o TO 3, Mean± SD = 0.2 ± 0.5 
7-21. IP ST CHANGES, z ISCSl\E!fiC (mm) 
No entry = 302, vaJ..id = 404 
Range = 0 TO 2 1 Mean± so= 0.1 
7-22. IF ST CHANGES, X WALL MOTION (mm) 
No entey = 302, Valid= 404 
Range = o TO 2, Mean± so = o.o 
7-23. IP ST CHANGES, Y WALL MOTION (mm) 
No entry= 302, Valid = 404 
Range = o TO 2, Mean ± so = 0.1 
7-24. IF ST CBANGES I Z WALL MC>TION ( m:n) 
No entry = 303, Valid = 403 
Range = o TO 4, Mean± so = 0.4 
7-25 • IP ST DEPRESSION, WORK toAD 
No entry = 520, Val.id = 186 
± 0.3 
± 0.3 
± 0.4 
± 0.7 
Range = 25 TO 200, Mean ± so = 91. ± 31 
7-26. IP ST DEPRESSION, % MAX WORK CAPACITY 
No entry = 521, Valid = 185 
Range = 15 TO 114, Mean ± so = 64 
7-27. IF ST DEPRESSION, HR. 
No entry = 521, Valid = 185 
Range = 76 'l'O 198, Mean ± so 
7-28. LBBB (O=N, l=Y) 
No entry = 298, valid 408 
D:istributi.on: 404 4 
7-29. ARRHYTHMIAS DURING TEST (VT> 3 BEATS) 
0= no 
1= yes 
No entry = 298, valid 408 
Di.Stri.but:ion: 402 6 
± 18 
± 21. 
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7-30# ARRHY'I'EMtAS DURING TEST (VF) 
o- no 
~=yes 
No entry = 298, valid 408 
Dl.strWution: 407 l. 
7-31. # ARlUlY'l'BMI.AS DURING TEST· (COUPLETS) 
0= no 
J.= yes 
No entry = 298, val.:id = 408 
Distribution: 378 30 
7-32. ARRHY'I'EMtAS DURING 'l'EST ( PVCs) 
o- no 
l.= yes 
No entry = 298, Valid = 408 
Distr~ution: 314 94 
7-33. NUMBER OP ARRHY'I'BMIAS DURING TEST (PVCS/MIN) 
No entry = 298, valid = 408 
Range = o TO 44, Mean± SD = 1#8 ± 5.1 
7-34. ARRHYTHMIAS DURING TEST (VF or \I'T or COUPLETS) 
0= no 
l.= yes 
No entry = 298, valid = 408 
D~tr1bution: 376 32 
8-1. DATE OF STUDY ( DDMMYY) 
No entry = 216, valid 490 
S-2. EJECTION FRACTION 
No entcy = 220, val.:i.d = 486 
Range= 0.04 TO o.s, Mean± so 
8-3. REGIONAL WALL MOTION 
l= all regions nonnal 
2= worst segment bypok~etic 
3= akinetic 
4= dyskinetic 
5= ambiguous recording 
No entry = 218, valid = 488 
D~tribution: 61 lOS 1.98 118 3 
8-4. REGIONAL EP, SEG l 
No entry = 288, valid = 418 
0.45 ± 0.16 
Range= o TO 0.18, Mean± so .... 0.06 ± 0.03 
8-5. 
8-6# 
120 
2 
No entry = 288, valid = 418 
Range = o TO 0.14, Mean± so 
3 
No entry = 288, valid = 418 
Range = 0 TO 0.21., Mean± SO 
0.05 ± 0.03 
0.07 ± 0#04 
8-7. .. 
No entry= 288, val.i.d "" 418 
Range= o TO 0.18, Mean± so= 0.06 ± 0.036 
8-8. 5 
No entry = 288, Val.i.d .,._ 418 
Range = o TO o.s, Mean± SD= 0.06 ± 0.04 
8-9. 6 
No entry = 288, Val.i.d = 418 
Range = o TO o. 7, Mean ± so = 0.06 ± 0.04 
8-10. LOCAL EP, SEG 1 
8-l.L 
8-12. 
B-14. 
B-15. 
No entry = 289, Yal.i.d = 417 
Range = o TO o. 76, Mean± so = 0.29 ± 0.12 
2 
No entry = 289, Val.i.d = 417 
Range = o TO 0.66, Mean± so= 0.29 ± 0.14 
3 
No entry = 290, Val.id = 41.6 
Range= 0.04 TO 0.99, Mean± so 
4 
No entry = 290, Val.id = 416 
0.42 ± 0.20 
Range = 0.03 TO 1, Mean± SD = 0.50 ± 0.23 
5 
No entry = 289, Val.id = 417 
Range = o TO 1, Mean ± so = 0.49 ± 0.18 
6 
No entry = 289, va1i.d = 417 
Range= o TO 0.87, Mean± so= 0.37 ± 0.1.3 
9-- CARDIAC CA'l"BETERRSATION #"####*MUH########################## 
9-1. DATE OF STUDY ( DDMMYY) 
No entry = 403, Val.id = 303 
9-2. REASON FOR CATBETERIZATION 
1= eJ.ecti.ve 
2= study protocol. 
3= unknown 
No entry = 405, Va.J..i.d = 301 
Distribution: 0 155 145 1 
9-3. EJECTION FRACTION 
No entry = 466, vaJ..id = 240 
Range= 0.12 TO 0.76, Mean± SD = 0.46 ± 0.1.4_ 
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9-4. REGIONAL WALL MOTION 
1= all xegi.ons normal. 
2= worst segment hypOk~etic 
3= aki.neti.c 
4= dyskinetic 
5= ambiguous recording 
No entry = 433, Valid = 273 
D~tr~ution: 22 109 63 77 2 
9-5. NUMBER OP VESSELS DISEASED 
0= no vessel disease 
1= one vessel disease 
2= two 
3.... three 
4= main stem. 
5= main stem & right 
6= ambiguous recording 
No entry = 405, valid = 301 
Di.str~ution: 8 96 103 87 0 7 o 
9-6. T..EAMl\N CORONARY SCORE 
No entry = 410, Valid 296 
Range= o TO 47, Mean± so= u.. ±e. 
9-7. Mr1'RAL INSUFFICIENCY >=GR 2 (Q.=N, l=Y) 
No entry = 409, Valid = 297 
DUtri:buti.on: 281 16 
9-8. LV END DIAST PRESSURE 
No entry = 420, valid 286 
Range ""' 2 TO 45, Mean ± SD = 20. ± 8 
9-9. LV END DIAST VOLUME 
No entry = 435, valid = 271 
Range = 1 TO 255, Mean ± so = 90 
9-10. LV END SYST VOLUME 
No entry = 454, valid = 252 
Range = 6 TO 212, Mean ± so = 49 
± 29 
± 28 
lD-- SPECIAL DATA PILES (CREATED PROM EXISTING PILES) :############# 
lD-1. AGE OP PATIENTS ON ADMISSION (YEARS) 
No entry = o, valid = 706 
Range = 22 TO 83.4, Mean ± SD = 58 ± l.l 
l.Q-2. LENGTB OF STAY IN CCU (DAYS) 
No entry = O, ~id = 706 
Range = 0 TO 78, Mean ± SD = 13 ± 9 
1D-3. EX. STR. TEST DONE (J.:OONE, 2-=NOT DONE) 
No entry = 96, valid = 610 
O:i.Stribution: 408 202 
lo-4. BOLTER TAPE DONE (l.•DONE, 2=NOT OONE) 
No entry = o, valid = 706 
Oistrl})ution: 390 316 
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l.Q-5. AP OUR. CCU STAY OR OUR. SPON. EX OR AT REST 
( O=NO, l.=YES) 
No entry = o, valid = 706 
Distribution: 539 167 
l.o-6. lATE VP OR VT IN PCU (O=N, l=Y) 
No entry = 83, Valid = 623 
D:istril>ution: 590 33 
J.Q-7. ECG: RBBB OR RBBB & LSB OR RBBB & LIB (O=N, 1=Y) 
No entry = 2, Valid = 704 
Distribution: 656 4.8 
J.o-8. MAX PRESSURE RATE PRODUCT DORING EST ( MMBG"*"HR) 
No entry = 298, valid = 408 
Range = 7600 TO 30430, Mean ± so = 15952 
l.Q-9. CHANGE IN BP DURING EST ( MMHG) 
No entry = 298, valid = 408 
± 3695 
Range = -20 TO 1.25, Mean ± SD = 40 ± 24 
l.Q-10. EST S'1' CHANGES, MAX X'lZ ISCBAEMIC (>1M) 
No entry = 302, Va.J.i.d = 404 
Range = o TO 3, Mean ± so = o.e: ± 0.7 
J.D-J.J.. EST Sl' CHANGES, MAX X'lZ WALL MOTION (MM) 
No entry = 302, Val.id = 404 
Range = o ro 4, Mean ± so = 0.5 ± 0.7 
1Q-12. EP RADIONUCLIDE OR ANGIO 
No entry = J.62, Valid = 544 
Range = 0.04 TO 0.8, Mean± SD = 0.45 ± 0.16 
lG-13. ARRHYTHMIAS DURING EST ( l=SOME, 2"""'NE) 
No entry = 298, valid = 408 
Distribution: 94 314 
lD-14. ARRHYTHMIAS DURING HOL.( l=SOME, 2=NONE) 
No entry = 316, valid = 390 
Distribution: J.SS 235 
l.D-1.5. DURATION OF FOLLOW-UP AFTER MI (DAYS) 
No entry = 5, val.id = 701 
Range = o ro 608, Mean ± so = 283. ± 150. 
l.D-1.6. DURATION OF POLWW-UP AFTER DISCB. 
No entry= 67, Valid= 639 
Range = -12 TO 597, Mean ± so -= 294. 
lQ-17. REF. G.BG DORING S:OSP. STAY 
1.-== PURE CABG 
± 1.29. 
2= OTBER HEART SURGERY WITB OR WITHOUT CABG 
3 =NO HEARl' SURGERY 
No entry = o, Valid = 706 
D:istribution: 51. 9 646 
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~Q-1.8. DEATH IN HOSPITAL ( O=N, 1""'Y) 
No entry ~ o, Val~d = 706 
Distribution: 602 104 
l.Q-19. VERDOOW HEMODYN. INDEX M ADM. 
No entry = 362, valid = 344 
Range= -9.415 TO 9.385, Mean± SD ~ 2.899 ± 3.209 
l.Q-20. t<iOLFENBUTTEL HEM. INDEX AT ADM. 
No entry = 333, Valid = 373 
Range= 1.977401.12994 TO 487.5, Mean± so= so. 
l.Q-21. REGIONAL LV WALL MOTION GBP OR ANGlO 
1= al.l. regions normal 
2= worst segment hypokinetic 
3= akinetic 
4= dyskinetic 
5= ambiguous recording 
No entry = 153, val.id = 553 
Distribution: 69 us 218 137 4 
l.Q-22. ST-depr.and DIGITALIS, PRE DISCH. ECG 
(O=No ST-depr,l=ST- ~th DIG,2=ST- without DIG) 
No entry = 216, val.id = 490 
Distribution: 426 27 37 
l.Q-23. RECURRENT NON-PA'l'AL MI PROM CCU & PCU 
0= none 
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1= transmural anterior 
2= transmural. inf/post 
3- unknown ( LBBB) 
4= not transmural. 
5• undefi.nabl.e 
No entry = 1., Valid 705 
DistrLbution: 668 1.3 13 0 7 4 
±53 
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Prediction of mortality in hospital survivors of 
myocardial infarction 
Comparison of predischarge exercise testing and 
radionuclide ventriculography at rest 
PFIORETTI,R W BROWER,M LSIMOONS, S K DAS;* R J BOS. W WIJNS,J H C REIBER, 
JLUBSEN,PGHUGENHOLTZ . 
From tk Tlwraxccnur, tk DcpcrrtmJ:111 of Nuclear Mdiciru:. Erasmus University and Univmity Hospital Dijk.:-igr, 
Roturdam; the Inu:runlvmity Cardiolo~' Instituu:, lJ.m.;tcrdam, The Netiu:rlands; and the •Diz.ision ofCDrdialogy, 
UrrF~ of Michigan, USA 
SUM • .'•iARY The relative merits of resting ejection fraction measured by radlonuclide angiography and 
predischarge exercise stress testing were compared for predicting prognosis in hospital survivors of 
myocardial infarction. Two hundred and fourteen survivors of myocardial infarction out of 338 
consecutive patienrs with acute myocardial infarction were studied over a 14 month period. Hospital 
monality was 130/o (45 of338) whereas 19 additional patients out of214 dled in the subsequent year 
(9"/o). High, intermediate, and low risk groups could be identified by left ventricular ejection 
fraction measurement. Mortality was 33% for nine patients with an ejection fraction <20%, 19"/o for 
58 patients with an ejection fraction between 20'% and 39"/o, and 3% for 147 patients with an ejection 
fraction >40"/o. Mortality was high (23%) in 47 patients who were unable to perform the stress test 
because of heart failure (19) or other limitations (28). The patienrs could be stratified further into 
intermediate and low risk groups according to the increase in systolic blood pressure during exer-
cise: six deaths occurred in 46 patients with a blood pressure increase of <30 mm Hg and two deaths 
occurred in 121 patients with an increase ;.:3() mm Hg. Ma:cimum workload, angina, ST changes, 
and ventricular arrhythmias were less predictive than blood pressure changes. 
It is concluded that the prognostic value of radlonuclide angiography at rest and of symptom 
limited exercise testing is similar. The latter investigation should be the method of choice since it 
provides more specific information for patient m:magement. 
European Heart Journal ( 1984) 5 (Supplement£). 97-IOO 
Ineligibility for predischarge exercise testing after 
myocardial infarction in the elderly: Implications for 
prognosis 
J. W. DECKERS. P. FtORITn. R. W. BRoWER. M. L SlMOONS. T. BAARDMAN AXD P. G. HuGE-.1-lOLTZ 
Thoraxcentcr, Erasmus Univcrsir_v "and University Hospital Dijk=igt. Rottcrdum, and the lntcrunirersiry 
Cardio!og_vlnstitufc, The Ncrhcrlands 
KEY WORDS: Myocardlal infarction. exercise test. prognosis. old age. 
This study describes the clinical profile and prognosis of ddcrZt·paticnls nor eligible for predischarge cxcrcL,·c 
resting. The dawbasc consisted of 133 parients 5H4 years of a~c. and 111 patients older than 64 years of 
age who suni1·cd an acurc myocardial infarction. Follow-up was one year. In the younger age group. 24 
( 18%) patients 1,.crc unab!t· ro perform the rest. in contrast to 63 (57%) ofthcddcrly subjects. In thes~· rwo 
groups. one-year mortality rates were /3% and 37%, compared v.·ith 6% and4%for the respcctiw: patients 
digibk for stres_,- testing. Clinical profile and radionuc!idc ejarion fraction bct»-ccn inr:ligiblc patients in 
both age groups 11-cre similar. Ejection fraction measurement was the bcsr predictor of lot f.' mortality in those 
patients 1r!w did nor hare an exercise test. Iris conc!uded thor inc/igibl1ityfor pred1:<chargc exercise rest 
id,·nrifies a high-r1:<k group. especia!Zr in patients older than 64 years of age. 
BrHamJ 1965;53;248-52 
Limitations of a QRS scoring system to assess left 
ventricular function and prognosis at hospital discharge 
after myocardial infarction 
P FIORETTI," R W BROWER,t E LAZZERONI,+ M L SIMOONS.• W WIJNS,'"' 
] H C REIBER,..- R] BOS."' P G HUGENHOLTZ* 
From the "*Thcraxcrnu:rin coopcrrnion -u,.jlh lhc Dcpanmcnt o[Nv.clcar Medicine, Era= Univcrsi1y and Univcrriry 
Hcspilal Dijk.:-igt. and the tinlcT1mivcrriry Cardiclcc· Insliwrc, Rotta'dam, The Netherlands: and W :j:Division of 
Cardiolqr;:, Ospcdalc Rcgicnalc, Parma, haly 
su.\l...~l.A.RY The value of a QRS scoring system derived from 12 lead electrocardiograms to estimate 
le:ft ventricular ejection fraction v.:as assessed i.n a prospective study of 285 hospital SUIVivors of 
myocardial inf:rrction. In these patients-both the QRS score and ejection fraction were measured by 
radionuclide ventriculography at discharge. The correlation between ejection fraction and QRS 
score \vas weak. In 22 patients who died during six to 12 months follow up the ability of the ejection 
fraction and QRS score tO pred.ic~ monalitv was assessed-in terms of sensitivity, specificity, predic· 
rive \'alue of a positive and negative test, and efficiency. For ejection fraction <400/o and a QRS score 
~6 seositiYity was respectively 73% and 64%, specificity 73% and 56%, predictive value of a positive 
test 18% and 11%, predictive value of a negative test 97% and 95%, and efficiency 73% and-56%. 
Both ejection fraction and QRS score may be used to identify patients at low and high risk during 
one year follow up, but, contrary to initial eA.-pectations, the QRS score appears to be of little value in 
estimating ejection fraction and is less accurate than ejection fraction in predicting late survival in 
hospital sun'ivors of myocardial infarction. 
European Heart Journal (1984) S (Supp/cm('ll/ E). 101-104 
Predischarge stress test after myocardial infarction in 
the old age: Results and prognostic value 
P. FlORETI1. J. W. DECKERS. R. W. BROWER, M. L. SJMOO:-lS. J. A. J. M. 8E.ELE:" A~D 
P. G. HUGI':l'HOLTZ 
Thora:.:cenra. Erasmus University and University Hospi:al Dijk:1:r:.r. Rotterdam and rhc !mcrunil'crsity. 
Cardiology Institute. The Ndhalands 
KEY WORDS: Stress test. myocardial infarction, old age. 
The aim o( this srudr 1ras ro C\'aluate the rcsufts of prcdisdwrgc srress resting in rhc elderly, and to assess the 
prognosti~ ,·aluc· ojthc test during one-year fol!ow·up. Th_c databaS<' con.1·ist~d of 48 p~tients older ~han ~4 
years of age and !09 patients 55---64 _wars of age. n·ho sun•n·cd a CUI<' myocardw! mfarenon: our of~3- con.,c-
curivc paricnts admitted for myocardial infarction. Stress-rest rcs~fts were not ~if(crent 111 the t110 groups. 
Durin!:, one-year follow-up morta!iry was 6% in the younger pat1ents and 4% m the_oldc•r group. and the 
incidC'~Ct.' of non-fatal reinfarctions was 8% in both groups. Morra:iry y.·as b<·~f pred1ctcd by tlu: e:.:r~·~r of 
blood pressure rL'<: (43±26mmMg in survivors vs 19±15 mmHg m non-.wrm:ors. P<O·OOJ ): Strc;:'-I''Sl 
rcsulrs were no more predictive when non-fatal rcinfarction 1ras added to morta!uy as an end-pomt. U e con-
clude that (or patients in .,.-hom the stress test is nor contraindicated, (I) age docs. not affect str~·ss test 
f<'.mfrs, (2) the cxn·nt of blood pressure rise during a stress rest is the best single pn'drctor of mortality. ( 3) 
stress tests art• nor prcdicth·c of rcinfarctions. 

